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Comparative evaluation of muscle proteolysis by compartmental model of 3-methylhistidine 
John A. Rathmacher 
In charge of major work: Steven Nissen 
From the Department of Animal Science 
Iowa State University 
Measurement of urinary 3-methylhlstidine (3MH) excretion is the primary in vivo method 
to measure muscle protein breakdown. This method requires quantitative collection of urine and 
is based on the assumption that no metabolism of 3MH occurs once released from actin and 
myosin. This is true in most in most species but in sheep and pigs a proportion is retained in 
muscle as a dipeptide balenine. In none of these species does urine 3MH yield any data on the 
metabolism of 3MH. The included studies propose that 3MH metabolism in sheep, cattle, pigs, 
dogs and humans can be defined from a single bolus dose of 3-[methyl-^H3]-methylhistidine 
tracer. A minimum of three exponentials was required to describe the plasma decay curve 
adequately. The kinetic linear-time variant models of 3MH in the whole animal were 
constructed by using the SAAM/CONSAM computer modeling program. Three different 
configurations of a three compartment model are described: (1) a simple 3-compartment model, 
in which plasma kinetics are described by compartment 1, out of which ail species had a 
undefinable exit; (2) a plasma-urinary 3-compartment model with two exits, a urinary exit out of 
compartment 1 and a second exit out of compartment 3 was used in sheep; and (3) a plasma 3-
compartment model with an exit out of the tissue compartment 3 was used in pigs. The models 
define steady state masses and fluxes of 3MH between three compartments in the body and, 
importantly entry into the system or de novo production of 3MH. The de novo production of 
3MH for humans, cattle, dogs, sheep and pigs were 3.1, 3.4, 12.1, 11.6 and 7.0 )umol-kg'^-d'\ 
respectively. The de novo 3MH production corresponded to fractional breakdown rates of 
muscle protein of 1.72 %/d for cattle, 3.99 %/d for dogs, 5.40 %/d for sheep and 2.80 %/d for 
pigs. From the complete model of 3MH metabolism a similar practical isotopic model (minimal) 
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was constructed. This was accomplished by lumping the three compartments together into one 
metabolic pool of 3MH. This minimal 1-compartment model utilized plasma samples obtained 
from 720 to 4320 min after isotope injection. The de novo production of 3MH as calculated by 
the model was not different from that calculated via the traditional collection of urinary 3MI-I 
(humans, 3.09 vs. 2.57//mol-kg'^-d'\ respectively, P>0.30; cattle, 3.41 vs. 3.20/;mol-kg'^-d'\ 
respectively, P>0.25). However, 3MH production estimated by the model compared to urinary 
production was different in dogs (92.7 vs 71.6 //mol/d, respectively, P < 0.10). Additionally, 
although numbers are limited, the data suggest that the model compartments may be an 
indicator of body muscle mass (r = 0.95, P<0.01) in humans and (r = 0.59 , P = 0.006) in pigs. 
These data indicate the compartmental model, allows the assessment of muscle proteolysis and 
3MH kinetics without collection of urine. 
ii 
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GENERAL INTRODUCTION 
Overview of Amino Acid and Protein Metabolism 
Progress in amino acid metabolism is iargeiy dependent on development of analytical 
methodology to answer metabolic questions. One of the first important developments was 
analytical methods to measure amino acid composition which allowed for static measurements 
related to amino acid composition and in turn quantitation of nutritional requirements. Next was 
the development of dynamic methods to measure the uptake and output of amino acids across 
organs allowing insight into how amino acids interrelate within the body. The most recent 
dynamic technique of measuring amino acid metabolism is the use of amino acid tracers. These 
techniques have generally allowed processes such as synthesis and proteolysis to be quantitated 
in vivo. As new methodologies are developed the basic understanding of metabolic mechanisms 
involved In the maintenance or turnover of protein pools is advanced. 
Interest in protein metabolism stems from the fact that proteins are involved in every 
aspect of mammalian metabolism. Proteins are diversified and are classified according to their 
function (eg. as structure, catalytic (enzymes) and transport proteins). The functional longevity 
of each protein varies; half-lives can range from minutes to days. The study of amino acid 
metabolism is also a diversified field, reflecting the fact that there are 20 amino acids l<nown to 
play a role in protein metabolism. Amino acids are the building blocks of proteins, as well as 
precursors for nucleotides, hormones and neurotransmitters. Amino acids are classified in 
general as essential or nonessential and further classified by their structure; hydroxy, basic, 
acidic, sulphur-containing, aromatic and imino. This diversity in amino acid structure leads to 
differences in catabolism, degradation, transport and tissue metabolism. 
Because amino acids are charged molecules in physiological situations, they will not 
freely cross the lipid membrane into the cell. Therefore they require proteins to mediate both 
active transport and facilitated diffusion across the membrane (Figure 1). The transport process 
is usually associated with a sodium ion pump. Sodium dependent systems include; B, ASC, 
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IMINO, p, X'AQ and A. Sodium independent systems included; b"'^ and L(43). Each of 
these systems transports specific amino acids but there is overlapping specificity. 
Once transported into the cell there are different pools of free amino acids in addition to 
different pools of proteins. Concentrations of free amino acids are low as compared to total 
amino acids In the body (2 to 3 percent) (85). The majority of free amino acids are composed 
of four amino acids: alanine, glutamic acid, glutamine and glycine. More than half of the free 
amino acids are found in skeletal muscle and the concentration of most amino acids are higher 
in the cell than in plasma, but the relative amounts of free amino acids has little relationship to 
composition of tissue proteins. 
There are three possible fates of free amino acids (Figure 1): 1) utilization for protein 
synthesis, 2) oxidation and gluconeogenesis and 3) formations of other metabolites (58). For 
most amino acids, synthesis and oxidation are the only pathways of significance. The 
controlling mechanisms of amino acid metabolism depend on the relationship between 
concentration and the K^, of the rate-limiting enzymes (42). The K„-values for amino-acid-
activating enzymes are lower than those for amino-acid-degrading enzymes. This ensures that 
amino acids are preferentially used for protein synthesis. Since there is no mechanism for 
storing amino acids, amino acids not needed for protein synthesis are degraded. Therefore, 
amino acids added above the requirement are simply oxidized. 
Aminoacyi-tRNA's are the direct precursors for protein synthesis and the aminoacyl-
tRNA pool turns over every .3 to 2 seconds which is technically difficult to estimate. It is 
important to know the specific activity of the precursor pool for protein synthesis calculations 
and from which pool of amino acids tRNA are charged. Some experimental observations 
indicate that tRNA are charged from an intracellular pool while other observations indicate a 
direct use from extracellular space without previous mixing with intracellular amino acids (37). 
Protein synthesis is a multi-catalytic process involving the whole cell. The process 
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Figure 1. Schematic outline of the pathway of uptake, utilization and reutilization of amino acids 
for protein synthesis and degradation. Amino acids (AA) outside are carried across the 
cell by either sodium dependent or independent transporters. These AA can either enter 
a free AA pool or be directly charged to tRNA. The amino acyl-tRNA are translated into 
protein. Protein turnover at different rates and are degraded by various systems within 
the cell. The AA released by protein breakdown can be carried across the cell membrane 
or reenter the free AA pool. The AA in the free pool can also be degraded. The 
degradation products can be used by the cell or transported out of the cell and used by 
other cell types. 
requires all three types of RNA, amino acids and activating enzymes as well as energy from ATP 
and GTP. There are two main stages of protein synthesis called transcription and translation. 
Transcription involves the synthesis of mRNA. Translation involves the reactions of ribosomal 
protein synthesis and consists of three phases; initiation, elongation and termination. The 
4 
primary structure of the protein is determined by the translation process, however, various post-
translational modifications may be needed to make the protein fully functional. The rate of 
protein synthesis can be regulated in two ways: 1) the amount of mRNA, and 2) the rate of 
translation to form the protein. 
Once a protein is synthesized, the protein is subject to protein breakdown. Protein 
turnover Is selective and specific proteins degrade within the cell at widely different rates. 
There are two general mechanisms involved in degradation, lysosomal and non-lysosomal 
systems. Goll et al. (25) describes three types of proteolytic systems involved in intracellular 
protein turnover. The lysosomal system is characterized by the following: 1) located in 
lysosomes at pH 3-5 and includes the catheptic peptidases, 2) involved in degradation of 
endocytosed proteins, and 3) involved in bulk degradation of some endogenous proteins, it is 
unclear how such degradation would produce different half lives for different proteins. A 
second systems is the error eliminating system and includes peptidases located in the cell 
cytoplasm. This system is specific for proteins containing errors of translation and requires 
ATP. The third system is the black-box system and this system also has peptidases in the 
cytoplasm. This system contains serine, cysteine and metalloproteases and this system may 
require ATP. The catabolism of amino acids involves the loss of the a-nitrogen early in the 
pathway. This is accomplished either by transamination or oxidative deamination. 
Transamination involves the interconversion of a pair of amino acids and a pair of ketoacids. 
The two important transaminases are alanine and glutamate, that catalyze transfer of amino 
groups from most amino acids to form alanine (from pyruvate) or glutamate (from a-
ketoglutarate. Most amino acids participate in transamination reactions except lysine, threonine, 
proline and hydroxyproiine. The oxidative deamination of an amino acid is accomplished by first 
dehydrogenating the amino acid and then spontaneously adding water decomposing to the 
corresponding a-ketoacid with a loss of ammonia. This reaction only occurs in the kidney and 
liver using amino acid oxidase. 
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Figure 2. Simple model for whole-body protein metabolism. 
Amino acids within the free amino acid and body protein pools are constantly being 
reutilized. The daily turnover of body proteins exceeds protein intake. Therefore, a portion of 
the amino acids resulting from intracellular protein degradation will be used again for synthesis 
and not be lost from the body. It is this process that often makes estimation of protein kinetics 
difficult. 
Methodologies to Measure Protein Metabolism 
The first whole-body models used for measurement of protein metabolism were based 
on stochastic analysis (Figure 2). This analysis ignores all of the various pools and components 
but focuses on the over all process, in spite of knowing that amino acid and protein systems 
exhibit multi-pool kinetics. The basic model is described in Figure 2. In this model a tracer is 
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given into a single homogeneous amino acid pool, which can be either oxidized (E) or 
incorporated into protein (S). The protein of the whole body is regarded as a single pool which 
eventually recycles (B) amino acids back to the metabolic pool, but because of its large size it 
assumes no label returns during the time course of the experiment. When the amino acid pool is 
constant, the turnover rate (flux or Q) is expressed as follows: Q = S + E = B + I. Two different 
approaches have been taken to describe the protein synthesis and breakdown in the whole 
body, precursor or end-product methods. 
The precursor method involves the constant infusion of a carboxyl-labeled leucine to a 
constant value, while simultaneously measuring expired carbon dioxide. There are a number of 
assumptions that are required for this model (23). It is assumed that the free amino acid pool is 
homogeneous and that the sample of blood taken is representative of leucine at sites of 
oxidation and protein synthesis. However, it has been shown that there is compartmentation of 
the label. In particular, intracellular leucine enrichment is lower than that of plasma. A second 
technical concern associated with this model is the quantitation of carbon dioxide production; 
the recovery of the labeled carbon dioxide is almost always less than 100% making correction 
for CO2 fixation necessary. This requires separate measurements of total COj and its 
enrichment. Often fixation is assumed to be .8, but within a particular experimental design this 
constant may vary widely causing increased variation in the oxidation rate. 
Improvements in the basic whole body kinetic model have been made since the original 
model underestimates protein breakdown. Nissen and Haymond proposed a two-pool model to 
describe the reversible transamination of leucine and a-ketoisocaproate (KIC) (63). The 
parameters of the model as well as B, S and E can be calculated from the four tracer 
measurements without having to sample expired air or knowing bicarbonate retention. This 
model improved upon the previous model, but still ignored intracellular and extracellular 
compartmentation. This model provided a basis for the "reciprocal model'; protein breakdown is 
measured using the transamination metabolite opposite to that which is infused (63). Therefore, 
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when leucine Is the tracer, KIC enrichment Is used to calculate protein breakdown and vise 
versa. The new development here is that B can be calculated using either tracer. Finally, 
Cobelli designed a 10 compartment model, which involves simultaneously infusing dual tracers 
of leucine and KIC and measuring the resulting four enrichment curves in plasma and one in 
expired air (15). This model accounted for the complexity of the leucine system, but the 
authors failed to adopt a multi-tissue scheme for slow and fast kinetic events (liver as compared 
to muscle). These data demonstrated there was no single intracellular pool for leucine and KIC. 
However, this model is mathematically difficult and is not solved easily. This model has not 
been used in a experimental design where protein metabolism is altered. The value of this 
model may be to test the structural errors of simpler but commonly used models. 
The other approach utilizes ^^N-labeled amino acid (glycine) and this approach 
recognizes the fact will not stay attached to one amino acid. Thus is regarded as a label 
for the entire free amino N pool. The labeling of urea and ammonia are representative of free 
amino N pool. The method involves infusion of labeled glycine and quantitation of in the 
urine. The same assumptions apply, but a problem with this model is that the two end products 
will give different answers. For example the rate derived from urea is higher than ammonia, 
and the difference is increased by feeding and intravenous compared to oral administration of 
tracer. These differences can be attributed to urea synthesis in the liver and ammonia synthesis 
in the kidney. 
Arterio-venous differences have been used to define net balances of amino acids. The 
balance across a tissue is the result of the same processes that apply in the whole body: amino 
acid deposition = input - amino acid catabolism = protein synthesis - proteolysis. All parts of 
this equation can be estimated knowing concentration, label enrichment and blood supply. 
However, this methodological approach does not give a true rate of protein synthesis or 
proteolysis but an approximate estimate. It is an estimate because internal recycling is not 
accounted for in the calculations. Both leucine and phenylalanine have been used and 
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phenylalanine is unique because it is not metabolized in muscle. There are practical limitations 
to this method, because quantitation of blood flow is difficult and concentration differences 
across a tissue are small. 
Quantitating Muscle Protein Metabolism 
In most young adult mammals skeletal muscle constitutes about 45% of body weight, 
whereas with ruminants it only comprises 30 to 35% of body weight (89). Schoenheimer and 
Rittenberg (73) established 50 years ago that the accumulation of muscle tissue depends on 
both the rate of muscle protein synthesis and the rate of muscle degradation, Despite this 
premise, most of the attention of scientists during the last 50 years has focused on the 
relationship between the rate of growth and the rate of muscle protein synthesis. Less 
attention has been given to the mechanisms controlling muscle protein degradation as compared 
to protein synthesis. This is primarily because methods for quantitating muscle protein 
degradation directly in vivo are limited. Methods that have been used for studying protein 
metabolism in vivo include the use forelimb and hind limb balances of amino acids in 
combination with tracer amino acids, where the net balance is the difference between the rate 
of tissue disposal of arterial AA and rate of tissue release of AA into the vein (21). However, 
most studies have involved indirect measurement of proteolysis; protein synthesis can be 
directly measured while proteolysis is estimated by difference. 
Protein synthesis is usually measured by the constant infusion of a radio-labeled amino 
acid, (leucine is commonly used), to a steady state plateau, at which time the experimental 
animal is sacrificed. Tissue samples are rapidly taken and frozen immediately. The specific 
activities of the tissue protein fractions are used in equations that are reviewed by Garlick et al. 
(22) and by Everett and Zak (19). The constant infusion method has been used successfully in 
cattle (46), pigs (74), and sheep (12). 
A second isotopic method used to evaluate protein synthesis is the large flooding dose 
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of phenylalanine (22), in which a bolus of radio-labeled phenylalanine is given along with a large 
(10X the plasma pool size ) non-physiological dose of natural phenylalanine. The fall in free 
amino acid specific activity is relatively small and linear over a 10 min period after the injection. 
Tissue samples are collected and assayed as with the constant infusion method and the 
equations are described in (22). The fractional breakdown rate of muscle protein can be 
estimated if the fractional accretion rate of muscle protein is known (fractional breakdown rate 
= fractional synthesis rate - fractional accretion rate, FBR= FSR - FAR). This approach to the 
study of protein degradation is somewhat unsatisfactory. The main problem with this method 
arises from the time scale of measurements. Synthesis is measured over a period of minutes or 
hours, while growth is integrated over the day and measured over a period of days or months, 
thus estimation of protein synthesis will vary over the course of the day and before and after a 
meal. These changes in protein synthesis could in turn grossly over or underestimate the 
degradation rate. 
The major problem with using isotope methods to measure muscle protein degradation in 
vivo directly, is that amino acids released from protein breakdown can be reutilized for protein 
synthesis (see Figure 1). An ideal amino acid for an in vivo marker of muscle protein 
breakdown must have the following characteristics (92): 1) amino acid is modified chemically 
after peptide bond synthesis, 2) chemically modified group does not undergo exchange once it 
appears in the protein-bound amino acid, 3) concentration is known or constant in muscle 
protein, 4) amino acid is not formed to important extent in other tissues, 5) released at the 
same time as other amino acids are released from the complete protein, 6) not reutilized, 7) 
does not undergo further metabolism in the body, 8) has a low renal threshold, and 9) 
quantitatively excreted in the urine. 3-Methylhistidine (N'-methylhistidine)(3i\/IH) has been 
proposed by Vernon R. Young and associates (89,91) to fulfill these characteristics and was 
also proposed previously by Asatoor and Armstrong (3) and Reporter (71). 
There have been many models proposed to measure in vivo amino acid/protein kinetics; 
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associated with each model are both theoretical and practical problems that must be addressed. 
Non-compartmental models are widely used and are limited by the necessary assumption that 
A A production appears in the sampling compartment into which the tracer is administered. (16) 
This assumption will underestimate the rate of appearance of an AA under study. In contrast, 
compartmental modeling requires certain physiological assumptions, about various components 
(compartments) of a metabolic system. A compartmental model is constructed based on known 
physiology of a metabolic system under study and relationship between exponential functions of 
the decay curve and the metabolic system (45). Therefore the next logical step to enhance our 
understanding of protein metabolism is to proceed from non-compartment models to multi-pool 
compartmental models. However, as the complexity of the model increases as the mathematics 
become more complicated and unique solutions also become more difficult. There are three 
primary assumptions with compartmental models. Firstly, the volume of the compartment 
remains constant. Secondly, the compartment is well stirred, so that any substrate entering a 
compartment is instantaneously distributed throughout the compartment. Finally, it is assumed 
that the rate constants are indeed constant. 
3-Methylhistidine, a result of myofibrillar protein catabolism, is used as a marker of 
protein turnover and we believe that the metabolism of this unique amino acid can be described 
by a compartmental model. 
Goals of the Presented Studies 
The goal of the proposed studies is to develop and validate a model of 3-methylhistidine 
(3MH) metabolism which will describe skeletal muscle proteolysis in domestic animals and 
humans. The overall hypothesis of this dissertation is that isotopic decay of a stable isotope 
tracer of 3MH can be described by a linear compartmental model. This model can than be used 
to accurately and easily estimate myofibrillar proteolysis in skeletal muscle in anabolic and 
catabolic situations. Specifically, these goals were to; 
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1. Develop a gas chromatograph - mass spectrometry method for quantitating 
natural 3MH and an isotopic enrichment in biological fluids. 
2. Develop a compartmental model of 3MH metabolism based on the isotopic decay 
of a stable Isotope of 3MH and use this model to determine the de novo 
production rate of 3MH in sheep and swine where urinary 3MH is not a valid 
index of muscle proteolysis. 
3. Develop a compartmental model of 3MH metabolism based on a isotopic decay 
of a stable isotope of 3MH in species where urinary 3MH is a valid index of 
muscle proteolysis and determine if the de novo production rate of 3MIH as 
estimated by the model is similar to urinary 3MH production in human subjects 
and cattle. 
4. Validate a compartmental model of 3MH metabolism as a suitable model for 
evaluating muscle proteolysis in dogs following surgery. 
5. Use this plasma kinetic model of 3MH metabolism as a practical diagnostic tool 
to determine 3MH release from muscle protein using a minimal model. 
6. Determine the relationship between body muscle mass and 3MH pool sizes. 
Before any of these studies could be started, a gas chromatograph - mass spectrometry 
method had to be developed to measure 3MH and isotopic enrichment of a tracer in plasma, 
urine and muscle. 3-Methyihistidine is a polar amino acid and derivatizes differently than other 
non-polar amino acids. Therefore, different procedures and an internal standard were used in 
developing an analytical method. 
The entire research effort was started because of goal two. There was no methodology 
available to measure muscle proteolysis directly in sheep and swine, whereas, urinary 3I\/IH had 
been used in humans, cattle, rats and rabbits as an index of muscle proteolysis. Methodology 
was needed in sheep and pigs to measure muscle proteolysis directly. In an effort to validate 
the model developed during goal two, experiments were started in cattle and humans. We 
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speculated that if the model estimate of 3MH production were equal to the traditional 
quantitative urine collection of 3MH then our model was valid. In addition, comparison between 
these species may answer some questions or raise others about differences in 3MH metabolism. 
Using this methodological approach, compartmental models of 3MH were developed and 
used following surgery in dogs fed different levels of dietary energy and protein. The model 
was then validated in a catabolic condition where muscle was sacrificed to supply amino acids 
and energy for wound healing and maintenance of tissues. In addition, these data will allow for 
a comparison of urinary 3MH production and 3MH production as estimated by the 
compartmental model. In this study a minimal model was developed from the complete 3-
compartment model of 3MH metabolism. This will allow for a practical estimation of muscle 
proteolysis requiring fewer blood samples and simplifying the model in a production situation 
instead of a basic research environment. 
As a result of these studies, an observation was made that muscle mass was correlated 
with the pool sizes of 3MH as estimated by the model. The majority of 3MH is found in skeletal 
muscle and within muscle there are intracellular compartments of 3MH. It would seem logical 
that the mass of these pools would be related to lean body mass. 
Explanation of Dissertation Format 
This dissertation has been prepared as independent papers for publication in refereed 
journals. The literature review describes the metabolism of 3-methylhistidine in humans and 
domestic animals and describes the validation procedures performed to confirm 3MH as an 
index of muscle proteolysis. In addition, factors which modulate muscle protein turnover are 
described. These modulators of muscle proteolysis are an area where the methodology 
described in this dissertation will be of use. Five individual scientific papers were prepared 
which relate the development of a compartmental model of 3MH metabolism used to estimate 
muscle proteolysis. Two of these papers have been published and three are under consideration 
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for publication. Following the papers is a general discussion followed by the list of references 
for the general introduction and discussion. There are five appendixes included at the end of the 
dissertation. Appendix A will assist the reader in modeling kinetic data of 3MH and Appendixes 
B through E are applications of the model of 3MH metabolism where muscle proteolysis maybe 
altered. 
LITERATURE REVIEW 
Overvlsw of S-Methylhlstidine Metabolism 
Historical background 
Tallen, Stein and Moore (79) were first to identify 3MI-I as a component in urine in 1954, 
but they were not sure what the source of this material was. The metabolism of 3MH was first 
investigated by Cowgill and Freeburg (17) after injecting a radio-tracer of 3MH into the 
bloodstream of rabbits, rats, chicks and frogs. The radioactivity was rapidly excreted in urine, 
recoveries ranging between 50 and 90% of injected dose were observed. In 1967, 3MH was 
identified as a component of actin (3) and of myosin and actin (27,39). 3-Methylhistidine is 
present in the globular head of the myosin heavy chain (MHO (38) and localized in the same 
area as the ATPase activity and actin binding sites. However, there is no evidence that 3MH is 
involved in any of these functions. There is one mole of 3MH per mole of MHC in the myosin of 
fast-twitch, white fibers, but 3MH is absent in the myosin of the muscle of the fetus, cardiac 
muscle, and of slow-twitch, red muscle fibers. Speculation as to why red, cardiac and fetal 
muscle myosin are devoid of 3MH could be due to: 1) lack of enzyme system for synthesis of 
3MH, or 2) differences in sequence or folding of the protein. (38). Actin also contains this 
unique amino acid and it is located at the 73rd residue of the polypeptide chain. Unlike myosin, 
3MH is found in all actin isoforms, including embryonic, smooth and cytoplasmic isoforms (13). 
The mechanism by which a methyl group is donated to 3MH is a post-translational 
event. It has been shown that S-adenosylmethionine was an effective methyl donor to histidine 
of the nascent polypeptide chains contained in actin and myosin (27,71). Furthermore, when 
histidine was used as the source of labeled amino acid, the specific activity of histidine and 
3MH were the same in muscle cultures (71). 
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Validation of 3-methylhittidine as a index of muscle protein breakdown 
Before 3MH could be used as an index of myofibrillar protein breakdown tliree 
assumptions had to be validated as outlined by Young and Munro (92): 1) it does not cliarge 
tRNA and is, therefore, not reutilized for protein synthesis, 2) it is quantitatively excreted In 
the urine in an identifiable form, and 3) the major portion of total body 3MH is present in 
si^eletal nfjuscle. 
To experimentally show 3MH was not reutilized for muscle protein synthesis, 3MI-I was 
demonstrated not to charge tRNA. This was accomplished using radio-labeled 3MH, 
demonstrating in vitro and in vivo that 3MH did not charge tRNA of the rat (90). IHowever, 
there was a high degree of incorporation of label achieved for histidine and leucine. As a marker 
of muscle protein breakdown, 3MH must be excreted quantitatively in the urine, that is, once 
3MH is released from actin and myosin of skeletal muscle it is not metabolized to any significant 
extent and is excreted in the urine. The usual experimental protocol used to confirm 
quantitative recovery, was to administer radio-labeled C^C) 3MH intravenously and measure the 
accumulative recovery in the urine. [^*C-methyl]-N'-methylhistidlne was quantitatively recovered 
in the urine of rats after being given either in an oral or in an intravenous dose (90). Ninety-
three percent of the tracer was recovered in the urine after the first 24 h and 98 to 100% was 
recovered after 48 h. Only trace amounts were recovered in the feces and no was 
recovered in the respired air. Similar recoveries were confirmed in humans (48) by recovering 
75% during the first 24 h and 95% in 48 h. In addition, quantitative recoveries were confirmed 
with rabbits (33), cattle (30,52), and chickens (17,40). However, the tracer was not 
quantitatively recovered in urine of sheep (29), pigs (31), and chickens (34). IVIore detail will 
be given about the domestic species in the following sections. 
In rats the radioactivity is distributed in two compounds, 3Mi-l and N-acetyl-SIVIH. The N-
acetyl form is the major form excreted in the rat (90). The liver is presumably the site of 
acetylation in the rat. The analysis of 3MI-I from rat urine requires a hydrolysis step. Whereas 
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3MH is major form excreted in humans and other species, but the N-acetyl form has been 
detected in human urine (4.5%) (48). 
The other major criterion is that urinary 3MH should be mainly a product of muscle 
protein turnover and not of other tissues. It is this assumption that has caused the most 
controversy in accepting the use 3MH as a index of myofibrillar protein catabolism. Haverberg 
et al. (36) showed that the mixed proteins in all of the organs sampled contained detectable 
levels of bound 3MH. However, when each organ as a whole was analyzed, skeletal muscle 
contained the majority (98%) of the total amount, but this study did not include an assessment 
of the amount of 3MH in skin and intestine. Nishizawa et al. (61) concluded that the skin and 
intestine contributed 10% of the total body production of 3MH. Comparative turnover studies 
of 3MH-containing proteins in intestine, skin and skeletal muscle of the rat suggest that the skin 
and the intestine contributed 17% of the 3MH excreted per day in the urine (60). These 
calculated values are based on the fitting of exponential regression lines to the specific activity 
of 3MH from the various tissues after giving [methyl-^Hlmethionine. The accuracy of this 
estimate is uncertain because the labeling technique used may be confounded by the 
reutilization of labeled methionine (92). IVIillward et al. (56) has also concluded that skeletal 
muscle, skin, and gastrointestinal tract contribute only 25, 7 and 10%, respectively, of the 3MH 
excreted in the adult rat, with the remainder being excreted by some unknown organ. The 
interpretation of these results have been highly criticized by C.I. Harris (28) and V.R. Young (59) 
citing inconsistences in the data, problems with Millward's interpretations, evidence for similar 
rates of turnover of actomyosin and mixed muscle protein. When realistic rates of protein 
turnover are used with Millward's data (56), muscle tissue remains the major contributor of 
3MH in urine. Millward and Bates (55) followed up their early paper with a similar experimental 
design to determine the tissue origin of 3IVIH by using decay labeling of 3MH. The overall 
synthesis rate of 3MH was 29.1 %/d, 77%/d for the intestine, and 1.1-1.6%/d for muscle. 
Although the muscle pool accounted for 86% of the bound 3MH, because of its slower turnover 
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rate it only accounts for 38 - 52 % of the observed excretion and the Intestine accounted for 
22% of the total. In a perfusion study (84) it was demonstrated that the hemicorpus and 
gastrointestinal tract of the rat released 3-methylhistidine at rates that indicated 59% and 41 % 
of the urinary excretion of 3MH originates form skeletal muscle and the intestine, respectively. 
In contrast to the published results demonstrating skeletal muscle as not the major origin 
of urinary 3MH, an observation has been published demonstrating the opposite. Based on 
duodenoileostomized rats with only 8% to 10% of small gut intact, the authors concluded that 
the small intestinet contribution to a 24-hour urinary excretion of SMH was insignificant (10). A 
similar study with short-bowel humans indicated that skeletal muscle was the major source of 
urinary 3MH (47). A patient suffering from an unknown disease who had no skeletal muscle 
was compared with normal subjects for 3MH production (2). The absence of skeletal muscle 
made it possible to determine the basal non-skeletal muscle-dependent excretion of 3MI-I. 
These data show skeletal muscle to account for 75% of urinary 3MH excretion. A recent paper 
in humans with varying degrees of infection (76) indicated that urinary 3IVIi-l was correlated with 
the release of 3MH from the leg. The splanchnic region contributed only 8% to urine 3MI-I. 
Furthermore, it was later shown with additional patients (77), that a significant linear 
relationship existed between the effluxes of tyrosine and phenylalanine and the efflux and 
urinary excretion of 3MH. Therefore, in humans it appears that urinary 3MI-I excretion is 
associated with net skeletal muscle protein breakdown. 
3-Methylhistidine metabolism in humans and animals is summarized in Figure 3. 3-
Methylhistidine is quantitatively excreted in the urine in these species, indicating a relationship 
between the production from actin and myosin and the excretion in the urine. One histidine 
residue in actin and one histidine residue in fast-twitch myosin are methylated in a post-
translational event using S-adenosylmethionine as the methyl donor. After degradation of these 
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Figure 3. Depiction of the origin of 3-methylhistidine in myofibrillar proteins and its fate following 
its release during the breakdown of actin myosin in humans, cattle, dogs and rats. 
muscle-specific proteins, 3MH is not reutilized to any significant and is rapidly excreted in the 
urine. 
3-Methylhistidine Metabolism in Cattle 
Cattle, like humans and rats, quantitatively excrete 3-methylhistidine in urine. Harris and 
Milne (30) demonstrated that between 82 to 99% of a [^^C}3MH dose were recovered after 6 
days in 21 to 98 month old non-lactating cows, steers, and a bull. Similarly, McCarthy et al. 
(52) recovered 90% of the injected tracer dose after 120 h in two heifers. 3-Methylhistidine is 
excreted in the urine unchanged (30), and occurs in muscle extracts both in the free form (4 to 
10 nmol/g muscle) and as a perchloric acid-soluble, acid-labile form which account for 85% of 
the total non-protein-bound 3MH. This compound was later identified as balenine (32), a 
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dipeptide composed of equal molar amount of p-alanine and 3-methylhistidine. Balenine was 
later identified In muscle extracts of sheep (29) and pigs (31). There appears to be a age-
related decline In the concentration of balenine in muscle, but this did not produce a measurable 
change in the recovery of radioactivity in urine. 3-Methylhistidine is present in whole blood of 
cattle ranging from a concentration of 2 to 6 nmol/ml blood. 
The distribution of 3-methylhistldine among organs has been determined for cattle 
(Holstein) (61). Skeletal muscle comprised 93.4% of the total 3MH in the analyzed cattle 
tissues. The concentration of 3MH was 3.5106 //mol of 3MH/g muscle protein or .587 //mol/g 
wet muscle in growing steers. This value is commonly used to calculate the protein-bound pool 
of muscle 3MI-I, when determining the fractional breakdown rate of skeletal muscle. Other 
values for the level protein-bound 3MH in the muscle of cattle have been reported, 5.6 /imol/g 
protein (67) and I.Spmol/g protein (3). This variability is of some concern, because in most 
studies, the amount of protein-bound 3MH is not determined. 
3-Methylhlstldine Metabolism In Sheep 
Sheep are unlike cattle, in that urinary 3MH is not a reliable index of muscle protein 
breakdown (29). After an intravenous dose of [^*C]-labeled 3MI-I, only 25 to 50% of the label 
was recovered after 7 days. The recovery progressively increased with the age (4 weeks to 7 
years) of the animal, becoming almost quantitative in the older animals after 3 weeks. The 
incomplete recovery was not due to excretion in the feces or elimination as expired gas, but 
was related to the presence of a muscle pool of non-protein-bound 3MH which was several 
times larger than the expected daily urinary excretion. The concentration of free 3MH in 
muscle ranged from 17 to 120 nmol/g of muscle. This pool in newly synthesized muscle tissue 
was maintained by retention of some of the 3MH released by breakdown of muscle protein. 
Only a small proportion of the 3MH released from protein breakdown was available for 
excretion, and the proportion excreted in the urine increased with age of the animal. Another 
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Figure 4. Schematic diagram of the origin of 3-methylhistidine (3MH) in myofibrillar proteins and 
its fate in sheep and pigs. Following SiVIH release the majority of it is conjugated with 
P-alanine to form balenine. 
non-protein-bound component of 3MH in muscle is the dipeptide, balenine (32), which 
comprises on the average approximately 82% of the total non-protein-bound 3MH in muscle. 
This percentage does not seem to change as the animal ages, and the same proportion was 
seen in cattle muscle (30). This dipeptide appeared to be synthesized in muscle from free 3MH 
and was not a terminal product of protein breakdown. The enzyme system responsible for the 
synthesis of the analogous peptides carnosine and anserine shows a broad specificity for 
histidine and histidine derivatives (41). The occurrence of balenine in sheep muscle should be 
considered a norm rather than a rarity. Sheep also have a much higher concentration of 3i\/IH in 
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blood than cattle, with values ranging from 17 to 50 nmol/ml of whole blood. The acid-labile 
form is present in blood in a higher proportion than was observed in cattle, averaging 30% in 
sheep of the total non-protein-bound 3MH. The concentration of protein-bound 3MH in sheep 
was similar to cattle, with an average concentration from the longissimus dorsi and leg being 
5.8 ;<mol/g protein (67). Buttery et al.(1977) reported a value of .6 /imol/g muscle. 
3-Methylhistidine Metabolism in Pigs 
The pig is another species in which the recovery of radio-labeled 3MH is less than 
quantitative (31). From five animals less than 21 % of the tracer dose was recovered after 7 d, 
after which the recovery was less than 0.3% per day. The incomplete recoveries of 
radio-labeled 3MH were associated with the presence of a large pool of non-protein-bound 3MH 
in muscle, the concentration of which increased with age. The 3MH in the muscle pool was 
present as free 3MH, with values ranging from 4 to 8 nmol/g muscle, and as a dipeptide which 
constituted more than 90% of the total non-protein-bound 3MH. The contribution of the 
dipeptide, balenine (32), increased with age, reaching 99.8% in older animals, which was 2 
/imol of the total non-protein-bound 3MH/ g of muscle tissue at approximately 9 months of age. 
The concentration in blood was not as elevated in as sheep, but was comparable to cattle, with 
values in pigs ranging from 6 to 19 nmol/ml of blood. 
In summary, urinary excretion of 3-methylhistidine can not be used as an index of 
myofibrillar protein breakdown in sheep and pigs, because 3MH is not quantitatively excreted in 
urine (Fig. 3). Sheep have elevated levels of 3MH in plasma and muscle, and a dipeptide of 
3MH is also present at high concentration. In pigs, the pool of non-protein-bound 3MH was 
maintained and increased in both established and newly synthesized tissue by retention of some 
of the 3MH released by muscle protein breakdown, only a proportion of which was available for 
excretion. 
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3-Methylhistidine Excretion to Determine Muscle Mass 
The meaningful explanation of protein kinetic measurement is dependent on the body 
composition. Body composition is usually distributed into two large fractions, fat and fat free 
mass (FFM). Fat free mass is still further divided into other groups, with skeletal muscle being 
the largest (50%) and most variable. Techniques to measure body composition are numerous 
and include: total body water, total body potassium, urinary creatinine excretion, underwater 
weighing, neutron activation analysis and bioelectrical Impedance (88). Urinary 3MH has also 
been used to estimate the FFM in humans (49,54) and more specifically muscle mass (50). 
FFM was correlated more closely with urinary 3MH excretion (r= .89) than urinary creatinine 
excretion (r = .67) (49). FFM could be calculated by the following equation: FFM = 
0.24(urinary 3MH excretion) + 8.65 ± 4.10. The authors were able to estimate muscle and 
non-muscle components of FFM by using total-body neutron-activation analysis (50). 3MIH 
excretion was more closely related to muscle mass (r = 0.91) than FFM (r = 0.81) and 3MH 
excretion was not related to the non-muscle components of FFM. Muscle mass is calculated as 
follows: Muscle mass = -3.45 + .118(3MH excretion) ± 2.07. 
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PAPER I. MEASUREMENT OF 3-METHYLHISTIDINE PRODUCTION IN LAMBS BY USING 
COMPARTMENTAL-KINETIC ANALYSIS 
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ABSTRACT 
The kinetics of 3-methyihistidine (3MH) metabolism in four crossbred lambs were studied. Each 
lamb was injected with an intravenous dose of S-methyl-Imethyl-^l-lal-histidine (c/s-SMi-l), and the 
stable isotope disappearance in plasma and appearance in both urinary excreta and muscle were 
measured. Immediately after the administration of tracer, there was a phase of rapid 
disappearance of tracer from the plasma, which was followed by a more gradual decrease in d^-
3MH from the plasma during the last 4 d of the experiment. A minimum of three exponentials 
was required to describe the plasma decay curve adequately. The kinetic model of 3MH in the 
whole animal was constructed by using the SAAM/CONSAM computer modeling program. Two 
different configurations of a three-compartment model are described: 1) a simple three-pool 
model, in which plasma kinetics were entered into pool 1 out of which they had one undefinable 
exit; and 2) a plasma-urinary three-pool model with two exits, in which the urinary kinetics 
were entered as an exit out of pool 1 and required a second exit out of pool 3 to produce an 
adequate fit. In addition, muscle kinetics from biopsies of the longissimus dorsi were entered 
either into pool 2 and 3, using the plasma-urinary model. Steady state mass and transport rate 
values were obtained for each model construct described, and a de novo production rate 
corresponding to a fractional breakdown rate of myofibrillar protein of approximately 5 %/d was 
also calculated. The model predicted that only 15 % of 3MH was excreted in urine as free 
3MH, which is consistent with current knowledge of 3MH excretion in sheep. The simple three-
pool plasma kinetic model could therefore be used to estimate by a relatively simple 
injection/sampling technique the extent of muscle protein turnover in lambs. 
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INTRODUCTION 
The primary sequence of actin and of the fast-twitch, white myosin in skeletal muscle 
contains the unique amino acid 3-methylhistidine (N'-methyihistidine)(3MH)(Johnson et at. 
1967). During degradation of these muscle proteins, free 3MH is released, but because 3MH 
does not have a specific ffiNA, it is not reutilized for protein synthesis (Young et at. 1972). 
Instead of being used for protein synthesis, 3-methylhistidine is quantitatively excreted in the 
urine of man, rat, cattle, and rabbit (Young et a/. 1973; Young et a/. 1972; Harris and Milne, 
1981; Harris et at. 1977) and is therefore thought to be a marker of skeletal muscle protein 
breakdown. This method depends on quantitative urine collection and accurate measurement of 
urinary 3MH and on the assumption that no metabolism of 3MH occurs in vivo. In most species 
no metabolism occurs, but in sheep (Harris and Milne, 1980), a proportion of 3MH is thought to 
be retained in muscle as a dipeptide (balenine) of 3MH and p-alanine (Harris and Milne, 1987). 
In sheep, therefore, urine 3MH cannot be used to estimate muscle protein breakdown, because 
3MH production from muscle is not equal to urinary 3MH production. 
To date, no attempts at integrating tracer and tracee data into a comprehensive whole 
animal kinetic model of 3-methylhistidine metabolism in sheep or any other species have been 
reported. The initial studies showing the inadequacy of 3MH as an index of muscle protein 
breakdown in sheep required the intravenous administration of a dose of labeled 3MH, but the 
decay curve of [^*C13MH in plasma was not characterized (Harris and Milne, 1980). The 
development of the SAAM/CONSAM computer modeling program (Berman and Weiss, 1978) 
has made possible the detailed analysis of tracer observations at multiple sites in the body and 
has facilitated the interpretation of findings in the context of a physiologically identifiable kinetic 
model. 
The objective of the present study was to characterize the kinetic behavior of 
intravenously administered c/j-SMH in growing lambs and to develop a kinetic model of 3MH 
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metabolism based on the analysis of tracer response of plasma, urine excreta, and muscle. This 
kinetic model will also offer an alternative method for quantitating the de novo 3MH production 
rate in vivo, which could be used to estimate the fractional breakdown rate of muscle. The 
design strategy emphasized detailed observations over time, and serves as a reference for 
comparison with results obtained in other investigations in which the turnover of muscle protein 
may be altered. 
MATERIALS AND METHODS 
Materials 
3-Methyl-[methyl-'H3]-histidine ((/3-3MH) was purchased from MSD Isotopes, Merck 
Chemical Division, (99.5% isotopic purity, St. Louis, MO). 3-Methylhistidine, 1-methylhistidine, 
Jack bean Type IX urease (61,000 units/g), and Dowex-50W in the hydrogen form were 
obtained from Sigma Chemical Co. (St. Louis, MO). Acetonitriie and MTBSTFA (N-methyl-N-(f-
butyldimethylsilyl) trifluoroacetamide) were purchased from Regis Chemical Co. (Morton Grove, 
IL). Ammonium hydroxide, perchloric acid, hydrochloric acid, and filter columns were procured 
from Fisher Scientific (Fair Lawn, NJ). Plastic microinjection sample vials were obtained from 
Sun Brokers, Inc. (Wilmington, NC). 
[l.ll-^^Oj-l-Methylhistidine was prepared by exchanging the carboxyl oxygens in '^0 
water at low pH. To 50 mg of dry crystalline IMIH, 1 ml of Hj^^O was added (96% '^0) 
(Cambridge Isotopes, Woburn, MA). HCI gas was bubbled through the mixture for 1-2 min. 
The sample was capped and incubated at 100°C for 30 min, after which it was neutralized with 
3 N NaOH. The resulting neutral amino acid solution was diluted to 100 ml, with the final 
product being 86% [1,1]-^^02-1-Methylhistidine as assessed by GC-MS. 
The cation exchange columns were prepared by adding 3 ml of Dowex-50W cation 
exchange resin (50:50 v/v) in the hydrogen form to filtering columns and washing with 4 x 1 -ml 
aliquots of 0.01 N HCL. 
Animals and Experimental Protocol 
Four crossbred (Dorset x Sulfolk) lambs (three wethers and one ewe) weighing 25 ± 0.5 
kg were obtained from a herd at iowa State University. They were approximately 3-4 months 
of age. The lambs were fed twice daily a pelleted (Table 1) and had free access to nipple 
waters. Nine days before the initiation of the experiment, the lambs were transferred to 
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Table 1. Composition of the diet (percentage of total mix, as-fed) 
Ingredient Percentage As-fed 
Com, grain cracked 45.07 
Oats, grade 2 ground 20.01 
Soybean meal (expeller) 20.01 
Dehydrated alfalfa 10.01 
Molasses (sugarcane) 3.00 
Limstone 0.75 
Dicalcium Phosphate 0.25 
Salt 0.25 
Vitamin premix 0.50 
Pell-aid 0.15 
Requirement Supplied 
Daily intake (kg)* 1.58 1.58 
Metabolizable Energy (Meal)* 4.00 4.03 
Crude Protein (kg)* 0.22 0.27 
Calcium (g)* 7.2 8.5 
Phosphorous (g)* 3.4 6.1 
'Calculated from National Research Council values (1985). 
stainless steel metabolism cages designed for the collection of urine. On the morning of study a 
catheter was placed into each jugular vein to facilitate tracer injection and withdrawal of blood 
for each lamb. Approximately 2 h later a bolus dose of c/j-SMH, approximately 52 /t/moles in 10 
ml of sterile saline, was injected into one catheter and was flushed with saline. Blood (10 ml) 
was collected from the other jugular vein and transferred to EDTA coated tubes at 2, 7, 10, 15, 
45, 90, 150, 210, 270, 720, 1440, 2880, 4320, 5760 and 7200 min postinjection. Blood was 
placed directly in an ice bath until it could be centrifuged and plasma collected and stored at -
70° C. After the injection of tracer, muscle was taken by needle biopsy (60 to 70 mg) at 12, 
60, 300, 1440 and 4320 min from the longissimus dorsi after the area two from midline was 
treated with local anesthesia. The muscle sample was immediately placed on ice and stored at -
70oC. During the first 5 d of the tracer experiment, consecutive 24 h total urine outputs were 
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collected. Aliquots of each urine collection were kept frozen at -20° C. Additional baseline 
blood, muscle, and urine samples were collected before injection to subtract background 
enrichment from the experimental samples. 
Internal Standards 
Because of its structural similarity to 3MH and its undetectability in the plasma of sheep, 
1-Methylhistidine was used as an internal standard ( 50//I of 3540 //M stock solution) in the 
analysis of 3MH concentration in plasma. But [l.ll-^'Oj-l-iVlethylhistidine (40//I of 
a 2955 //M stock solution) was used as the internal standard for the quantitation of 3MH in 
urine because a significant quantity of 1MH accumulates in urine. 
Analysis of Plasma 3-Methylhistidine 
One ml of plasma and 50//I of 1MH internal standard (3.5 mM) were added to a plastic 
sample tube (12 ml). Three ml of 1.5 N PCA was added, and the tube was vortexed and 
centrifuged at 2300 x ^ for 15 min at 5°C. The supernatant was poured onto a prepared cation 
exchange column. After draining through the column, the supernatant was rinsed with 4 1 -ml 
aliquots of 0.01 N HCI, and the rinses were discarded. Then, 3-methylhistidine and internal 
standard (1MH) were eluted from the column with 4 1-ml washes of 25% NH4OH into a 20-ml 
scintillation vial. The eluant was heated to 65°C in a block and dried under a stream of nitrogen 
gas. When the eluant seemed dry, any remaining water was azeotroped off by the sequential 
addition of two 100-/yl aliquots of methylene chloride and the drying off of samples between 
each addition. To derivatize the dried sample and to prepare it for GC-MS analysis, 100 //I of 
acetonitrile and 100 pi MTBSTFA (N-methyl-N-(f-butyldimethylsilyl) trifluoroacetamide) were 
added and allowed to incubate overnight at room temperature. 
The derivatized sample was transferred into an injection vial and capped. Gas 
chromatography-mass spectroscopy was accomplished by means of a Hewlett-Packard gas 
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chromatograph/mass selective detector (Model 5890/5970B). The column used was a 25 m x 
0.22 mm i.d. x 0.11 //m film thickness, cross-linked methyl silicone gum phase capillary column 
(HP-1, Hewlett Packard, Avondale, PA). The injector was set at 285°C, the transfer line at 
285''C and the initial oven temperature at SOX. After splitless injection, the oven was 
programmed to hold for 0.5 min and ramped (ramp 1) to 240''C at 50°C/min which was held for 
4.1 min, followed by a ramp (ramp 2) to 300°C at SOT/min, which was held for 1 min. The 
retention times were between 6.5 and 7.5 min for 3MH and 7.0 and 8.0 min for 1MH, 
depending on column age and exact length. The major ion fragments for 3MH and (/3-3MH were 
monitored by means of selective Ion monitoring. 3-Methylhistidine was monitored at 238 amu 
and its stable isotope, (/a-SMH, at 241 amu, whereas 1MH was detected at 340 amu. 3-
methylhistidine in plasma was quantified from a linear peak height standard curve. When dg-
3MH was used as a tracer, as will be described, it was quantified in plasma in the same manner, 
that is, by subtracting the natural background enrichment, (/3-3MH/3MH, from detected (/3-3MH. 
Standards were prepared by pipetting known quantities of 3MH from a 50-/iM stock 
solution into plastic sample tubes (12 ml) along with 50 /jI of 1 MH internal standard. One ml of 
double deionized water was added to each standard tube. Because the neutralizing capacity of 
standards was small compared to that of plasma, the standards were acidified with only 0.25 
ml of 1.5 N perchloric acid and treated the same as was the plasma sample. 
Analysis of Urine 3-Methylhistidine 
Unlike plasma, urine contains substantial amounts of 1-methylhistidine, making 1MH an 
impractical internal standard. Therefore, di-labeled ^^Oj-IMH was used as the internal standard 
with which to quantitate 3MH in urine. Standards were prepared as outlined except that 40 fj\ 
of ^^Oj-IMH was used as the internal standard. A urine sample was prepared by transferring 1 
ml to a microfuge tube and removing particulate matter by spinning for 3 min. From this tube, 
100//I of urine was pipetted into a plastic sample tube (12 ml) with 40/il of internal standard. 
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In addition, 1 ml of double deionized HgO was added to the tube, and the contents were 
acidified with 5 //I of 3 N HCI. The urine sample was vortexed, poured over a cation exchange 
column (prepared as outlined) and allowed to drain. The column was rinsed with four 1-ml 
washes of 0.01 N HCI and eluted with four 1-ml washes of 25% ammonium hydroxide, which 
were collected in a scintillation vial and dried with a stream of nitrogen gas on a heating biocl( at 
65X. Once dry, the urea in the sample was hydrolyzed with 1 ml of urease solution (3.5 
mg/100 ml) by incubating the sample on a heating block for 2 h at 37''C. The sample was again 
dried on the heating block, derivatized with lOO/vl acetonitrile and 100//I MTBSTFA and 
incubated overnight at room temperature. The derivatized sample was transferred into an 
injection vial and injected in a Hewlett-Packard gas chromatograph by using the same 
conditions and ramps as described earlier. The retention time for 3MH was the same in urine as 
in plasma and exhibited the same mass spectra. [1,1]^°02-1-Methylhistidine had a retention 
time similar to that of natural 1MH, but major ions from the mass spectra were 4 amu heavier. 
3MH and (/g-SMH were quantified by peak height as explained for plasma analysis except that 
^"Oj-IMH replaced 1MH in the calculations. 
Analysis of Free 3-Methylhistidine in Muscle 
Approximately 70 mg of muscle was transferred into a plastic sample tube (12 ml) with 
40 lA of internal standard. In addition, 1.5 ml of double deionized HjO was added to the tube, 
and the contents were homogenized by using a Polytron tissue homogenizer with a 1.5 cm 
stator generator. The homogenation was performed at 15,000 rpm for 15 sec. The blades of 
the homogenizer were washed with 0.5 ml of double deionized HjO and added to the sample 
tube. One ml of 1.5 N PCA was added, and the tube was vortexed and centrifuged at 2300 x g 
for 15 min at 5°C. The supernatant was poured onto a prepared cation exchange column. The 
protein pellet was resuspended twice in 0.5 N PCA and recentrifuged at 2300 x ^ for 15 min at 
S'C. Both times, supernatant was poured over a cation exchange column and allowed to drain. 
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The column was rinsed with four 1-ml washes of 0.01 N IHCI and eluted with four 1-ml washes 
of 25% ammonium hydroxide, which were collected in a scintillation vial and then dried with a 
stream of nitrogen gas on a heating block at 65X. The dried sample was derivatized and 
injected into a Hewlett-Packard GC-MS as described previously. 
Kinetic Modeling 
Modeling of 3-methylhistidine kinetics was done with the SAAM/CONSAM computer 
program (Boston etal. 1981). Exponential equations were initially fitted to the plasma 
concentration of (/3-3MH time curves to characterize the complexity of the response and to 
allow for comparisons with other studies. The first step in constructing a compartmental model 
was to determine the minimum number of compartments and interconnections suitable for the 
data. Thus, only the plasma kinetic data were used, which were expressed as fraction of 
dose/ml. These data were used in addition to prior knowledge of 3MH metabolism in sheep 
(Harris and Milne, 1980). Secondly, this basic model was expanded to include a urinary exit in 
which data were expressed as fraction of dose. The connections between compartments were 
adjusted to optimize the fit and eventually included a second exit out of the model. Finally the 
muscle enrichment of 3MH from the muscle biopsies was incorporated into the model, and all 
data were simultaneously fitted. In addition, steady state masses and transport rates were 
calculated for each model, and the de novo production rate calculated could be used to calculate 
a fractional degradation rate for the myofibrillar proteins. The nomenclature and illustrations 
used in describing the model are the same as in the SAAM(Simulation Analysis and Modeling) 
manual (Berman and Weiss, 1978). Brief definitions of the terms used are given;L(l,J) = 
Fraction of material transported from compartment J to I per unit time (fraction/min), R(I,J) = 
Transport of tracee (natural 3MH) from compartment J to I per unit time (nmol/min) under 
steady state conditions, U(l) = Entry of tracee into compartment I from outside of the model 
per unit time (nmol/min). The de novo production of unlabeled 3MH from breakdown of actin 
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and myosin proteins into intracellular muscle pool under steady state conditions. IVI(I) = Mass 
of tracee (unlabeled 3MH) in compartment I. K(l) = Proportionality constant associated with 
compartment I. CONSAM assumes that a component number is specified under an H DATa 
header statement in the input file, and it will automatically multiply the category associated with 
this component by K(l) to calculate QC(I). QC(I) is CONSAM's notation for calculated values. 
Data associated with a component, I, are called QO(l). K(l) represented the inverse of the space 
of distribution. The number of compartments in the model is arbitrary and reflects simply the 
choices of compartment numbers made during the development of the model. 
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RESULTS 
Tracer Response Profiles 
The mean tracer enrichment in plasma and muscle and the percentage recovery of tracer 
in urinary excreta are presented in Table 2. The t/a-SMH data exhibited a typical disappearance 
pattern (Fig. 1). After the injection of tracer, (/j-SMH was lost rapidly from the plasma during 
the first 150 to 180 min, followed by a transition period through 720 min, in which the 
decrease in tracer concentration seemed to level off. The final phase was characterized by a 
gradual decline in tracer during the remaining 5 d of the kinetic study. 
During the preliminary fitting of exponential equations to the plasma kinetic data, we 
found that a minimum of three exponential terms was required to achieve an adequate fit. The 
exponential equations for individual animals are given below, where c(t) is the concentration of 
S-methyl-tmethyl-^Hgl-histidine in plasma at time t (min postinjection); 
Lamb 9173: c(t) = 1 .seexp®®"""" + 4.02exp'' '"' + 0.757exp°°''^®°' 
Lamb 9183: c(t) = 1.47exp® ®°®'®" + 4.44exp° "®' + O-gMexp" """^' 
Lamb 9186: c(t) = 1.57exp°°»"''*' + 4.13exp° '®" + 1.61exp°®®®'®' 
Lamb 9169: c(t) = 1.45exp®'"'°^^^' + 5.84exp°"'' + 1.77exp°°°®"' 
Model Development 
The model developed used linear first-order differential equations; therefore, it is based on 
the assumption of steady-state kinetics in the animals over the duration of the experiment. No 
significant differences were seen in individual lamb plasma levels or in urinary production of 
3MH during the duration of the experiment, so the lambs were assumed to be in steady-state. 
No animal by-products were included in the diet so it was assumed that the only source of 
natural 3MH was from the degradation of actin and myosin. 
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Table 2. Mean tracer response profiles in plasma, muscle and urine of four lambs injected with 
52.6 ^mol of S-Methyl-Emethyl-^Hgl-histidine* 
Period after Plasma Muscle Percentage tracer 
dose enrichment'' enrichment" recovery in urine** 
(min) Mean ± SE Mean ± SE Mean ± SE 
2 0.181 ± 0.0206 
7 0.111 ± 0.0128 
10 0.104 ± 0.0084 
12 0.020 ± 0.0069 
IS 0.091 ± 0.0070 
45 0.081 ± 0.0007 
60 0.029 ± 0.0088 
90 0.063 ± 0.0049 
150 0.055 ± 0.0048 
210 0.052 ± 0.0035 
270 0.050 ± 0.0045 
300 0.024 ± 0.0029 
720 0.039 ± 0.0033 
1440 0.033 ± 0.0020 0.034 ± 0.0074 3.41 ± 1.01 
2880 0.025 ± 0.0018 5.89 ± 1.45 
4320 0.019 ± 0.0009 0.018 ± 0.0031 7.96 ± 1.66 
5760 0.015 ± 0.0003 9.41 ± 1.85 
7200 0.011 ± 0.0008 10.80 ± 1.88 
'Values represent a mean ± SE of four lambs, see procedures ffor detailes. 
''Calculated as the background corrected 3-Methyl-[methyl-^H3]-histidine/3-methylhistidine peak 
height abundance (ion 241/238). 
"Enrichment of tracer in longissimus dorsi biopsies was calculated as the background corrected 3-
Methyl-[methyl-^H3]-histidine/3-methyIhistidine peak height abundance (ion 241/238). 
''The percentage of 3-Methyl-[methyl-^H]]-histidine accumulating in the urine. 
The stages of model development are illustrated in Figures 2-4 to describe the 
sequential addition of different metabolic pools. The model configuration is included in an inset 
in each figure. The first step (Fig. 2) was to describe the plasma kinetic data in terms of a 
compartmental model. This was a simple three-compartment model, in which the plasma data 
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Figure. 1. The fitting of the time course of plasma S-methyl-Imethyl-^Hgl-histidine (D3-3MH) 
disappearance from plasma of lamb 9183 is presented. The symbols represent the 
observed values, and the line are the values calculated by SAAM, with a three 
exponential fit given. The residual sum of squares for two and three exponential fit 
is given. C(t) is the concentration of (D3-3MH) (nmol/ml plasma) at time T (min post 
Injection). 
were entered into compartment 1 as fraction of injected dose/ml. Compartment 1 was 
connected in a series with compartments 2 and 3, and there was one exit out of the system 
from compartment 1. This plasma model required a minimum of three compartments to produce 
an adequate fit between the values calculated by the model and the observed data points. 
Model parameters and steady state masses and transport rates are shown in Table 3. The 
plasma curve is characterized by a sharp decline in tracer during the first phase and a more 
gradual decline during the last 5 d. Steady state transport rates indicate that there is rapid 
exchange of 3MH (nmol/min) between pools 1 and 2, compared with a slowly turning over pool 
3. The four-lamb average de novo 3MH production rate {U(2)} was 205 ± 3.6 nmol/min. The 
fractional breakdown rate of myofibrillar protein could be calculated in the same manner as 
Harris and Milne (1980), assuming that muscie was 35% of body weight and that protein-bound 
3MH was .6 /imoi/g of muscle. The average de novo production rate into compartment 2 
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Figure 2. Plasma S-methyl-tmethyl-^Hal-histidine (dg-SMH) for lamb 9183 following a injection. 
The tracer d3-3MH was converted to fraction of dose /ml by dividing by the injected 
dose as depicted on the y- axis. The symbols (*) indicate actual measurements while 
the line represents model prediction. Also depicted is a graphical represented of the 
kinetic model (Model A) used to describe this curve. dj-SMIH was injected into pool 1, 
and an exit was through same pool. 
corresponded to a average fractional breakdown rate of 5.4 %/d. 
The next stage in the model development was incorporate the urine kinetic data. We 
first attempted to include the accumulative urine recovery of (/g-SMH tracer as the sole exit out 
of compartment 1. This model was inadequate to describe both the plasma and urine kinetic 
data, in asmuch as we saw a significant decrease in the plasma sum of squares. This would be 
expected because only a proportion of the radioactivity was recovered in the urine of sheep 
after an intravenous dose of [^^C13MH, whereas a large proportion was retained (hiarris and 
Milne, 1980). We next modified this plasma-urinary model (Fig. 3) to include a second exit out 
of compartment 3, an exit meant to represent an exit into a balenine (l-iarris and Milne, 1980; 
Harris and Milne, 1987) "sink" that turns over very slowly or not at all during the time frame of 
the study. This model, illustrated in Figure 3, was constructed by including the plasma kinetic 
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Figure 3. The simultaneous fit of plasma and urine kinetic data from lamb 9183. Plasma is 
represented as a fraction of dose of S-methyl-Imethyl-^Hsl-histidine Idg-SMH) per ml 
(solid line) while the urine is represented as a fraction of dose of dj-SMH, (dotted line). 
Also illustrated is the proposed model (Model B) compatible with the data, in which 
urine exit was from pool 1, and another exit occurred from pool 3. 
FRACTION OF DOSEIML  FRACTION OF DOSE 
0 ? ) J * e  
T I M E  ( m i n  x  1 0 0 0 )  
Figure 4. The predicted enrichment of 3-methyl-[methyl-^H3]-histidine in muscle when entered 
either into compartment 2 (solid line) or 3 (dotted line) by using the proposed model 
B (Plasma and urine kinetic model, Fig. 3) (lamb 9186). The stars represent the actual 
observed measurements. 
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Table 3. Kinetic parameters of 3-methylhistidine metabolism with steady state 3-methylhistldine 
masses and transport rates for two different compartmental models in four lambs* 
(Estimated parameter and steady state value means with their standard errors. Each 
mean is composed of four values generated by SAAM/CONSAM (Bosten et al. 1981) 
during the final fit of the data) 
Simple plasma* Plasma + urine*" 
(A) (B) 
Mean ± SE Mean ± SE 
K(l), ml " 0.000138 ± 0.0000123 0.00013 ± 0.00001 
Space distribution, ml 7380 ± 607 7620 ± 649 
L(2,l), min'* 0.113 ± 0.0235 0.104 ± 0.0224 
L(l,2), min ' 0.0661 ± O.OISO 0.0598 ± 0.0144 
L(3,2), min ' 0.00340 ± 0.000977 0.00331 ± 0.00116 
L(2,3), min'' 0.00303 ± 0.000241 0.00217 ± .000422 
L(0,1), min*' 0.000804 ± 0.0000738 NA 
L(10,l), min ' NA 0.000114 ± 0.0000256 
L(0,3), min'' NA 0.000337 ± 0.0000415 
M(1)V /xmoles 261 ± 24.6 271 ± 26.8 
M(2), ftmoles 478 ± 86.3 503 ± 96.0 
M(3), /(moles 473 ± 83.0 543 ± 90.9 
U(2), itmol-min'' 0.205 ± 0.00360 0.201 ± 0.00600 
R(2,l), /xmol-min ' 28.8 ± 5.14 27.3 ± 5.03 
R(l,2), /tmol-min'' 29.0 ± 5.14 27.3 ± 5.03 
R(3,2), /imol-min'' 1.42 ± 0.224 1.39 ± 0.331 
R(2,3), /itmol-min'' 1.42 ± 0.224 1.21 ± 0.327 
R(0,1), fxmol-min'' 0.205 ± 0.00360 NA 
R(0,3), /tmol-min'' NA 0.172 ± 0.00440 
R(10,l), ^mol-min'' NA 0.029 ± 0.00510 
'For detailes of procedures. 
''Model A is a simple 3 compartment plasma model with one exit out of the system from 
compartment 1 {L(0,1)}. See Fig. 2 for an illustration. 
°Model B, plasma-urinary model with two exits out of system, is a modification of the simple 
plasma model in which the accumulative urinary 3-methylhistidine kinetic data were included as an exit out 
of compartment 1 {L(10,l)}, and a second exit was included out of compartment 3 {L(0,3)}. See Fig. 3 
for an illustration. 
'*L(I,J) = Fraction of material transported from compartment J to I per unit time (fraction/min). 
R(I,J) = Transport of tracee (natural 3MH) from compartment J to I per unit time (nmol/min) under steady 
state conditions. U(l) = Entry of tracee into compartment I from outside of the model per unit time 
(nmol/min). The de novo production of unlabeled 3MH from breakdown of actin and myosin proteins into 
intracellular muscle pool under steady state conditions. M(I) = Mass of tracee (unlabeled 3MH) in 
compartment I. K(I) = Proportionality constant associated with compartment I. CONSAM assumes that a 
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Table 3 (cont.) 
component number is specified under an H DATa header statement in the input file, and it will 
automatically multiply the category associated with this component by K(I) to calculate QC(I). QC(I) is 
CONSAM's notation for calculated values. Data associated with a component, I, are called QO(I). K(I) 
represented the inverse of the space of distribution. The number of compartments in the model is arbitrary 
and reflects simply the choices of compartment numbers made during the development of the model. 
Steady state values were initiated by multiplying the average plasma concentration of 3-methylhistidine by 
the space of distribution. NA=not applicable. 
data in compartment 1, and the urinary kinetic data were described by an exit out of 
compartment 1 {L(10,1)}. With this model, we saw close agreement between observed and 
calculated values for describing both plasma and urinary data simultaneously (Fig. 3). The 
kinetic urinary 3MH curve shown in Figure 3 was similar to the accumulative recovery of 
radiolabled-3MH described by Harris and Milne (Harris and Milne, 1980), in whose work the 
majority of tracer is excreted during the first 24 h, and excretion is gradual thereafter. Model 
parameters and steady state masses and transport rates were obtained. 
and presented in Table 3. The steady state values obtained for this model were very similar to 
those of the previous plasma model, except that the 3MH leaving the system was partitioned 
into two exits: a small urinary exit averaging 29.4 ±5.1 nmoi/min and a much larger exit out of 
pool 3 averaging 172.1 ± 4.4 nmol/min. This urinary exit accounted for only 15% of the total 
3MH leaving the system. The de novo production rate of 3MH into compartment 3 was 201.6 
± 6.0 nmol/min, which corresponded to an average fractional breakdown rate of 5.4 %/d. 
The final phase in the development of the 3MH kinetic model was to relate the 
developed kinetic models to 3MH production in muscle by using the enrichment of 3MH from 
muscle biopsies of the longissimus dorsi. The kinetic data from muscle were entered into either 
compartment 2 or compartment 3 by using the plasma-urinary kinetic model with two exits (Fig. 
4). When the muscle kinetic data were entered into compartment 2, the values at 12, 60 and 
300 min calculated by the model overestimated the observed values at these same times and 
42 
produced identical values at 1440 and 4320 min. When the data were entered into 
compartment 3, however, the model underestimated the early time points and slightly 
overestimated the latter time points. 
A summary of 3MH kinetics and measurement of physiological characteristics are 
shown In Table 4. The mean plasma concentration was 35.7 ± 2.5 nmol/ml while muscle 
was 29.2 ± 3.2 nmol/g (wet) weight of muscle. The urinary production rate estimated from 
model B was 26.1 ± 4.5 nmol/min. The actual urinary 3MH production rate was similar to the 
values calculated from model B, that is 29.4 nmol/min (Table 3). Whereas urinary recovery of 
3MH is incomplete, a compartmental model can be used to calculate kinetically a de novo 
production rate based on plasma kinetics (Table 3, 205 nmol/min). 
Table 4. Lamb status and natural 3-methylhistidine measurements 
Lamb 9173 9183 9186 9169 
Sex & & d" 9 
Mean ± SE Mean ± SE Mean ± SE Mean ± SE 
Weight, kg 25.9 27.3 25.0 25.0 
Plasma 3MH*, nmol/ml 38.5 ± .2 30.3 ± .2 32.8 ± .1 41.2 ± .2 
Urinary 3MH production, nmol/min 
22.1 ± 1.4 38.6 ± 4.5 26.1 ± 1.9 17.6 ± 1.7 
Model calculated urinary 3MH 
production'', nmol/min 
23.4 ± 1.1 41.4 ± 1.3 34.4 ± 1.3 18.7 ± 1.0 
Model calculated 3MH production', 
nmol/min 191.7 ± 63.8 205.8 ± 5.7 213.2 ± 6.7 205.5 ± 7.1 
Muscle 3MH'', nmol/g 34.5 ± 4.7 29.0 ± 5.7 20.4 ± 1.3 33.1 ± 4.5 
•3MH = 3-methylhistidine. 
''Urinary 3MH production was calculated from a compartmental model (Model B) based on 
plasma and urinary kinetics of 3-methyl-[methyl-^H]]-histidine. 
°3MH production calculated from a compartmental model (Model A) based on plasma kinetics of 
S-methyl-Imethyl-Hjl-histidine. 
^Non-protein-bound 3-methylhistidine in muscle. 
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DISCUSSION 
The major objectives of this study were to show that the 3MH kinetics of a stable 
isotope could be described by a compartmental model and to determine whether a de novo 
production rate of the tracee could be estimated. This method is of value to estimate the 
fractional breakdown rate of muscle protein because urinary 3MH is invalid for use in species 
such as sheep and pigs. Other methods for studying muscle protein degradation directly are 
limited, and methods are available that allow for indirect calculation of muscle degradation if the 
fractional accretion rate of muscle protein is known (Garlick, 1980). 
We have described the in vivo kinetics of 3MH in lambs by means of two different 
models, starting with a very simple three-compartment model requiring only the sampling of 
plasma and than to a model requiring the sampling of plasma and urine. The simple plasma 
model (model A) and the more complex plasma-urine model (models B) gave nearly identical 
results, demonstrating the usefulness and accuracy of the simple plasma model. In addition, the 
biopsies from the longissimus dorsi were used for representing the total skeletal musculurature 
from which 3MH is primarily produced. These data used in a simulation of the plasma-urinary 
model forced skeletal muscle to be the only source of 3MH produced de novo. However, it is 
thought the skin and intestines may also contribute 10 to 15 % of the daily 3MH produced 
(Young and Munro, 1978; Harris, 1981; Nishizawa et al. 1977; Millward and Bates, 1983). 
Therefore a lower production rate could be expected for the model when muscle is forced to be 
the only source of de novo production. 
The models were constructed based on prior knowledge of 3MH metabolic pools in 
sheep (Harris and Milne, 1980). It had been demonstrated that only a small percentage of 3MH, 
which is released from actin and myosin, is actually excreted in the urine, with the remaining 
majority retained as balenine in muscle. It was assumed that the tracer was initially distributed 
into a plasma plus extracellular water space of compartment 1, which had an exit into a urine 
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pool (compartment 10). This assumption was based on the space of distribution of 
compartment 1 {K(1), Table 3} which was 7381 and 7619 for model A and B, respectively. 
This space of distribution for compartment 1 was 30% of the body weight of these four lambs 
and would be approximately equal to the extracellular water space. Additionally, model B 
accurately predicted the daily excretion of 3MH in the urine: 26.1 was observed compared to 
29.4 nmol/min predicted. Compartments 2 and 3 are most lilcely intracellular pools of free 
nonprotein-bound 3MH, with a second exit out of pool 3 was most Nicely into a balenine "sink." 
The second exit was assumed to be an exit into a balenine pool that was thought to turn over 
very slowly or not all during the duration of the study because balenine seems to accumulate in 
the muscle of sheep. Nevertheless, when the concentration of free 3MH in muscle of the 
longissimus dorsi was extrapolated to the total musculature of the lambs, the observed pool size 
of muscle free 3MH was only one-half to the model calculated compartment size of either 2 or 
3. This might be expected if the enrichment of our tracer in muscle differed between muscles 
or groups of muscles as the longissimus dorsi was used to represent the whole musculature, 
and the contribution of 3MH from smooth muscle actin to the size of compartments 2 and 3 
must also be taken into account. 
The structural configurations of these models are not unique, and alternative 
arrangements may also be compatible with the data. It was possible with simple plasma model 
A to place the exit from the system at any of the three compartments and to obtain identical 
agreement between observed and model calculated values. Again with model B the second exit 
could be placed at any of the three compartments. It is also possible to enter the muscle 
response into either compartment 2 or 3 as single metabolic pool and to obtain a solution. The 
present models represent a framework and methodological approach describing steady state 3-
methylhistidine kinetics in the whole animal and constitutes a working theory for testing by 
further experimentation with designs altering muscle protein breakdown. 
In conclusion, the rate of 3MH production is an important tool in understanding the 
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regulation of muscle protein degradation. The advantages of these models are that 1) it does 
not necessitate quantitative urine collection (plasma model); 2) it reduces error due to the 
frequency of plasma sampling versus the infrequency of urine collection in the other models; 3) 
it measures the total production rate independent of the determination of free or conjugated 
forms; 4) it gives information about pool size and transfer rates; and 5) it does not require 
restraint of the animals for long periods. The model does, however, need further validation as a 
method for estimating 3MH production in other species. 
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ABSTRACT 
Urinary 3-methyihlstidine (3MH) excretion has been used as an index of muscle protein 
breakdown in cattle. An alternative means to estimate muscle proteolysis in cattle is to 
estimate the de novo production of 3MH from plasma kinetics isotopically. Three cross-bred 
steers (average 229 kg) were given a 5.0-mg bolus intravenous injection of 3-methyl-[methyl-
'Hsl-histidine ((/3-3MH) after which 16 serial blood samples and three consecutive 24-h urine 
samples were taken. The enrichment of 3MH in plasma was determined by gas 
chromatography/mass spectrometry, and compartmental analysis of the kinetic data was 
preformed using the SAAM modeling program. The 3MH production rates per day (3MHPR, 
A/mol per day) were 732, 782, and 725, and the fractional breakdown rate (FBR, percentage per 
day) were 1.61, 1.72, and 1.58 as determined by urinary excretion of 3MH, by a three pool 
catenary model (plasma kinetics, Model A) and by a more descriptive three pool model with two 
response curves (both plasma and urine kinetics. Model B), respectively. Model A and Model B 
estimates of 3MHPR and FBR were similar (P > .25) to those of estimates obtained from urinary 
3MH excretion. Kinetic modeling also allows for calculation of compartment mass and flux of 
3MH between compartments and indicates that once 3MH exits the muscle pool it is rapidly 
excreted via the urine. In conclusion, kinetic modeling offers an alternative approach to 
estimating the 3MH production rate. 
Key Words: 3-methylhistidine, Isotope, Cattle, Compartmental, Model, SAAM/CONSAM 
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INTRODUCTION 
The turnover of myofibrillar proteins is often calculated from urinary excretion of 3-
methylhistidine (3MH) and has been validated for use in tattle studies (Harris and Milne, 1981; 
McCarthy et a!., 1983). Upon degradation of actin and fast-twitch myosin, 3MH is released 
and, not reutilized or modified to any significant extent, it is rapidly excreted in the urine (Young 
etal., 1972). 
To date, no attempt at integrating tracer and tracee data into a comprehensive whole 
animal kinetic model of 3-methylhistidine metabolism in cattle or any other species has been 
reported. The development of the SAAM/CONSAM computer modeling program (Berman and 
Weiss, 1978) has made possible the detailed analysis of tracer observations at multiple sites in 
the body and has facilitated the interpretation of findings in the context of a physiologically 
identifiable kinetic model. 
An alternative method of quantitating 3MH production in vivo would be to isotopically 
measure the de novo production rather than excretion. The first objective of this research was 
to develop compartmental models based on the kinetics of a stable isotope of 3MH ((methyi-
^H3]3-methylhistidine, (y3-3MH) in plasma and urine. Second, the model-calculated values for 
the 3MH production rate, and fractional turnover rate of myofibrillar protein for steers were 
compared with the values calculated from the quantitation of urinary 3MH. 
MATERIALS AND METHODS 
Animals and Experimental Protocol 
Three crossbred steers (average BW 229 kg) were obtained from Department of 
Animal Science ruminant nutrition farm at Iowa State University. The steers had ad libitum 
access to a finishing diet and water throughout the duration of the study. Seven days before 
the initiation of the experiment, the steers were transferred to metabolism cages designed for 
the collection of urine. On the morning of study one catheter was inserted into the jugular vein 
to facilitate both tracer injection and withdrawal of blood. Approximately 1 h later, 3-Methyl-
[methyl-'lHjlhistidine (MSD Isotopes, Montreal, Canada) ((/3-3MH) with a bolus dose of 
approximately 30 ^moles dissolved in 10 mL of sterile saline was injected into the catheter and 
was flushed an additional 10 mL of saline. Blood (10 mL) was collected and transferred to 
EDTA coated tubes 1, 2, 5, 10, 15, 30, 45, 90, 150, 210, 270, 330, 720, 1440, 2880, and 
4320 min postinjection. Blood was directly placed in an ice bath until the blood could be 
centrifuged and plasma was collected and stored at -70° C. During the first 3 d of the tracer 
experiment, consecutive 24-h total urine outputs were collected. Aliquots of each urine 
collection were kept frozen at -20° C. Additional baseline blood and urine samples were 
collected before the injection to subtract background enrichment from the experimental samples. 
Analysis of Plasma 3-Methylhistidine 
One milliliter of plasma and 50iuL of 1-methylhistidine (1MH) internal standard (3.5 
mM) were added to a plastic sample tube (12 mL). Then, 3 mL of 1.5 /V perchloric acid was 
added, and the tube vortexed and centrifuged at 2300 x 9 for 15 min at 5°C. The supernatant 
was poured onto a prepared cation exchange column (Dowex-50W in the hydrogen form, Sigma 
Chemical, St. Louis, MO). The 3-methylhistidine and internal standard (1MH) were eluted from 
the column with 25% NH4OH into a 20-mL scintillation vial. The eluant was heated to 65°C in a 
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block and dried under a stream of nitrogen gas. To derivatize the dried sample, 100 juL of 
acetonitrile (Regis Chemical, Morton Grove, IL) and 100 //L MTBSTFA (N-methyl-N-(t-
butyldimethylsilyl) trifluoroacetamide. Regis Chemical) were added to the sample and allowed to 
incubate overnight at room temperature. 
The derivatized sample was transferred into an injection vial (Sun Brokers, Wilmington, 
NC), capped, and analyzed by gas chromatography/mass spectroscopy (Hewlett-Packard gas 
chromatogram/mass selective detector. Model 5890/59708, Avondale, PA). The column used 
was a 25 m X 0.22 mm i.d. x 0.11 ^m film thickness, cross-linked methyl silicone gum phase 
capillary column (Hewlett-Packard, HP-1, Avondale, PA). The major ion fragments for 3MH and 
(/g-SMH were monitored by using selective ion monitoring. 3-Methylhistidine was monitored at 
238 amu and its stable isotope, (/3-3MH, at 241 amu, whereas 1MH was detected at 340 amu. 
3-methylhistidine in plasma was quantified from a linear peak height standard curve. When d^-
3MH was used as tracer, the enrichment, c/j-SMH/SMH, was quantified in plasma by first 
subtracting the natural background enrichment, (/3-3MH/3MH, from detected (/3-3MH. 
Analysis of Urine 3-Methylhistidine 
Unlike plasma, urine contains substantial amounts of 1 -methylhistidine, which makes 
1MH an impractical internal standard. Therefore, dilabeled [1,1]-'°02-1-Methylhistidine 
((^°02)1MH) (40//L of a 2955 juM stock solution) was used as the internal standard to 
quantitate 3MH in urine. A urine sample was prepared by transferring 1 mL to a microfuge tube 
and removing particulate matter by spinning for 3 min. From this tube, 100 /t/L of urine was 
pipetted into a plastic sample tube (12 mL) with 40 lA. of internal standard. In addition, 1 mL of 
double-deionized HjO was added to the tube, and the contents were acidified with 5 //L of 3 N 
HCI. The urine sample was then vortexed and poured over a cation exchange column and 
subsequently eluted with 25% ammonium hydroxide, the eluent was collected in a scintillation 
vial and then dried with a stream of nitrogen gas on a heating block at 65°C. Once dry, the 
urea in the sample was hydrolyzed with 1 mL of urease solution (3.5 mg/100 nnL) (Jacic Bean 
Urease Type IX, Sigma Chemical, St. Louis, MO) by incubation on a heating blocic for 2 h at 
37°C. The sample was again dried on the heating block and derivatized with 100 /ji acetonitrile 
and 100;/L MTBSTFA and incubated overnight at room temperature. The derivatized sample 
was transferred into an injection vial and injected in a Hewlett-Packard gas chromatograph/mass 
selective detector. The retention time for 3MH was the same in urine as in plasma and 
exhibited the same mass spectra. [l.ll^'Og-l-Methylhistidine had a retention time similar to 
that of natural 1MH, but major ions from the mass spectra were 4 amu heavier. 3-
Methylhistidine and (/3-3MH were quantified by peak height as explained for plasma analysis 
except that replaced 1MH in the calculations. 
Kinetic Modeling 
The response curves of (/3-3MH in plasma and urine were evaluated using the 
Simulation, Analysis, and Modeling/Conversational SAAM (SAAM/CONSAM) computer program 
(Boston et al., 1981). The tracer data were interpreted with linear compartmental models, 
which were described by a linear first order differential equation for each compartment in the 
model (see Berman and Weiss, 1978). The first compartmental model constructed was a 
catenary 3-compartment model (Model A; Figure 1), configured by entering the molar 
enrichment of plasma c/j-SMHrnatural 3MH into compartment 1 over time. These data were 
used in conjunction with prior knowledge of 3MH metabolism in cattle (Harris and Milne, 1981) 
in constructing the model. Harris and Milne (1981) have demonstrated in cattle the presence of 
body pools of free 3MH in blood and muscle. There is also a dipeptide pool of 3MH (balenine; 
Harris and Milne, 1987) in muscle. 
Based on the recovery of radiolabeled 3MH (Harris and Milne, 1981; McCarthy et al., 
1983), after 3MH is released from the polypeptides, actin and myosin, it is rapidly excreted in 
the urine of cattle. Therefore, if Model A is truly an accurate representation of 3MH 
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Figure 1. This diagram is a graphical illustration of a three compartment kinetic model used for 
Model A and Model B. Model A was configured with plasma kinetics entered into 
compartment 1 and the model had an exit out of the system from compartment 1. 
Kinetic Model B, a more descriptive three compartment model, was configured with 
two response curves, the plasma kinetic entered into compartment 1 and urine kinetics 
as a exit via compartment 1 into a urine sink. 3MiH = 3-methylhistidine 
metabolism, then the exit out of the system from compartment one of Model A should be an 
urinary exit. The exit out of the system from compartment one of model A was then described 
by the response curve of urine (/3-3MH. The urinary data were expressed as a fraction of the 
dose. This more descriptive model (Model B, illustrated in Figure 1) included two response 
curves (compared to only one for Model A): the urinary excretion of SMIH as a exit from 
compartment 1, in addition to the plasma response curve entered in compartment 1. 
In constructing these models we attempted to minimize residual sum of squares;a 
three -compartment model produced a lower sum of squares than did a two compartment 
model. In addition, the tracer models of Figure 1 define steady state pool sizes and fluxes, 
which, along with a de novo production, were calculated for each model. These calculations 
can be found in the SAAM manual (Berman and Weiss, 1978). The de novo production rate 
could be used to calculate a fractional degradation (breakdown) rate for the myofibrillar proteins. 
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The degradation rate was calculated by the following equation; FBR - 3MH production rate 
divided by the total protein bound 3MH pool. To calculate the total protein bound 3I\/IH pool, it 
was assumed that the percentage of muscle on a live weight basis was equaled to 33% and the 
concentration of protein bound 3MH was equal to .6 //mol/g of muscle. 
Statistical Analysis 
The means for the 3MH compartmental models and urinary production and turnover 
rates were compared by paired Mest (Steel and Torrie, 1980). 
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RESULTS 
The SAAM modeling program was used to describe the kinetics of t/g-SMH in three 
steers. After the bolus injection of tracer, the enrichment of (y3-3l\/IH:3MH decreased very 
rapidly in plasma during the first 6 h, but the rate of decline was much less during the last 72 h 
(Figure 2). In addition, (/3-3MH also accumulated In urine more rapidly during the first 24 h than 
during the next 48 h (Figure 2). Two variants of a three compartment model were used, one to 
describe the response curve in plasma (Model A, Figure 1) and one to describe response curves 
of both plasma and urine simultaneously (Model B, Figure 1). Both of these compartmental 
models were adequate in describing 3MH kinetics in steers and produced similar steady state 
compartment mass and transfer rates between compartments (Figure 3). The plasma curves, 
shown in Figure 2 for Model A, produced a good agreement between the observed and the 
calculated values by the model. The same curves were produced also by Model B (curves not 
shown). The de novo production rate of 3MI-I calculated in steady state by Models A and B and 
the fractional breakdown rate of myofibrillar protein were compared with values calculated from 
the quantitation of urinary 3MI-I (Table 1.). Estimated values by these models were not different 
from estimates calculated from the quantitation of urinary 3MH excretion (P > .25). There 
were also no differences between Models A and B (P > .25). 
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Figure 2. The decay curves of the [methyl-^H3]-3-methylhistidine:3-methylhistidine isotopic 
ratio/dose in plasma for each steer were given. The symbols (*) represent the 
observed data points and the solid line ( ) is calculated data produced using Model A 
by SAAM. The fraction of [methyl-^Hjl-S-methylhistidine that accumulates in urine 
after a bolus injection of tracer is presented on the Y2 axis for each steer. The 
symbols (*) represent the observed data points and the dotted line ( ) is the 
calculated data produced by using Model B by SAAM. 
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Table 1. 3-Methylhistidine (3MH) production and fractional breakdown rates of myofibrillar 
protein calculated from kinetic models and urinary collection 
MODEL Steer 1 Steer 2 Steer 3 Mean' SE 
Uiinaiy 
3MH production rate, /tmol/d 
Fractional breakdown rate, %/d 
Kinetic model A (plasma)** 
3MH production rate, /tmol/d 
Fractional breakdown rate, %/d 
Kinetic model B (plasma & urine)" 
3MH production rate,/imol/d 
Fractional breakdown rate, %/d 
*No statistical differences between model 3MH production and fractional breakdown rates (P > 
.25). 
''A compartmental model based on 3-methyl-[methyl-^H3]-histidine (</]-3MH) plasma kinetics (see 
Figure 1). 
'A compartmental model based on 3-methyl-[methyl-^H3]-histidine fiij-SMH) plasma and urine 
kinetics (see Figure 1). 
724 
1.61 
757 
1.53 
715 
1.53 
732 
1.61 
13 
.04 
666 885 796 782 64 
1.56 1.89 1.70 1.72 .10 
548 876 751 725 96 
1.28 1.87 1.61 1.58 .17 
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IN URIN( • .11  ^.01 
Figure 3. This diagram represents the steady-state compartment size (//moles, Mean ± 
SE) and transfer rate (/imoles/min, Mean ± SE) of 3-methylhistidine (3MH) 
between compartments for the plasma model (Model A). Actual measurement in 
the urine represents quantitative collection of urine and measurement a 3MH 
excretion rate. 
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DISCUSSION 
The developed model employed the use of linear first order differential equations; 
therefore, it is based on the assumption of steady-state kinetics in the animals over the duration 
of the experiment. No significant differences were seen in individual steer plasma levels or in 
urinary production of 3MH during the duration of the experiment, so the steers were assumed to 
be in steady-state. There was no animal by-products in the diet, so it was assumed that the 
only source of natural 3MH was from the degradation of actin and myosin. 
We have compared the in vivo kinetic of 3MH in steers by two different models with that 
of the quantitation of urinary excretion, The catenary three compartment model (model A) only 
required the sampling of plasma, whereas the plasma and urine model (Model B) required the 
sampling of plasma and urine. The models gave similar, if not identical, results and confirmed 
that the exit out of compartment 1 was via the urinary exit. The models demonstrated that 
they could estimate the production rate of 3MH and FBR of myofibrillar protein as effectively as 
the quantitatoin of urinary excretion. Although the SE for urinary excretion was lower than for 
either Model A or B, only a limited sample size was used and may be premature to conclude 
whether one model is more variable than another. Also, the compartmental models are 
measuring a total de novo production rate rather than a urinary excretion rate. In addition, 
when the data is expressed as percentage of body weight the 3MH production rates were not 
as variable. The mean FBR value calculated for Model A was 1.72 %/d (Table 1). The FBR 
values of 1.22%/d at a growth stage of 217 kg (Nishizawa et al., 1979), 1.41 %/d at growing 
stage of 236 kg (Harris and Milne, 1981) and 2.07 %/d at a growth stage of 400 kg (Gopinath 
and Kitts, 1984) have been reported for cattle. 
The advantages of this compartmental model are that 1) it does not necessitate 
quantitative urine collection, 2) it measures the total production rate, not dependent on the 
determination of free or conjugated forms, 3) it gives information about pool size and transfer 
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rates, and 4) it does not require restraint of the animals for long periods. 
The structural confiouration of these models are not unique, and alternative arrangements 
may also be compatible with the data. It was possible with simple plasma model (A) to 
construct a two compartment model. The present construct represents a framework and 
methodological approach describing the steady state 3MH kinetics in the whole animal and 
constitutes a working theory for testing by further experimentation with designs that alter 
muscle protein breakdown. 
Implications 
In conclusion, the decay of S-Methyl-Imethyl-^Hjlhistidine can be compartmentally 
modeled and seems to be reflective of 3MH production in vivo. Kinetic compartmental modeling 
offers an alternative approach to determining the 3MH production rate, and the preliminary data 
presented here suggest that it is as effective as quantifying urinary SiVIH. 
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ABSTRACT 
Unlike humans and some other mammals, direct in vivo methodology are not available to 
accurately evaluate muscle turnover in pigs. Urinary 3-methylhistidine (3MH) excretion which is 
used as an in vivo marker of muscle protein breakdown humans and cattle is not valid in pigs. 
The present study proposes that data from a single bolus dose of S-fmethyl-'Hal-methylhistidine 
tracer can mathematically describe 3MH metabolism in pigs. Plasma concentration of the tracer 
is described by a linear time-variant 3-compartment model by using the SAAM/CONSAM 
computer modeling program. The model defines masses and fluxes of 3MH within the pigs 
and, in particular, the intracellular de novo production of 3MH which should reflect muscle 
proteolysis. The de novo production of 3MH as calculated by the model was 621 jumol/d 
corresponding to fractional breakdown rate of 2.66 %/d which is similar to values reported by 
using indirect methodology. These data also suggest that certain model compartments may be 
an indicator of body muscle mass (mass of compartment 3, r = 0.59, P = 0.006). The 
mathematical model developed does not depend on urine collections and can be used to assess 
changes in muscle proteolysis in vivo. 
Key Words; 3-Methylhistidine, metabolism; compartmental modeling; stable isotope tracer; 
muscle protein turnover 
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INTRODUCTION 
Skeletal muscle is one of the primary tissues in whole body protein metabolism (Young , 
1970) and in most young adult animals comprises about 45% of body weight. Schoenheimer 
and Rittenberg (Schoenheimer and Rittenberg , 1940) established 50 years ago that the 
accumulation of muscle tissue depends on both the rate of muscle protein synthesis and the 
rate of muscle protein breakdown. Despite this premise, most of the scientific attention during 
the last 50 years has focused on muscle protein synthesis. 
Muscle proteolysis studies in pigs are almost totally absent because methodology to 
directly evaluate muscle protein breakdown in pigs is lacking. While many studies have 
evaluated the fractional synthesis rate of muscle protein (Garlick et al., 1976; Simon et al., 
1978; Mulvaney et al., 1985; Culham et al., 1990; Bergen et al., 1989), only a few studies 
have attempted to measure the fractional breakdown rate of muscle protein (Bergen et al., 
1989; Mulvaney et al., 1985) in pigs. The fractional breakdown rate in these studies were 
accessed indirectly by the difference between synthesis rates and muscle protein accretion rates 
as described by Millward et al. (Millward et al., 1975). 
Urinary 3-methylhistidine (3MH) has been used a direct method to estimate muscle 
proteolysis in humans (Long et al., 1975; Young and Munro , 1978) and cattle (Harris and Milne 
, 1981a; McCarthy et al., 1983; Nishizawa et al., 1979) because once released from actin and 
fast-twitch myosin 3MH is not reutilized and rapidly excreted in the urine. However, urinary 
3MH can not be used as an index of muscle proteolysis in pigs because only a small percentage 
is excreted in the urine in pigs (Harris and Milne , 1981b). Recently it has been demonstrated 
that an alternative method to estimate 3MH production can be accurately described by a 
compartmental model in lambs (Rathmacher et al., 1993) (which, like pigs, do not quantitatively 
excrete in urine). This methodology is dependent on the disappearance of a tracer from plasma 
and has been validated in cattle (Rathmacher et al., 1992b) which quantitatively excrete 3MH in 
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urine. 
The objective of the current study was to describe the isotopic decay of a tracer of 3MH 
in plasma by a compartment model and to use this model to estimate 3IVIH production. The 
kinetic parameters reported in this paper can be used in subsequent studies to evaluate muscle 
proteolysis. Additionally, the relationship between 3MH compartments and lean tissue mass 
was examined. 
MATERIALS AND METHODS 
Animals and Experimental Protocol 
Twenty crossbred barrows, with an average body weight of 67 ± 1 kg, were obtained 
from the research farm herd at Lilly Research Laboratories (Greenfield, IN) and acclimated to 
metabolism crates designed for collection of urine and feces. The study protocol was approved 
by Animal Care Committee at Lilly Laboratories and all studies were performed at the 
metabolism unit of Lilly Research Laboratories (Greenfield,IN). The pigs were fed a minimum of 
a 10% crude protein corn-soy diet and watered twice daily at 7.00 and 15.30 hours. 
Approximately 21 days before the tracer study was performed, a catheter was inserted 
surgically into the femoral vein and fed into inferior vena cava. The catheter was tunneled under 
the skin an exteriorized on the back. The exit wound was treated with an antiseptic daily. On 
the morning of the study, a baseline blood sample was taken 30 min before the morning meal. 
Thirty minutes following the morning meal a bolus dosing of 3-[methyl-^H3]-methylhistidine (dy 
3MH, 11.4 mg; MSG Isotopes, Montreal, Canada), dissolved in 25 mL of sterile saline was 
given intravenously through the catheter. The catheter was flushed with additional 20 mL of 
saline to remove any remaining tracer. Serial blood samples were taken at 1, 2, 4, 6, 8, 10, 15, 
30, 45, 90, 120, 150, 180, 240, 300, 360, 480, 600, 720, 1440, 2160, 2880, 3600, 4320 
and 5760 min following the dosing of tracer. Blood (10 mL) was transferred to a EDTA-coated 
tube and placed directly into a ice bath until it could be centrifuged, after which the plasma was 
collected and stored at - 70°C. An aliquot of urine was saved from the five consecutive 24-h 
total urine output following the dosing of tracer and stored at -20°C. Average daily nitrogen 
balance was determined during the kinetic time period while the animals were in the metabolism 
crates . Subsamples of urine and feces were obtained and stored at -20°C. After the last blood 
sample was taken the pigs were taken to a local processing plant and slaughtered. Immediately 
following exsanguination muscle biopsies were taken from the Longissimus dorsi and 
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Semitendinosus muscles and frozen in liquid nitrogen and stored at -70°C. Carcass were 
weighed, and backfat and loineye area measured. One half of the carcass was dissected into 
skin, bone and soft tissue (lean plus fat). The soft tissue was ground three times and frozen in 
dry ice and stored at -20°C. 
Laboratory Analysis 
Plasma 3MH and the isotope enrichment of dg-SMH were measured using previously 
described procedures (Rathmacher et al., 1992a). Urine 3MI-I was analyzed by a modified 
procedure (Rathmacher et al., 1992a). Briefly, 5 mL urine and 170 nmoles of l-fmethyl-^Hj]-
methylhistidine internal standard was transferred to a large culture tube with 5 mL of urease 
buffer (3.5 mg /100 mL phosphate/EDTA buffer, pH 6.7; jack bean urease Type IX, Sigma 
chemical, St. Louis, MO) and incubated at 37°C to remove the urea. The remainder of the 
analysis follows the procedure as outlined in (Rathmacher et al., 1992a). Muscle 3MIH 
concentration was determined using 1 -[methyl-^IHsl-methylhistidine as the internal standard by 
the procedures described in (Rathmacher et al., 1993). The soft tissue of the carcass (non-
bone) was analyzed for moisture, fat and protein (AOAC , 1985). The protein-bound 3MH was 
determined in the soft tissue by removing the fat from 4 g of tissue (AOAC , 1985). The fat-
free residual was analyzed for protein (AOAC , 1985). Twenty-five mg of the fat-free residual 
and 310 nmoles 1-[methyl-'Hal-methylhistidine internal standard were hydrolyzed in 12 mL of 6 
N HCI for 20 h at 110°C. Five mL of hydrozalate was pipetted onto a cation exchange column 
(Dowex-50W in the hydrogen form, Sigma Chemical, St. Louis, MO). The column was washed 
with six 1-mL .01 N HCI washes. The 3MH was eluted from the column with 25% NI-I4OH into 
a 20-mL scintillation vial and dried at 65°C under a steady stream of nitrogen gas. The samples 
were derivatized analyzed by gas chromatography/mass spectrometry as previously reported 
(Rathmacher et al., 1992a). The urine obtained was processed for the determination of 
creatinine using a kit (Sigma diagnostics, creatinine kit No. 555-A, St. Louis, MO). Nitrogen 
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Figure 1. Schematic of a 3-compartment model used to analyze the kinetics of distribution, 
metabolism and de novo production of 3-methylhistidine (3MH). IVI,, IVI, and IVIs 
represent the mass of 3MH in compartments 1, 2 and 3, respectively. Lj.,, l-o.3> 
L2,3, and Lj j are fractional transfer rate coefficients of 3MH within the system. The 
tracer, 3-I®H3-methyl]-methylhistidine (Dg-SIVIH), was injected into compartment 1. 
Sampling was performed from compartment 1(A). De novo production of 3MH was 
into compartment 2. 
content of feed, urine and feces was determined (AOAC , 1985). 
Kinetic Modeling 
Mathematical modeling of the tracer data from plasma was performed on a personal 
computer using SAAM/CONSAM-31 .p modeling program (Berman and Weiss , 1978; Boston et 
al., 1981). Model code 10 was used to explain the tracer data and used a set of linear 
differential equations having constant coefficients. A minimum of three compartments were 
previously needed to accurately describe the kinetics and metabolism of 3MH (Rathmacher et 
al., 1992b). The initial model was identical to one previously validated in cattle (Rathmacher et 
al., 1992b) and was similar to the model in Figure 1, but the exit from the system was 
compartment one. Initial parameters were the kinetic parameters used to describe 3MH 
metabolism in cattle. However, this model was inadequate to describe the isotopic decay in 
swine, because the structure and parameters did not allow for an adequate fit of the data. The 
fractional standard deviations for were high resulting In a poor convergence of the observed 
data between 240 and 1440 min with the calculated data estimated by the model. Previous 
studies demonstrated that only small percentage of the released 3MH from muscle protein 
breakdown is actually excreted In the urine with the majority being conjugated as a dipeptide, 
balenine, and retained in muscle (Harris and Milne , 1981b). Therefore, a physiology-based 
model was constructed (Figure 1) and was used to describe the complete isotopic decay in 
plasma (Figure 2) after a dose of tracer. The kinetic data were entered Into compartment 1 as 
the ratio of tracer to trace as previously described for stable isotope kinetic data (Cobelll et al., 
1987). In this model, it is assumed compartment 1 represents plasma and extracellular fluid, 
while compartments 2 and 3 represent intracellular 3MH pools in tissues. In addition, 
irreversible loss into tissue pool (balenine) was derived from compartment 3 and the de novo 
steady state production of 3MH appears into an intracellular tissue compartment 2. The exit 
from the system was assumed to be an exit into balenine 'sink' that turns over slowly or not at 
all during the time frame under study. Steady state masses and transport rates were calculated, 
and the de novo production rate calculated could be used to calculate a fractional degradation 
rate for the myofibrillar proteins. The nomenclature and illustrations used in describing the 
model are the same as in the SAAM(Slmulatlon Analysis and Modeling) manual (Berman and 
Weiss, 1978). Brief definitions of the terms used are given; L(I,J) = Fraction of material 
transported from compartment J to I per unit time (fraction/min), R(I,J) = Transport of tracee 
(natural 3MH) from compartment J to I per unit time (nmol/min) under steady state conditions, 
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PIG 282 
0.001 
TIME (MIN X 1000) 
Figure 2. Disappearance of tracer, S-I^Ha-methylJ-methylhistidine, as a ratio of S-I^IHs-methyl]-
methylhistidine:3-methylhistidine in plasma as described by a 3-compartment model of 
3-methylhistidine (see Figure 1). Symbols (*) represent observed data, and the line (-) 
represents best fit generated by the model. 
U(l) = Entry of tracee into compartment I from outside of the model per unit time (nmoi/min), 
The de novo production of unlabeled 3MH from breakdown of actin and myosin proteins into 
intracellular muscle pool under steady state conditions, MID = Mass of tracee (unlabeled 3MH) 
in compartment I, K(l) = Proportionality constant associated with compartment I. CONSAM 
assumes that a component number is specified under an H DATa header statement in the input 
file, and it will automatically multiply the category associated with this component by K(l) to 
calculate QC(I). QC(I) is CONSAM's notation for calculated values. Data associated with a 
component, I, are called QO(l). K(l) represented the inverse of the space of distribution. 
The number of compartments in the model is arbitrary and reflects simply the choices of 
compartment numbers made during the development of the model. 
The de novo production rate could be used to calculate a fractional degradation 
(breakdown) rate for the myofibrillar proteins. The degradation rate was calculated by the 
following equation: FBR = 3MH production rate divided by the total protein bound 3MH pool. 
The total protein-bound 3MH pool, was calculated as follows: grams of protein soft tissue x 
3.8742 //mol 3MH/ g protein. 
Statistical Analysis 
Fractional transfer rates and steady state compartment masses and transfer rates are 
listed for each individual animal as well as the mean and SE. Pearson correlation coefficients 
were used to evaluate the relationship between model parameters and body composition using 
the SAS statistical software (SAS Inst., Inc., Gary, NC). 
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RESULTS 
Kinetic Modeling 
The mean plasma SMIH concentration (10.4 nmol/mL) was 42% lower than mean 3MH 
concentration in muscle (21.5 nmol/g of wet muscle tissue) (Table 1). The excretion of 3MH 
into urine was only 7.30 yumol/d (n = 5), 1.24% of what was calculated by the model. The d, 
-3MH data exhibited a typical disappearance pattern (Figure 2). After the injection of tracer, dy 
3MH was lost rapidly from the plasma during the first 150 to 180 min, followed by a transition 
period through 720 min, in which the decrease in tracer concentration seemed to level off. The 
final phase was characterized by a gradual decline in tracer during the remaining 5 d of the 
kinetic study. 
Table 1. Animal characteristics 
n Mean SE 
Weight*, kg 
Plasma 3-methylhistidine, nmol/mL 
Muscle 3-methylhistidine'' 
20 
20 
87.1 
10.4 
1.10 
1.15 
Longissimus dorsi, nmol/g 
Semitendinosus, nmol/g 
Urinaiy 3-methylhistidine°, /tmol/d 
20 
20 
5 
19.5 
23.5 
7.30 
1.65 
2.81 
1.40 
'Weight the day of slaughter. 
''Concentration was determined of a muscle biopsy and is expressed on a wet tissue weight. 
'Urianry 3-methylhistidine was only measured in five animals. 
The model developed used linear first-order differential equations; therefore, it is based 
on the assumption of steady-state kinetics in the animals over the duration of the experiment. 
No extreme differences or slope were seen in individual pig plasma levels (Figure 3) or in urinary 
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production of 3MH during the duration of the experiment, so the pigs were assumed to be in 
steady-state. No animal by-products were included in the diet so it was assumed that the only 
source of natural 3MH was from the degradation of actin and myosin. 
The kinetic model parameters (L,,,) are presented in Table 2. Variations of the 
parameters were evaluated by the coefficient of variation (%CV = 100 x SD + mean) of each 
individual parameter. Ranges for %CV were from 10 to 43% for La,,, 12 to 30% for L,,2, 6 to 
40% for Lo,„ 11 to 47% for Lj j, and 10 to 41 % for Lj.s. These parameters were within the 
16-
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Figure 3. Concentration of 3-methylhistidine (• ± SE) (average of 20 pigs) are plotted for the 
duration of the experiment. There was a random distribution about the overall average 
(10.4 nmol/mL) with no slope (••••• ). 
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acceptable range. A %CV greater than 100% is not acceptable for a model parameter 
estimation (Wolfe , 1992). In previous studies using cattle, the %CV's for the Lu were less 
than 50%. 
The 3-methylhistidine model compartment mass (M,) and mass transfer rates (R,,,) are 
presented in Table 3. Compartment 2 is 2.6 times larger than compartment 1, and 
compartment 3 is 5.61 times larger than compartment 1. Steady state transport rates indicate 
that there is rapid exchange of 3MH (nmol/min) between pools 1 and 2, compared with a slowly 
turning over pool 3. The twenty-pig average de novo 3MH production rate was 621.3 ± 25.34 
//mol/d. The average de novo production rate into compartment 2 corresponded to a average 
fractional breal<down rate of 2.66 ± .203 %/d. 3-methylhistidine expressed on a creatinine 
ratio basis is an indicator of the amount of myofibrillar protein degraded per muscle mass and 
was 0.224 ± 0.011 //mol/mg. 
Estimates of lean tissue were correlated with the model parameter M(3), mass size of 
compartment 3 (Table 4). M(3) ranged from 306,464 to 1,153,050 nmoles and estimates of 
lean tissue ranged as follows: predicted lean (kg) estimated by previously reported equation 
(Mowrey et al., 1991) based on carcass measurements ranged between 27.6 and 43.5; 
analyzed soft tissue (muscle and fat) protein of the protein (l<g) ranged between 4.28 and 8.48; 
analyzed fat free mass of soft tissues (protein + water) (leg) ranged between 26.1 and 40.0. 
Model parameter M(3) was correlated with lean (r = 0.46, P = .04), tissue protein (r = 0.47, 
P = 0.04) and fat free mass (r = 0.59, P = 0.006). 
Estimates of muscle proteolysis was also correlated to nitrogen balance. Nitrogen 
balance ranged from 12.0 to 34.1 g/d and estimates of muscle proteolysis ranged between 
0.147 and 0.326 3MH;creatinine ratio (//mol/mg) and 1.34 to 4.55 %/d for the FBR. Nitrogen 
balance was negatively correlated with the 3MH;creatinine ratio (r = -0.57, P = 0.008) and with 
FBR (r=-0.54, P = 0.01). 
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Table 2. Kinetic parameters and steady state values of a three compartment model of 3-
methylhistidine metabolism (n = 20) 
Mean SE 
K|, min'' * 0.00012 0.000015 
Space of distribution, mL*" 11326.2 1307.06 
Fractional transfer rate, (L,j)°, min'' 
1-2,1 0.2292 0.02414 
LI,2 0.09224 0.01195 
U.3 0.0009 0.00008 
^3,2 0.0140 0.00248 
1-2,3 0.0061 0.00113 
Compartment mass (Mi)'', nmoles 
M(l) 95778 5891.2 
M(2) 246530 12969.0 
M(3) 538162 52192.8 
U(2) 432 17.6 
Mass transfer rates (R|j)°, nmol/min 
R2.. 21278 2483.0 
Rl,I 21278 2483.0 
Ro,3 432 17.6 
R3.2 3134 477.5 
1^2,3 2702 465.1 
De novo 3-methylhistidine production 
/tmol/d 621.3 25.34 
/xmoMcg'-d' 7.18 0.335 
Fractional breakdown rate, (%/d)' 2.66 0.203 
3-Methylliistidine : creatinine, /tmol/mg 0.224 .011 
*K(1) is the inverse of the space of distribution of compartment one. 
''Volume of distribution is the volume of compartment one. 
''Lij, the fractional transfer rate from compartment j to i. 
''M(i), the mass of compartment i. 
'Rij, the mass transfer rate from compartment j to i. 
The fractional breakdown rate was calculated by dividing the daily production rate of 3-
methylhistidine (3MH) by the protein-bound 3MH muscle pool. The protein-bound pool of 3MH was 
calculated by multiply the protein content of the soft tissue times the analyzed content of 3MH, 3.8742 
^mol of 3MH /g of protein. 
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Table 3. Relationship of model parameters with body composition and nitrogen balance 
Correlation' Coefficient P-value 
M(l)'' (nmoles) to estimations of muscle mass 
predicted lean (kg)" 
tissue protein (kg)'' 
fat free niass(kg)* 
ether extract (kg)' 
M(2) (nmoles) to estimations of muscle mass 
predicted lean (kg) 
tissue protein (kg) 
fat free mass (kg) 
ether extract (kg) 
M(3) (nmoles) to estimations of muscle mass 
predicted lean (kg) 
tissue protein (kg) 
fat free mass (kg) 
ether extract (kg) 
Urinary creatinine* (mg/d) to estimators of muscle mass 
predicted lean (kg) 
tissue protein (kg) 
fat free mass (kg) 
Nitrogen balance** (g/d) to indicators of muscle proteolysis 
3-methylhistidine : urinary creatinine (/tmol/mg) 
fractional breakdown rate of muscle protein (%/d) 
-0.37 
-0.25 
-0.24 
0.23 
-0.10 
-0.06 
-0.04 
-0.33 
0.46 
0.47 
0.59 
-0.43 
0.73 
0.48 
0.69 
-0.57 
-0.54 
0.11 
0.28 
0.30 
0.32 
0.68 
0.81 
0.87 
0.15 
0.04 
0.04 
0.006 
0.08 
0.0002 
0.03 
0.0008 
0.008 
0.01 
'Pearson's correlation coefficients are presented with the corresponding level of significance. 
Twenty animals were used in this analysis. 
''M(i) = the mass of compartment i in nmoles. 
°Lean tissue (kg) was predicted using a previously reported equation (Mowrey el al., 1991). 
''Crude protein (kg) of the soft tissue in the carcass (muscle and fat). 
'Crude protein and water minus ether extract (kg) of the soft tissue in the carcass (muscle and 
fat). 
'Ether extract (kg) of the soft tissue in the carcass (muscle + fat). 
'Urinary creatinine (mg/d) determined during the time period of the kinetic study. 
''Nitrogen balance (g/d) determined during the time period of the kinetic study. 
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DISCUSSION 
Kinetic Modeling 
The major objectives of this study were to show that the 3MH kinetics of a stable 
isotope could be described by a compartmental model and to determine whether a de novo 
production rate of the tracee could be estimated. This method is of potential value to estimate 
the fractional breakdown rate of muscle protein because urinary 3MH is invalid for use in pigs 
(Harris and Milne , 1981b). We have described the in vivo kinetics of 3MH in pigs by means of 
a simple serial model requiring 3-compartments and sampling of only plasma to characterize the 
complete metabolism of 3MH (Figure 1 and 2). The kinetic parameters, L|,|, compartment mass 
M| and ass transfer rates R|,j are presented as a reference for future modeling of 3MH 
metabolism in pigs. 
The model presented is based on previous knowledge of 3MH metabolic pools in other 
species (Rathmacher and Nissen , 1992; Rathmacher et al., 1993; Rathmacher et al., 1992c) 
and based on the kinetic behavior of 3MH as modeled in these species. 3-Methylhistidine had 
been reported as a natural component of urine, muscle and plasma (Harris and Milne , 1981b) in 
the pigs. There is also present in muscle a very large pool of balenine, which was maintained 
and increased in both newly established and newly accreted muscle tissue by the retention of 
some 3MH released by muscle protein breakdown. The L,j (min'M parameters for pigs compared 
to lambs, a species which also retains a large proportion of 3MH as balenine, were slightly 
different: exchange of label between compartments 2 and 1, Lj,, (0.229 vs 0.104) and L,,2 
(0.092 vs 0.0599), were higher for pigs; exchange of label between compartments 2 and 3, L3 2 
(0.0140 vs 0.0033) and 13,3 (0.0061 vs 0.0022), were also faster for swine; and exit out of 
compartment 3 was much faster for pigs as compared to lambs, Lq.s (0.0009 vs .00011). 
Some of these differences can be explained physiologically, the primary exit of 3MH in pigs is 
into a balenine pool and very little is actually excreted in the urine, where as in sheep 15% of 
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the 3MH is excreted into urine and 85% is synthesized into baienine.The pool sizes of pigs are 
approximately half that of lambs. However, even with smaller compartment masses the pig 
still transfers more 3MH tracee (R,,|) between compartment 2 and 3. 
Based on the size of compartment 1, M,, has a mass similar to extracellular water 
space. Compartments M, and M, are most probably intracellular muscle pools of 3MH (Table 3), 
based muscle biopsy data from lambs (Rathmacher et al., 1993). The exit out of pool 3 was 
most likely into a balenine "sink." The exit was assumed to be an exit into a balenine pool that 
was thought to turn over very slowly or not all during the duration of the study because 
balenine seems to accumulate in the muscle of pigs. The assumption is based on observations 
reported by Harris and Milne (Harris and Milne , 1981b). 
There are currently no valid methods for directly accessing muscle protein breakdown 
in pigs. Other methods for studying muscle protein degradation are limited, and methods that 
are available allow for indirect calculation of muscle degradation if the fractional accretion rate 
of muscle protein is known or estimated (FBR = FSR-FAR) (Millward et al., 1975). In this sludy, 
the average PER was 2.66 %/d. These results are similar to that report for 45 kg pigs 
(longissimus dorsi 2.5 %/d and semitendinosus 3.3 %/d) (Mulvaney et al., 1985) and to pigs of 
similar weight {semitendinosus 3.4%/d) (Bergen et al., 1989). 
Use of urinary 3MH to specifically estimate muscle proteolysis has been criticized 
because skin and gastrointestinal tract may contribute to daily production of 3MH (Nishizawa et 
al., 1977; Millward et al., 1980). However, recent data in humans with varying degrees of 
infection indicate the release of 3MH from the leg was highly correlated with the urinary output 
of 3MH (Sjolin et al., 1989) and the splanchnic region contributes less than 10% to total urinary 
3MH production. The model, as currently constructed, cannot distinguish between muscle, 
skin, and intestinal production of 3MH. Based on these observations it is reasonable to assume 
that the compartmental model is largely reflective of muscle metabolism. 
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Relationship of model parameters 
An advantage of a compartmental model of 3MH is that it provides additional 
Information about the metabolism of 3MH. Urinary 3MH cannot provide information about 
compartment sizes nor about transport between compartments. In Table 4 we demonstrate a 
relationship between estimators of muscle mass (estimated lean, protein in the soft tissue and 
fat free mass of soft tissue) and M3, an intracellular pool of 3MH. The relationship of FFM 
with urinary 3MH has been demonstrated in humans (Lukaski and IVIendez , 1980; Lukaski et 
al., 1981; Mendez et al., 1984). Therefore, this initial information indicates that the model may 
have practical application as an estimator of muscle mass. 
In attempt to indirectly validate the model, muscle proteolysis as estimated from the 
model de novo 3MH production rate were related to nitrogen balance. Based simply on size, the 
skeletal muscles are of major quantitative importance in overall protein metabolism. Muscle 
protein turnover accounts for 25% of whole body protein breakdown (Young and Munro , 
1980). The estimates of muscle proteolysis presented in this paper were negatively correlated 
nitrogen balance. 
The present model represent a framework and methodological approach describing 
steady state 3-methylhistidine kinetics in the whole animal and constitutes a working theory for 
testing by further experimentation with designs altering muscle protein breakdown. An 
advantage of a compartmental model of 3MH is that it provides additional information about the 
metabolism of 3MH. Urinary 3MH cannot provide information about compartment sizes nor 
about transport between compartments. The significance of transfer rates between 
compartments and compartment sizes is not yet fully understood. This model does not 
necessitate quantitative urine collection and therefore, reduces error due to the frequency of 
plasma sampling versus the infrequency of urine collection in the other models. The model 
measures the total production rate independent of the determination of free or conjugated 
forms, even though the majority of 3MH exit the model presumably into a balenine pool the 
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model can account for it. The model does, however, need further validation as a method for 
estimating 3MH production, but was validated indirectly in growing steers (Rathmacher et al., 
1992b). The preliminary data presented there suggested that the model was as effective as 
quantifying urinary 3-methylhistidine. 
Implications 
There are currently no methods to directly quantitate muscle protein breakdown in 
pigs. The decay of a tracer of 3-methylhistidine can described by a Icinetic compartmental 
model and allows for the estimation of de novo 3-methylhistidine production. Based on 3-
methylhistidine production the fractional breakdown rate can be quantitated and are similar to 
previously reported values. This methodology is less evasive and will be useful in testing further 
experimentation with designs that alter muscle protein breakdown. 
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APPENDIX 
This table illustrates a sample saam31 (simulation, analysis and modeling) problem deck. The 
following is the input deck as it would be entered into saam and a brief explanation of what 
these parameters mean will follow the deck. 
123456789012345678901234567890123456789012345678901234567890 
1 A SAAM31 CRATE 10 PIG 282 
2 C BLOCK 3 GROUP 2 
3 C 3-METHYLHISTIDINE SWINE 
4 C 
5 C 11/91 
6 H DAT 
7 M(l) 
8 M(2) 
9 M(3) 
10 U(2) 
11 R(2,l) 
12 R(l,2) 
13 R(0,3) 
14 R(3,2) 
15 R{2,3) 
16 XG(1)=F(1)/P(90) 
17 lOlG(l) /66318.9 FSD=.l 
18 0 
19 1 0.510054 
20 2 0.331941 
21 4 0.237059 
22 6 0.212967 
23 8 0.189671 
24 10 0.175456 
25 15 0.151927 
26 30 0.119257 
27 45 0.107447 
28 60 0.099849 
29 90 0.090196 
30 120 0.083549 
31 180 0.076337 
32 240 0.071592 
33 300 0.061342 
34 360 0.063427 
35 480 0.058349 
36 600 0.057174 
37 720 0.044086 
38 1440 0.031401 
39 2160 0.021269 
40 2880 0.011802 
41 4320 0.006743 
42 5760 0.003104 
43 H PAR 
44 IC(1) 1 
45 K(l) 1.672225E-04 9.999998E-07 1. OOOOOOE+00 
46 L(2,l) 3.663404E-01 9.999998E-03 9. OOOOOOE-•01 
47 L(l,2) 1.315510E-01 9.999998E-04 9, OOOOOOE-01 
48 L(0,3) 9.801533E-04 9.999998E-07 1. OOOOOOE-02 
49 L(3,2) 1.893098E-02 9.999998E-06 5. OOOOOOE-02 
50 L(2,3) 9.395287E-03 9.999998E-06 5. OOOOOOE-02 
51 P(90) 16.45 
52 H STE 
90 
53 M{l)=16.45/K(l) 
54 U(2) 4.899166E+02 1000 
55 Y 
Explanation of line In problem deck. 
Line # 
1 Title. 
2 C Indicates a comment line. 
6 Signifies a data stream to follow. 
7-9 Request steady state data on M(i), Mass of compartment I. 
10 Request the rate of de novo 3MH production be reported. 
11-15 Request the, R(j,i), mass transfer rate from compartment i to j be reported. 
16 Tell SAAM to express calculated data as ratio of traceritracee. 
17 Defines the data entered in compartment 1; 101G(1) = specifies the following 
data to be entered into compartment 1, 66318.9 = Dose of tracer In 
nmoles,FSD = Fractional standard deviation (variation associated with data). 
18-19 Data Input, time Is in min, data is entered as tracer;tracee and converted to 
fraction of dose by dividing by the dose. 
43 H PAR, Signifies the start of a parameter stream. 
44 Initial conditions in compartment 1 
45 Inverse space of distribution 
46-50 Fractional tranfer coefficients (L,,|) for value of last iteration with minimun and 
maxium costraints 
51 Actual concentration of 3MH in plasma, nmol/ml 
52 H STE, Signifies that a steady state solution is requested 
53 Equation describing the mass of compartment 1 
54 Estimate of the production rate into compartment 2 
55 Stop command 
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PAPER IV. A COMPARTMENTAL MODEL TO MEASURE 3-METHYLHISTIDINE 
PRODUCTIONS IN DOGS FOLLOWING SURGERY 
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ABSTRACT 
After surgery the repair of injured tissues places a high demand on protein and energy needs of 
the animal. Wasting of tissues can occur especially to muscle protein in these circumstances. 
To understand the role of muscle proteolysis in this process, the urinary amino acid 3-
methylhistidlne (3MH) has been used as an index of muscle protein degradation in humans and 
in animals. This method requires the quantitative collection of urine and yields no detail 
information about the metabolism of 3MH in vivo. The goal of the current research was to 
develop an alternative method to measure 3MH production and apply it to a post-surgery model 
of protein metabolism. In five dogs selected at random from 40 experimental dogs, the 
metabolism of 3MH was defined from a single dose of deuterated tracer (.62 mg, 
methyll-methylhistidine). The resulting isotopic decay curve in plasma (0 to 4320 min) was 
described by a linear 3-compartment model. The complete model defined masses and fluxes of 
the tracee between the three compartments in the body and entry into the system or de novo 
production of 3MH. From the complete model of 3MH metabolism a similar practical isotopic 
model (minimal) was constructed by lumping the three compartments together into one 
metabolic pool of 3MH. This minimal 1-compartment model utilized plasma samples obtained 
from 720 to 4320 min after isotope injection. The de novo production of 3MH as calculated by 
the complex and minimal models were not different (92.7 vs 94.3 /ymol/d, respectively, P > 
0.25). However, urinary 3MH production (71.6 ^mol/d) was 25% lower than the model 
estimates of 3MH production and significantly lower than as estimated by the minimal model (P 
< 0.05). To investigate the effect of post-surgery nutrition on muscle protein degradation, 40 
beagle females were fed either 50% of their energy and protein requirement (treatment 50/50) 
or 100% of their energy and protein requirement (treatment 100/100). In addition, a powdered 
supplement was added to the two diets and supplied 20% of the energy and 50% of the protein 
requirement (treatments 70/100 and 120/150). On d 13, animals were injected with the tracer 
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and production measured using the minimal model. Treatments 100/100 and 120/150 
decreased 3MH production as compared to treatment 50/50 (12.4 and 10.1 vs 16.6 
|/mol'ko'^'d'\ respectively, P < 0.05). The fractional breakdown rate of muscle protein was 
increased by treatment 50/50 as compared to the other dietary treatments, P < 0.05. In 
summary, these data demonstrate that 3MH production can be estimated by compartmental 
analysis without the collection of urine in dogs and that adequate dietary intake of energy and 
protein is needed to prevent the catabolic effect of surgery on skeletal muscle. 
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INTRODUCTION 
Surgery injury is accompanied by metabolic events that are generally catabolic to 
muscle tissue, characterized by a negative nitrogen balance and a decrease in muscle mass 
(Cuthbertson 1931; Cuthbertson 1930). Skeletal muscle is the largest protein store in the body 
comprising 40% of the total protein content of the body. (Young 1970) and, It supplies needed 
energy and amino acids for, wound healing, tissue protein synthesis and immune function 
(Blackburn et al. 1977; Remillard and Martin 1990). 
The role of protein synthesis and proteolysis in regulating the catabolic process after 
surgery is largely unknown. Similarly the interaction of surgery with nutritional status and Its 
effect on protein turnover is not known (Remillard and Martin 1990). 
Urinary 3-methylhistidine has been used as an index of muscle breakdown and the 
excretion of 3MH has been shown to increase following injury and infection (Boileau et al. 
1972; Young and Munro 1978; Long et al. 1979). Although the method has been useful, total 
quantitative urine collection makes the method difficult to implement. An alternative method for 
quantitating 3MH production in vivo is to use an isotopic compartmental model to measure the 
de novo production of 3MH rather than excretion. This isotope methodology has been used in 
several species (Rathmacher et al. 1992e; Rathmacher et al. 1992b; Rathmacher et al. 1992c; 
Rathmacher et al. 1992c; Rathmacher et al. 1993a; Rathmacher et al. 1993) and metabolic 
conditions (Rathmacher et al. 1993b; Rathmacher et al. 1992d; Link et al. 1991). The objective 
of the present research was to evaluate the usefulness of compartmental models of 3MH 
metabolism in dogs and to use the model to evaluate the effect of post-surgery nutrition level on 
muscle protein breakdown. 
METHODS AND MATERIALS 
Animals 
Forty intact female research beagles, between the ages of nine months and two years 
and average initial weight of 7.6 leg were obtained from a commercial supplier (IHazelton l<ennel, 
Hazelton, Wl). The dogs were current on all vaccinations and were tested free of intestinal 
parasites and heartworm before beginning the study. The beagles underwent a five day 
acclimation period to accustom themselves to the diet and the research environment. 
For the experimental phase, each dog was randomly assigned to one of four diet group 
in a random blocit design (n = 10 per treatment). Each dog was individually housed in a 
metabolism crate for urine and fecal collection and had free access water. The crates were 
stainless steel (1m x 1m x 1m) with slatted floors. 
Diet 
During the Pre-operative period, days -5 to -1, all dogs were fed Hill's Science Diet-
Canine Maintenance Dry. The energy requirement was calculated using the basal energy 
requirement (BER) of [30 kcal x wt (kg) + 70] times a cage rest adjustment factor of 1.25 
(Lewis et al. 1990) and the protein requirement was calculated as 4.5 g protein for every 100 
kcal of energy. The daily requirement was divided and fed in a morning and evening meal, 8.00 
and 15.00 h, respectively. The composition of diets is presented in Table 1. The chemical 
composition of Hill's Science Diet-Canine Maintenance Dry was: moisture 6.7%, crude protein 
23%, fat 14.2%, fiber 1.3% and metabolizable energy 4290 kcal/kg and the chemical 
composition ProBaiance (SmithKline, Beecham, Animal Health, West Chester, PA) was: 
moisture 3.0%, crude protein 28%, fat 21.0%, fiber 1.0% and metabolizable energy 3300 
kcal/kg. 
Post-operative energy needs were based on the BER times a post-operative 
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adjustment of 1.35 (Lewis et al. 1990) and the protein requirement was calculated as 4.6 g 
protein for every 100 kcal of energy. The maintenance diet was all from the same lot in order 
to prevent lot to lot variation. The experimental post-operative diet consisted of four treatment 
groups: 
Treatment 50/50 These dogs were offered Hill's Science Diet by mouth in the amount 
calculated to meet 50% of the post-operative energy and protein needs. 
Treatment 100/100 These dogs were offered Science Diet by mouth in the amount 
calculated to meet 100% of the post-operative energy and protein needs . 
Treatment 70/100 (PB> These dogs were offered Science Diet by mouth to meet 50% 
of the calculated post-operative energy and protein need. In addition, they received a 
protein source from ProBalance, <PB), a powdered supplement, in quantities sufficient 
to provide a minimum of 100% of the dogs' daily protein need and 70% of the energy 
need. The ProBalance, mixed with warm water, was fed through a gastrostomy 
catheter for the first three days post-operatively. One-half of the amount was 
administered in the morning and the other one-half in the afternoon. After day 3 the 
ProBalance was added dry to the food. Other dogs not receiving the supplement were 
given warm water only. 
Treatment 120/150 (PB) These dogs were offered Science Diet by mouth to meet 
100% of the calculated post-operative energy and protein need. In addition, they 
received a protein source from ProBalance (PB) in quantities sufficient to provide a 
minimum of 150% of the dogs' daily protein need and increased the energy content of 
the diet to 120% of the energy need. The ProBalance was fed through a gastrostomy 
catheter for three days post-operatively. In certain cases it was not possible to utilize 
the catheter due to loss of patency. One-half of the amount was administered in the 
morning and the other one-half in the afternoon. After day 3 the ProBalance was 
added dry to the food. 
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Table 1. Composition of dietary treatments for each kilogram of dog weight. * 
Dietary treatments'' 
50/50 70/100 100/100 120/150 
Hill's Science Diet°, g-kg''>d'' 5.8 5.8 11.6 11.6 
ProBalance"*, g-kg^'-d"' 0 3.1 0 3.1 
Total, g'kg''*d'' 5.8 8.9 11.6 14.7 
Energy, kcal'kg'''d'' 24.9 35.1 49.8 60.0 
Protein, g-kg^'-d"' 1.33 2.20 2.67 3.54 
Fat, g-kg-'-d'' .82 1.48 1.65 2.30 
4 
* Post-operative diets were fed from day 0 to day 15 with diet adjustments every five days 
according to the dog's weight. The first dose of ProBalance was given approximately 12 hours following 
the surgical procedure with dry food being offered in the evening of day 1 (approximately 24 hours 
postoperatively). ProBalance was fed through a gastrostomy tube for 3 days post operative mixed with 
warm water. 
** Treatments represent the percentage of dietary energy and protein, respectively. Protein 
requirement is the percentage of assumed protein recommendation (4.5 g protein/100 kcal). Energy 
requirement during the post-operative period was based on the basal energy requirement adjusted for post­
operative care. Before surgery (day -1 to -5), the energy requirement was based on the basal energy 
requirement adjusted for cage rest and the dogs were fed at the rate of 10.8 g-kg '-d ' of Hill's Science 
Diet^ 
° Hill's Science Diet, Canine Maintenance Dry. Chemical composition: moisture 6.7%, crude 
protein 23%, fat 14.2%, fiber 1.3%, metabolizable energy 4290 kcal/kg. One-half was fed in the morning 
and one-half was fed in the evening. 
** ProBalance, a product of SmithKline, Beecham, Animal Health. Chemical composition; 
moisture 3.0%, crude protein 28%, fat 21.0%, fiber 1.0%, metabolizable energy 3300 kcal/kg. ProBalance 
was mixed as a 50% solution of water and was fed via a stomach tube on day 1, 2 and 3. One-half was fed 
in the morning and one-half was fed in the evening. After day 3, ProBalance was mixed dry with the 
maintenance diet. 
Experimental Design 
Study protocol was approved by The Committee on Animal Care at Iowa State 
University. All studies were performed at the Laboratory Animal Resources, Central Facility and 
animal care was supervised by the clinical veterinarian. On experimental days -5 to 15 urine 
and feces were collected. Cage rest maintenance diet was fed from days -5 to -1 and surgeries 
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were performed on day 0 after an overnight fast. Anesthesia was induced by injection of a 
barbiturate (Thiopental) into the cephalic vein and maintained by a inhalation mixture of 2-3% 
halothane gas in oxygen. A ventral mid-line exploratory procedure was performed followed by 
the placement of an indwelling gastrostomy tube (Foley catheter) and a gastropexy. Three 
additional 5.0 cm skin incisions were made dorso-laterally and each wound stapled with six 
staples. All the dogs were monitored post-operatively until they were alert and able to eat and 
drink. The gastrostomy tube was removed on day 3 post-operative and the midline sutures 
were removed on day 10. Post-operative diets were fed from day 0 to day 15 with diet 
adjustments every five days according to the dog's weight. The first dose of ProBalance was 
given approximately 12 hours following the surgical procedure with dry food being offered in the 
evening of day 1 (approximately 24 hours postoperatively). 
3-Methylhistidine plasma kinetics were evaluated by compartmental analysis on day 
13. On the morning of day 13 a 20-gauge catheter was inserted into the saphenous vein for 
administration of tracer and blood sampling. Approximately one hour after the catheters were 
placed, a baseline blood sample was taken and the dogs then were given 3.6 //moles of 
methyll-methylhistidine (MSD Isotopes, St. Louis, MO) (d3-3MH) into the catheter in a bolus, 
dose. The isotope was previously dissolved in .9% normal saline and filtered. The catheter 
was then flushed with an additional 5 mL .9% normal saline to remove any traces of isotope. In 
five randomly selected dogs tracer was given and blood samples were taken at 2, 15, 90, 180, 
360, 720, 1440, 2160, 2880, and 4320 min and were transferred to EDTA-coated tubes. The 
35 remaining dogs were given 3600 nmoles of 3-[^H3-methyi]-methylhistidine ((/3-3MH) and 
blood samples were taken at 720, 1440, 2160, 2880, and 4320 min by venepuncture of the 
jugular vein using Vacutainer EDTA-coated tubes. Blood samples were placed directly into an 
ice bath until they could be centrifuged and plasma collected and stored at -70°C. 
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Analytical Methods 
An aliquot of the plasma was processed for determination of 3MH concentration as 
well as the L-3-[methyl-'H3]-histidine:3-methylhistidine isotope enrichment by a previously 
described method (Rathmacher et al. 1992a). The urine obtained was processed for the 
determination of creatinine using a diagnostic kit (Sigma diagnostics, creatinine kit No. 555-A, 
St. Louis, MO). Urinary 3MH concentration was determined (Rathmacher et al. 1992a) and 
urine production was measured In all dogs. Daily urinary 3MH production was calculated for 
each dog after exogenous dietary 3MH had been subtracted (77.8 /vmol/kg of Hill's Science Dry 
and 66.4 ^mol/kg of ProBalance). 
Compartmental Modeling 
Mathematical modeling of the tracer data from plasma was performed on a personal 
computer using SAAM/C0NSAM-31.p modeling program (Berman and Weiss 1978; Boston et 
al. 1981). The tracer data was explained using linear compartmental models. Five dogs 
selected at random were used to construct and evaluate the complete model. The estimate of 
3MH production will be compared to 3MH production as estimated from collection of urine. 
The model proposed is based on known physiology and is identical to one previously validated in 
cattle (Rathmacher et al. 1992b). A minimum of three compartments were previously needed to 
accurately describe the kinetics and metabolism of 3MH (Rathmacher et al. 1992b). The 
physiology-based model is presented in Figure 1A and was used to describe the complete 
isotopic decay in plasma (Figure 2A) after a dose of tracer. The kinetic data were entered into 
compartment 1 as the ratio of tracer to trace as previously described for stable isotope kinetic 
data (Cobelli et al. 1987). In this model, it is assumed compartment 1 represents plasma and 
extracellular fluid, while compartments 2 and 3 represent intracellular 3MH pools in tissues. In 
addition, irreversible loss into urine was derived from compartment 1 and the de novo steady 
state production of 3MH appears into an intracellular tissue compartment 3. 
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The same data from the five dogs were modeled using a subset of the plasma kinetic 
data (720 to 4320 min). In this case, the 3-compartments of the complete isotopic plasma 
decay model are lumped together to form a 1 -compartment model. The 1 -compartment model, 
represented in figure 1B, represents the metabolic pool of 3MH as a single pool with a single 
exit and a single entrance for do novo production into the pool. The kinetic data from 720 to 
A. COMPLETE MODEL 
t, D,.3MH DENOVO 
•14 
URINE 
B. MINIMAL MODEL 
* 0,.3MH 
DENOVO 
URINE 
Figure 1. A) Schematic of a 3-compartment model used to analyze the kinetics of 
distribution, metabolism and de novo production of 3-methylhistidine (3MH). M,, 
and M3 represent the mass of 3MH in compartments 1, 2 and 3, respectively. 
Lj,!' 1-0,1.1-2,3. and Lj.s are fractional transfer rate coefficients of 3MH within 
the system. The tracer, 3-[^H3-methyl]-methylhistidine (D3-3MH), was injected into 
compartment 1. Sampling was performed from compartment 1 (A). De novo 
production of 3MH was into compartment 3. B) Schematic of a 1-compartment 
model used to analyze the kinetics of distribution, metabolism and de novo 
production of 3MH. 
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4320 min was entered into compartment in the same manner as for the 3-compartment model 
(Figure 2B). The 3MH plasma kinetic data from remaining 35 dogs was described by the 1-
compartment model and the de novo production of 3MH estimated. 
Statistical Analysis 
The data were analyzed using the General Linear IVIodels (GLM) of SAS (SAS Inst., 
Inc., Gary, NO). The Least Squares Means were reported. The 1- and 3-compartment 
estimates of 3MH production were compared to urinary 3MH production by one-way ANOVA 
A 
OOQ 10281 1 
t.l 
0.01 
0.001 4 0 
TIMI (MIN X 1000) 
B 
1 Doa 10291 
TIMI (MIN X 1000) 
Figure 2. A) Disappearance of tracer, S-I^Ha-methyll-methylhistidine, as a ratio of 3-[^H3-
methyl]-methylhistidine:3-methylhistidine in plasma as described by a 3-compartment 
model of 3-methylhistidine (see Figure 1A). Symbols (*) represent observed data, and 
the line (-) represents best fit generated by the model. B) Disappearance of tracer, 
3-[^H3-methyli-methylhistidine, as a ratio of 3-[^H3-methyl]-methylhistidine:3-
methylhistidine in plasma as described by a 1 -compartment model of 3-m6thylhistidine 
(see Figure IB). 
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and means compared by a T test. The effects of post surgery nutrition level on muscle 
proteolysis were analyzed by randomized block ANOVA and treatment means were compared by 
a T test. Comparison of the powdered supplement, ProBalance, to dry food alone was 
accomplished by a contrast, 50/50 and 100/100 vs 70/100 and 120/150. 
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RESULTS 
Model Development 
The model developed used linear first-order differential equations; therefore, it was 
based on the assumption of steady-state kinetics in the five randomly selected dogs over the 
duration of the experiment. Plasma levels of 3MH did not change over the period of the study, 
so steady state was assumed. A representative decay of c/g-SMHtSMH following injection of 
tracer through 4320 min is presented in Figure 2A. The decay curve was best described by 
three compartments using the model described in Figure 1A and resulted in an adequate fit 
between the observed and calculated data points. The slope of curve was similar to that of 
other species evaluated with this model (Rathmacher et al. 1992b; Rathmacher et al. 1992e; 
Rathmacher et al. 1992c). The decay curve was characterized by a rapid decrease in the d^-
3MH;3MH ratio during the first 6 hours followed by a slow linear decay over the three days of 
blood sampling. 
The kinetic model parameters (L|j) used to describe the kinetic response is presented 
in Table 1 for the complete 3-compartment model. In addition, the steady state compartment 
mass (M,|, de novo 3MH production and mass transfer rates (Rg) values are presented in Table 
1. The mass of 3MH in compartment 2 was 2.5 times larger than compartment 1 and 
compartment 3 was 3 times larger than compartment 1. The quantity of 3MH transfer between 
compartments 1 and 2 was 6 times faster than the transport of 3MH between compartments 2 
and 3. 
A minimal model (720 to 4320 min) is depicted in Figure 1B and a represented curve 
is presented in Figure 2B. The minimal model essentially lumps together the three metabolic 
pools of the 3-compartment into one body pool of 3MH. This model has one exit out of the 
system and an entrance for the de novo production of 3MH from muscle protein breakdown. 
The curve appears to be linear on a semilog plot from 720 to 4320 min and an acceptable fit 
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COMPLETE 
Figure 3. Daily 3-methylhistidine (3MH) production expressed as jumol/d for each method of 
quantitating 3MH production. URINE = urinary 3MH excretion, COMPLETE = 3-
compartment model estimation of 3MH production and MINIMAL = 1-compartment 
model estimation of 3MH production. 'Significantly higher than urine at P < 0.10. 
"Significantly higher than urine at P < 0.05. 
was obtained between the observed and calculated data points. The sum of the three 
compartments of the complete model was 156,930 nmoles (calculated from Table 1) compared 
to 154,573 ± 26119 nmoles for the body compartment of 3MH as calculated by the minimal 
model. The fraction of 3MH leaving the minimal model (Lqj ) was slower than the fraction 
leaving compartment 1 of the complete, 0.00049 compared to 0.0030 min'\ respectively. 
The estimations of de novo 3MH production as calculated by the models were 
compared to traditional quantitation of urinary 3MH ANOVA (P = 0.085). The coefficient of 
variation associated with urine, complete and minimal models used for quantitating 3MH 
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production were 4.7, 4.4 and 7.7%, respectively. There were no differences when comparing 
of 3MH production (Figure 3) of the 3-compartment complete and 1 -compartment minimal 
models. However, urinary 3MH production was 25% lower than model estimation of 3MH 
production. The minimal model estimation of 3MH production was higher(P < 0.05) and the 
complete model tended to be higher(P < 0.10) than urinary 3I\/IH production. Urinary 3MH 
production was, however, highly correlated to the model estimation of 3MH production with a 
correlation coefficient of r = .70 ( P < .0001, n = 40). 
Post-surgery Nutrition 
In a previous report (Sperling et al. 1993), the dogs on the 50/50 treatment lost more 
weight over the course of the experimental period than any other treatment. The dogs given 
the nutritional powdered supplement (Treatments 70/100 and 120/150, 2.13 and 1.53 l<g, 
respectively) tended to lose less weight than the treatments without additional supplement 
(Treatments 50/50 and 100/100, 3.00 and 1.68 kg, respectively). Treatments 50/50 and 
70/100 (-15.60 and -11.86 g nitrogen, respectively), which were limited in energy, were in 
greater negative nitrogen balance than treatments 100/100 and 120/150 (-7.07 and -3.78 g 
nitrogen, respectively). The dogs fed the nutritional supplement were in less negative nitrogen 
balance when compared to treatments without supplementation. 
The dietary treatment 120/150 resulted in 40% higher daily urinary creatinine 
production than treatment 50/50 (P < 0.10) and was numerically higher (250.8 vs 185,1 
mg/d) than the 100/100 treatment group (Table 3). There were no significant treatment 
differences in urinary 3MH production on a daily basis or when expressed on body weight basis. 
However, when represented as a ratio of daily creatinine production, treatments 100/100 and 
120/150 resulted in a 50% lower 3MH to creatinine ratio ( P < 0.10) compared to treatment 
50/50 suggesting a reduction in proteolysis per unit of muscle mass. 
The dogs limited in both energy and protein (treatment 50/50) had a 3MH production 
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rate (as estimated by compartmental analysis) of 123.9 /imol/d while the dogs on treatments 
70/100, 97.9//mol/d (P < 0.05) and 120/150, 82.1#/mol/d IP < 0.05) had lower 3MH 
production rates. The dogs fed adequate energy and protein (treatment 100/100) tended to 
have a lower production rate of 3MH than the limited fed dogs (18% decrease, P< 0.10). 
When the model-calculated 3MH production rate was expressed on body weight basis, 
treatments 100/100 and 120/150 were 25 and 40% lower ( P < 0.05) than dogs on treatment 
50/50 (Table 3). As with urinary 3MH:creatinine ratio, the model estimation of 3MH:urinary 
creatinine ratio were lower (P < 0.05) for dietary treatments 100/100 and 120/150 as 
compared to treatment 50/50 (50 and 57%, respectively). 
To compare the data to the literature, the fractional breakdown rate was calculated for 
total mixed muscle protein and for myofibrillar muscle protein. The former was calculated by 
dividing the 3MH excretion rate in ^/mol/d by the protein-bound 3MH muscle pool. This is 
estimated by assuming that skeletal muscle was 40% of live body weight and protein bound-
3MH was assayed to be .67 (n = 6), .78 (n = 7), .81(n = 10) and .75 (n = 8) /umol/g of wet 
muscle tissue for treatments 50/50, 100/100, 70/100 and 120/150, respectively. Myofibrillar 
muscle protein was assumed to be 65% of the total muscle protein. The fractional breakdown 
rate and myofibrillar breakdown rate for treatment 50/50 were increased as compared to the 
other dietary treatments (P < 0.01). 
A contrast was used to compare feeding dry food alone or in combination with a 
palatable powdered protein supplement. De novo 3MH production rate as calculated on a daily 
and per kilogram of body weight basis were 20% lower in dogs supplemented with ProBalance 
than the dogs fed dry food alone at P < 0.05 significance level. In addition, the fractional 
breakdown rate for total protein and myofibrillar protein was 27% improved when ProBalance 
was added to treatments 50/50 and 100/100. The same trend was noted for urinary 3MH 
production values but was not significant. 
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Table 2. Kinetic parameters and steady state values of a three compartment model of 3-
methylhistidine metabolism (average of 5 dogs). 
Mean SE 
K(l), mL '* 0.0011 0.0003 
Volume distribution, ml'' 1215.0 321.0 
Fractional transfer rates (L|j)°, min'' 
L2<-I 0.1053 0.03621 
LI«-2 0.0583 0.02555 
0.0237 0.02040 
^34-2 0.0057 0.00240 
^24-3 0.0079 0.00249 
Compartment mass (Mi)**, nmol 
M(l) 17456 4929 
M(2) 67956 17847 
M(3) 72693 12950 
Mass transfer rates (Rij)", nmol/min 
R2«-I 2430.8 676.3 
R|«-2 2499.9 673.9 
Ro«-i 69.0 4.5 
^34-2 418.5 69.3 
R2<-3 487.5 71.0 
De novo 3-methylhistidine production 
^mol/d 92.7 4.4 
/imoMcg''*d' 12.1 0.7 
3-Methylhistidine:creatinine ratio, /xmol/mg 0.397 0.017 
*K(1) is the inverse of the space of distribution of compartment one. 
''Volume of distribution is the volume of compartment one. 
the fractional transfer rate from compartment i to j. 
''M(i), the mass of compartment i. 
"Rj,.!, the mass transfer rote from compartment i to j. 
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Table 3. The effect of nutrition on 3-methylhistidine metabolism in dogs two weeks after 
surgery 
Treatment- - - - • 
50/50 100/100 70/100* 120/150' SEM 
Percentage of energy requirement 50 100 70 120 
Percentage of protein requirement 50 100 100 150 
Net weight loss, kg 3.00' 2.131 1.68> 1.53) 0.226 
Urinary creatinine, mg/d 185.1* 250.8»-'' 196.3»''' 259.0'' 27.9 
Urinary S-methylhistidine, ^mol/d 81.6 69.5 66.7 74.8 6.8 
Urinary S-methylhistidine, /(mol-kg''-d'' 11.4 8.4 9.0 9.1 1.2 
3-Methylhistidine:creatinine ratio, /xmol/mg 0.616» 0.293'- 0.413'-'' 0.306'' 0.111 
Model parameters'* 
K(l), mL " 0.00012'J 0.0001 iJ 0.00014' 0.00010) 0.00001 
Volume distribution, ml** 8580.»'''' 9261.' 10747.' 828 
Lo«-i*, min"' 0.00047J O.OOO49I 0.00068' 0.00041) 0.00005 
M(l)', /imol 195.9) 160.5) 112.0' 178.4) 15.1 
Plasma 3-methylhistidine, /(M ** 23.2' 18.8'J I5.7J I6.9) 1.9 
De novo 3-methylhistidine production 
/xmol/d'' 123.9'' 102.2'-''J 97.9" 82.1) 8.1 
/tmol*kg''*d''' 16.6' 12.4) 13.2'J 10.1) 1.5 
3-methylhistidine:creatinine ratio, /tmol/mg 0.828' 0.414) 0.573'') 0.360) 0.121 
Fractional breakdown rate", %ld 
mixed muscle protein ** 6.20' 3.98'" 4.08'" 3.36"- .52 
myofibrillar protein 4.03' 2.59'" 2.65'" 2.18-" .34 
* Twenty percent of the energy and SO percent of protein were provided by ProBalance 
(SmithKline Beecham, Animal Health,West Chester, PA). 
The model used was a one compartment model. 
° K(l) is the inverse of the space of distribution of compartment one. 
Volume of distribution is the volume of compartment one. 
' The fractional transfer rate from compartment one to out (urine). 
' The mass of compartment one. 
*•'' Means in same row with different superscript differ, P<0.10. 
Means in same row with different superscript differ, P<O.OS. 
Significant contrast, ProBalance vs dry food, P < O.OS. 
Means in same row with different superscript differ, P<0.01. 
" The fractional breakdown rate was calculated for total mixed muscle protein and for 
myofibrillar muscle protein. The former was calculated by dividing the 3MH excretion rate in ^mol/d by 
the protein-bound 3MH muscle pool. This is estimated by assuming that skeletal muscle was 40% of live 
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Table 3. (cont.) 
body weight and protein bound-3MH was assayed to be .67 (n=6), .78 (n=7), .81(n= 10) and .75 (n = 8) 
^mol/g of wet muscle tissue for treatments 50/50, 100/100, 70/100 and 120/150, respectively (P > .25). 
Myofibrillar muscle protein was assumed to be 65% of the total muscle protein. 
I l l  
DISCUSSION 
Model Development 
The major objectives of the present study w/ere to demonstrate that the kinetics of a 
stable isotope of 3MH could be described by a compartmental model and to determine whether 
the de novo production rate of the tracee could be estimated in dogs. We have described the in 
vivo kinetics of 3MH in dogs by means of a simple serial model requiring 3-compartments and 
sampling of only plasma to characterize the complete metabolism of 3MH (Figure 1A and 2A). 
The kinetic parameters, Ly, compartment mass M, and mass transfer rates R;,, are presented as a 
reference for future modeling of 3MH metabolism in dogs. 
The model presented is based on previous knowledge of 3MH metabolic pools in other 
species (Rathmacher and Nissen 1992; Rathmacher et al. 1992c; Rathmacher et al. 1992e) and 
based on the kinetic behavior of 3MH as modeled in these species. 3-Methylhistidine had been 
reported as a natural component of urine and plasma (Blazer-Yost and Jezyk 1979) in the dog. 
The L|j parameters for dogs were similar to those reported for other species quantitatively 
excreting 3MH, cattle (Rathmacher and Nissen 1992) and humans (Rathmacher et al. 1993). 
Based on the size of compartment 1, M,, has a mass similar to extracellular water space. 
Compartments Mj and M, are most probably intracellular pools of 3MH (Table 2). Muscle biopsy 
data from lambs (Rathmacher et al. 1992c) indicate that compartments 2 and 3 are muscle 
specific for 3MH. 
There was a need to minimize the number of blood samples required to estimate 3MH 
production in dogs. The plasma samples from 720 to 4320 min was modeled using a minimal 1 -
compartment model depicted in Figure 1B. This model depicts one single metabolic pool of 3MH 
with on entrance for tracee into the compartment and with one exit into urine. The mass of the 
single compartment was equal to the sum of the three compartments in the 3-compartment 
model. This model should allow for a more practical estimation of 3MH production in clinical 
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situations. 
This study confirmed that the minimal 1-compartment model estimates of 3MH 
production were similar to the complete 3-compartment estimate of 3MH production. In 
contrast, in ruminant animals the 1-compartment model overestimated 3MI-I production by 30% 
as compared to the estimates as calculated by the 3-compartment model, but the models were 
highly correlated (r = .93) (Rathmacher et al. 1993). Model estimates of 3MH production were 
higher than urinary 3MH production (Figure 3), however, they were highly correlated. Model 
and urinary 3MH production results were compared in cattle (Rathmacher et al. 1992b). Model 
and urinary 3MH production were similar in these cattle, but tended to return lower urine values. 
In addition, human model estimates were 16% higher than urinary estimates (Rathmacher et al. 
1993) when the model estimates were expressed on body weight basis or on urinary creatinine 
basis. Partial explanation for lower values is acetylation of 3MH. Long et al. (1975) estimated 
that 4.5% of the urine 3MH was acetylated in humans. 3-Methylhistidine could also be 
conjugated with p-alanine forming the dipeptide, balenine, which appears to accumulate in some 
species (Harris and Milne 1987). An advantage of the compartmental model is additional 
metabolism of 3MH will not affect estimates of 3MH production whereas urinary 3MH 
quantitation will not detect any further metabolism of 3MH. 
Use of urinary 3MH to specifically estimate muscle proteolysis has been criticized 
because skin and gastrointestinal tract may contribute to daily production of 3MIH (Nishizawa et 
al. 1977; Millward et al. 1980). However, recent data in humans with varying degrees of 
infection indicate the release of 3MH from the leg was highly correlated with the urinary output 
of 3MH (Sjolin et al. 1989) and the splanchnic region contributes less than 10% to total urinary 
3MH production. The model, as currently constructed, cannot distinguish between muscle, 
skin, and intestinal production of 3MH. However, based on previous studies it is reasonable to 
assume that changes in 3MH production are largely reflective of muscle metabolism. 
An advantage of a compartmental model of 3MH is that it provides additional 
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information about the metabolism of 3MH. Urinary 3MH cannot provide information about 
compartment sizes nor about transport between compartments. The significance of transfer 
rates between compartments and compartment sizes is not yet fully understood. 
Post-surgery Nutrition 
A consequent of surgical trauma, infection and sepsis is the catabolic destruction of 
muscle protein. Post-surgical recovery is characterized by an increase in nitrogen excretion 
which is thought to arise primarily from skeletal muscle. During recovery from surgery it is 
common for hospitalized animal patients to show signs of malnutrition (Remillard and Martin 
1990) while estimates as high as 50% in human patients have been reported to be malnourished 
(Bistrian et al. 1976). Using the dog as an animal model, the present study was designed to 
evaluate four different nutritional levels of energy and protein on skeletal muscle proteolysis. 
One group represented malnourished patients fed 50% of their energy and protein requirement 
and another represented normal dogs fed 100% of their energy and protein requirement while 
recovering from surgery. A commercial nutritional supplement was used to vary protein and 
energy mixtures consumed. The supplement supplied additional 50% of protein and 20% of 
energy requirement. The diets were low in 3MH (77.8 //mol/kg of Hill's Science Dry and 66.4 
/imol/kg of ProBalance) but were subtracted from the 3MH production measures. 
Urinary 3-methylhistidine has been shown to be a valid index for measuring muscle 
proteolysis (Young and Munro 1978; Long et al. 1988; Sjolin et al. 1989) and has been used to 
evaluate muscle degradation following surgery (Rennie et al. 1984; Carii et al. 1990; Taggart et 
al. 1991; Long et al. 1979). A goal of this study was to demonstrate the value of 
compartmental model of 3MH metabolism for quantitating the de novo production of 3MH. The 
effects of 3MH production presented using compartmental analysis were similar as those using 
traditional collection of urine. The values were highly correlated, (r = .70) providing confidence 
in the models ability to provide an estimate of 3MH production in dogs recovering from surgery. 
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The malnourished dogs fed 50% of their energy and protein requirement (treatment 
50/50) had higher 3MH production rates as compared to dogs fed adequate or excess energy 
and protein (treatments 100/100 and 120/150) and tended to be elevated as compared to 
treatment 70/100. The fractional breakdown rate of mixed muscle proteins was increased as 
compared to the other treatments. The estimated fractional breakdown rate was based on the 
assumption that skeletal muscle comprised 40% of body weight. The estimate for treatment 
50/50 Is conservative considering the weight loss that occurs with this treatment likely lowered 
the percentage of muscle In these dogs. Previous studies have shown how nutrition can modify 
3MH production. Young et al. (1973) demonstrated a 34% decrease in 3l\/ll-l production from 3 
to day 20 of starvation. In another study, early starvation, 2 to 3 days, was shown to increase 
3MH production as compared to the day before fasting started (Giesecke et al. 1989). Rats 
restricted In protein (Haverberg et al. 1975) only showed a marked and progressive decrease in 
3MH production per unit of body weight, whereas the rats restricted in both energy and protein 
showed a initial rise In 3MH production per unit of body weight and was maintained for 14 days. 
The critical nutritional component needed to minimize protein breakdown appears to be 
protein. Supplementing 100% of the protein requirement but only 70% of the energy 
requirement readily decreased muscle breakdown to minimal values. Additional supplementation 
of energy and protein did not further decrease proteolysis. Similar changes have been noted 
where total parenteral nutrition has been demonstrated to be beneficial following surgical trauma 
(Kinney and Elwyn 1983; Carll et al. 1990; Wernerman et al. 1986). 
In conclusion, the compartmentai model accurately predicts 3-methylhistidine 
production in vivo and may give a more accurate account of 3-methylhistidine production than 
urinary collection. Furthermore, the compartmentai model is useful for studying the effects of 
post-surgical nutrition. In terms of post-surgical nutrition, it appears that meeting the protein 
requirement Is critical in minimizing muscle protein catabolism and that hypersupplementation of 
energy and protein provides no added benefit. 
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ABSTRACT 
Control of protein reserves in skeletal muscle is poorly understood primarily because of lack 
of simple and accurate methods to measure muscle protein pool sizes as well as and the rate of 
turnover of these pools. Urinary 3-methylhistidine (3MH) excretion has been proposed as a 
noninvasive in vivo marker of muscle protein breakdown, but such analysis requires quantitative 
collection of urine and yields little details about the metabolism of 3MH. In this study, we 
propose that data from a single bolus dose of tracer can be described by a kinetic model which 
defines 3MH metabolism in humans. Plasma concentration of the tracer was described by a 
linear time-variant 3-compartment model. The model defines masses and fluxes of 3MH within 
the subjects and, in particular, the intracellular de novo production of 3MH. The de novo 
production of 3MH as calculated by the model was not different from that calculated via the 
traditional collection of urinary 3MH (3.09 vs. 2.57 ^mol-kg''-d'', P>0.30). Additionally, 
although numbers are limited, the data suggests that the model compartments may be an 
indicator of body muscle mass (r = 0.95, P<0.01). These data indicate that 3MH production, 
as estimated by a compartmental model, allows for the assessment of alterations in muscle 
proteolysis. 
kinetics; metabolism; compartmental modeling; stable isotope tracer; myofibrillar protein 
turnover 
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INTRODUCTION 
Assessment of muscle protein turnover is difficult because of limitations in methodology. 
Urinary 3-methylhistidine (3MH) has been used as a marker of myofibrillar proteolysis in humans 
(27) because, once released from muscle, it is rapidly excreted in urine. This method depends 
on quantitative urine collection, accurate measurement of urinary 3MI-i, and no metabolism of 
3MH in vivo. An isotopic method for determining 3MH production in vivo would be useful. 
Previous studies have attempted to validate the quantitative urinary excretion of 3IVIH. 'Re­
labeled 3MH was injected, but its isotopic dilution was not described (11). We have recently 
demonstrated that the kinetics and metabolism of 3MH can be accurately described by using a 
compartmental model in cattle (20), which also quantitatively excrete 3MH into the urine (8). 
The same kinetic approach was utilized in sheep and swine (21,22), species that retain 3Mi4 in 
muscle (7,9). This same isotopic dilution of a tracer of 3MI-I was therefore utilized to examine 
the kinetics and metabolism of 3MH in humans and to calculate the de novo production of 3MI-I. 
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MATERIALS AND METHODS 
Subjects and Protocols 
Normal volunteers with no evidence or history of diabetes meliitus nor of cardiac, liver, renal 
or pulmonary diseases were studied. The subjects consisted of 3 males and 1 female, ranging 
in age from 31 to 37 years, in body weight from 47 to 92 kg, and in body mass index (BMI) 
from 19.2 to 25.5 (Table 1). The purpose and possible risks of the study were explained to all 
subjects, and their voluntary written consent was obtained. The study protocol was approved 
by the Committee for the Protection of Human Subjects of the Institutional Review Board at 
Vanderbilt University School of Medicine. All studies were performed at the Clinical Research 
Center (CRC). Subjects were placed on a balanced weight-maintenance diets for at least 1 
week before the start of the study. Meat was excluded from the subjects' diets for three days 
before the study and during the study. 
All studies were performed after a 10-12 h overnight fast. On the morning of the 
experiment (6.30 to 7.00 hours), an 18-gauge angiocatheter was placed in a superficial hand 
vein of the nondominant arm for blood sampling. The hand was heated to 55°C to ensure 
Table 1. Subject characteristics 
Parameter A 
Subjects 
B C D 
Age, yrs 35 37 31 31 
Sex 9 d* cC 
Weight, kg 92 47 78 69 
Body Mass Index 25.5 19.2 21.6 24.4 
Fat, % 32.3 28.7 13.5 22.4 
Fat, kg 29.1 13.7 10.0 18.13 
Fat-free mass, kg 61.1 34.0 64.3 50.8 
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complete arterializatlon (1). In addition, an 16-gauae angiocatheter was inserted into the 
contralateral forearm vein for the infusion of L-S-Imethyl-^Hjl-histidine (MSD isotopes, 
Montreal, Canada). Finally, another catheter was threaded retrograde into the brachial vein of 
the dominant arm and used for sampling of the forearm tissue. 
Each study was four days in duration. Starting at t = 0 (8.00 hours), subjects were 
administered a bolus infusion of L-S-Imethyl-'Hjj-histidine at 0.13 //mol/kg into the forearm vein 
of the dominant arm. The infusate was passed through a Millex-GS sterilizing filter (0.22jum; 
Millipore Products Divisions, Bedford, MA) before the infusion. Blood samples were obtained 
from the superficial hand vein and from the deep forearm vein at 0, 1, 2, 5, 10, 15, 30, 45, 90, 
150, 210, 270, 330, and 720 min postinjection. During this time, the subjects were required 
to stay on the CRC, although they were allowed to ambulate freely within their room. Free 
access to food and drink was allowed after the 330-min sample. After 720 min, the catheters 
were removed and the patients were allowed to go home. For the following three days, the 
subjects returned to the CRC each morning before eating for further blood sampling by 
percutaneous venous puncture at 1,440, 2,880, and 4,320 min postinjection. Urine was 
collected over 24 h periods the day before and for 3 days after tracer infusion. 
Analytical Methods 
Blood was collected in heparinized syringes, transferred to tubes containing NajEDTA (15 
mg/tube), and centrifuged. The plasma obtained was immediately placed on ice. An aliquot of 
the plasma was processed for determination of 3MH concentration as well as the L-3-[methyl-
^H3]-histidine:3-methylhistidine isotope enrichment by a previously described method (19). The 
remainder of the plasma was frozen at -70°C. The urine obtained was processed for the 
determination of creatinine both as a measure of the completeness of the collection (17), and 
for the estimation of lean body mass (3). Urinary 3MIH concentration and production were also 
measured (19). 
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1.2 2.3 
Figure 1. Schematic of a 3-compartment model used to analyze the kinetics of distribution, 
metabolism, and de novo production of 3-methylhistidine <3MH). M,, Mj, and M, 
represent the mass of 3MH in compartments 1, 2, and 3, respectively. Ljj, L,,2, Loj, 
L,,], and Lj,, are fractional transfer rate coefficients of 3MH within the system. The 
tracer, 3-[^H3-methyl]-methylhistidine (D3-3MH), was injected into compartment 1. 
Sampling was performed from compartment 1(V). De novo production of 3MH was 
into compartment 3. 
Body composition was determined for each subject from the measurements of body density 
estimated by underwater weighing (6). Body weights in air and underwater were measured to 
the nearest 25 g by using Detecto (Webb City, MO) and Chatillon Spring (New Gardens, NY) 
scales, respectively. Residual lung volume was determined (simultaneously with underwater 
weighing) with a closed-circuit, nitrogen-dilution method (17). Nitrogen concentration during re-
breathing was measured with a Med-Science 505-D Nitralizer (St. Louis, MO). The percentage 
of body fat was estimated from body density by using the revised equation of Lohman et al. 
(10). 
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Data Analysis 
Mathematical modeling of the tracer data from plasma was performed on a personal 
computer using SAAM/CONSAM-31.0B modeling program (2,4). The tracer data was 
interpreted using linear compartmental models. The model proposed is based on known 
physiology and is identical to one used for cattle (20). We have previously determined that a 
minimum of three compartments were needed to accurately describe the l<inetics and 
0 
1 
a 0.1 
U 
U 
g 
g 0.01 
u 
0.001 
^ Observed 
— Model 
1 1 1 1 \ 
1 2 
TIME (MIN X 1000) 
Figure 2. Disappearance of tracer, S-I^IHs-methyll-methylhistidine, as a ratio of 3-[^H3-methyl]-
methylhistidine:3-methylhistidine in plasma as described by a 3-compartment model 
of 3-methylhistidine (see Figure 1). Symbols (^) represent observed data, and the line 
(-) represents best fit generated by the model. 
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metabolism of 3MH (20). These compartments will be used in this study. The physiology-
based model Is presented In Figure 1. and was used to describe the isotopic decay in plasma 
(Figure 2) after a dose of tracer. The kinetic data was entered into compartment 1 as the ratio 
of tracer to trace as previously warranted for stable isotope kinetic data (5). In this model, 
compartment 1 represents plasma and extracellular fluid, while compartments 2 and 3 represent 
tissue pools of intracellular 3MH. In addition, irreversible loss into urine is derived from 
compartment 1 and the de novo steady state production of 3MH appears into an intracellular 
tissue compartment 3. 
Statistical Analysis 
Values are presented for each individual subject as well as mean ± SE. Means for 3MH 
production and for 3MH to creatinine ratio for model and urine based calculations were 
compared by a Mest (24). Pearson correlation coefficients were used to evaluate the 
relationship between model parameters and body composition using the SAS statistical software 
(SAS Inst., Inc., Gary, NC). 
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RESULTS 
A steady state system was assumed because plasma levels of 3MH did not change over the 
period of the study. A representative decay of (/3-3MH:3MH is presented in Figure 2. The slope 
of curve was similar to that of other species evaluated with this model (20,21,23). The decay 
curve is characterized by a rapid decrease in the {/3-3MH:3l\/ll-l ratio during the first 6 hours 
followed by a slow linear decay over the three days of blood sampling. 
The kinetic model parameters (L|,|) are presented in Table 2. Variations of the parameters 
were evaluated by the coefficient of variation (%CV= 100 x SD -s- mean) of each individual 
parameter. Ranges for %CV were from 16 to 43% for Ljj, 24 to 46% for L,,2, 9 to 136% for 
Lo,,, 12 to 49% for Lg,,, and 15 to 115% for Lj.s. These parameters were within the acceptable 
range, except for Lo,i and ^ of subject A which were above 100%. A %CV greater than 
100% is not acceptable for a model parameter estimation (26). In previous studies using cattle, 
the %CV's for the L,,, were less than 50%. The larger %CV for parameters and L2.3 
,particularly for subject A, may be explained by too few points between 300 and 1440 min; 
additional data points will be needed to lower the variation. The 3-methylhistidine model 
compartment mass (M,) and mass transfer rates (R|j) are presented in Table 2. Compartment 2 
is 1.5 times larger than compartment 1, and compartment 3 is 13 times larger than 
compartment 1. The calculated of de novo production rate of 3MH and the urinary 3MH 
excretion rate is presented in Figure 3 expressed as /fmol-kg'^-d'\ and they were also expressed 
as a 3MH;creatinine ratio (jumol-mg''). In both cases the model estimate of 3MH production was 
not different (P > 0.30) from urinary 3MH production. Urinary 3MH production was lower than 
the model estimate of 3MH production in each subject, but these variables were highly 
correlated (r= 0.97, P=.033). 
Table 1 presents body composition characteristics, including estimates of fat (kg), body 
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Table 2. Kinetic parameters of 3-methylhlstldine metabolism and 3-methylhistldine model 
masses and mass transfer rates.* 
Subjects 
Parameter A B C D Mean SE 
L2,,, min""' 0.0509 0.1573 0.0196 0.1372 0.0759 0.0686 
L|,2, min*' 0.0224 0.1505 0.0111 0.1887 0.0614 0.0944 
Lo,„ min*' 0.0048 0.0051 0.0024 0.0035 0.0041 0.0017 
L2,3> min ' 0.0051 0.0141 0.0074 0.0148 0.0089 0.0074 
L2.3. ' 0.0004 0.0017 0.0029 0.0016 0.0017 0.0008 
M|, mnol/kg° 383 390 858 780 603 109 
M21 nmol/kg 952 421 1692 581 912 245 
M3, nmol/kg 15856 3584 5070 7240 7938 2377 
U3, nmol'kg''-niin ''' 1.83 2.00 2.04 2.72 2.15 0.17 
Rj,!, nniol'kg''*niin'''' 19.49 61.36 16.83 106.94 51.15 18.37 
Ri_2. nniol'kg"''niin'' 21.31 63.35 18.87 109.66 53.30 18.52 
Ro,,, nmol-kg''-niin'' 1.83 2.00 2.04 2.72 2.15 0.17 
R3,2, nmol-kg'''min'' 4.86 5.95 12.50 8.62 7.98 1.47 
R2_3, nmo!-kg''-niin'' 6.69 5.95 14.55 11.34 9.63 1.75 
'The kinetic parameters for a 3-compartment mode! of 3-methylhistidine metabolism are presented for 
each subject along with the mean and standard error. 
''Ljj, fractional transfer from compartment j to compartment i. 
°M|, mass of compartment i. 
**173, de novo production into 3. 
"Rij, mass transfer rate from compartment j to i. 
mass index (BMI), %fat, and fat free mass (FFM, kg) for each individual subject. Lean body 
mass was correlated to compartments of the model (Table 3). The compartment 2 mass (Mj, 
nmoles) was positively correlated with FFM (P = .09), and the model estimate of 3MH 
production was correlated with FFM but not significantly(r = 0.74, P = .25). BMI and fat were 
positively correlated with M3 (P =. 16 and P = .08). 
The arterial and venous plasma enrichments across the forearm are presented in Table 4. 
These data demonstrate that 3MH was released from the forearm and diluted the tracer. 
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Figure 3. A: Daily 3-methylhistidine production expressed as //mol-kg'^-d'^ for each individual 
subject and a mean of four individuals as calculated from urinary excretion (hatched 
bars) and by a 3-compartment model of 3-methylhistidine production (solid bars). 
*There was no mean difference between urinary and model 3-methylhistidine 
production, P >0.30. B: Daily 3-methylhistidine:creatinine ratio, ^mol-mg'^ for each 
individual subject and a mean of the four individuals as calculated from urinary 
excretion (hatched bars) and by a 3-compartment model of 3-methylhistidine production 
(solid bars). There was no mean difference between urinary and model 3-
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Table 3. Relationship of model parameters with urinary 3-methylhistidine production and body 
composition* 
Correlation Coefficient P-value 
S-Methylhistidine production 
model to urine** 0.97 0.03 
Body composition to model parameters 
fat free mass to Mj" 0.91 0.09 
fat free mass to model SMH** 0.74 0.26 
fat mass to M3* 0.92 0.08 
body mass index to M3 0.84 0.16 
'Model is a 3-compartment model of 3-methylhistidine production. 
'3-Methylhistidine production for model and urine have the units ^mol-d '. 
"Fat free mass has the units of kg, and M, is mass of compartment 2 in nmoles. 
""Model 3MH is the of estimate of production expressed as ^mol-d '. 
°Fat mass has the imits of kg, and M3 is the mass of compartment 3 in nmoles. 
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Table 4. Tracer to tracee fractional enrichment for venous and arterial plasma samples across 
the forearm* 
Time Venous enrichment Arterial enrichment 
Mean SE Mean SE Difference'' 
1 0.242 0.057 0.312 0.096 0.070 
2 0.246 0.050 0.287 0.085 0.041 
5 0.191 0.042 0.193 0.052 0.002 
10 0.148 0.022 0.162 0.042 0.014 
15 0.133 0.028 0.134 0.038 0.001 
30 0.111 0.012 0.105 0.026 -0.006 
45 0.079 0.012 0.093 0.023 0.014 
90 0.053 0.005 0.062 0.015 0.009 
150 0.048 0.013 0.051 0.014 0.003 
210 0.034 0.004 0.037 0.009 0.003 
270 0.026 0.003 0.026 0.007 0.000 
330 0.024 0.004 0.026 0.006 0.002 
'Mean and standard error (SE) for the isotopic ratio of tracer to tracee are presented. 
''Difference is equal arterial enrichment minus venous enrichment. 
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DISCUSSION 
The major objective of the present study was to determine whether a de novo production 
rate of 3MH was similar to urinary 3MH production. We have described the in vivo kinetics of 
3MH in human subjects by means of a simple catenary model requiring 3-compartments and 
sampling of only plasma. The kinetic parameters, L,,,, compartment mass M, and mass transfer 
rates R,,, are presented as a reference for future modeling of 3MH metabolism. 
The model presented is based on previous knowledge of 3MH metabolic pools in other 
species (20,21,23). The L,,, parameters for human subjects were similar to those reported for 
cattle (18) except for Lj.i which was lower for humans (.24 vs. .07 min '). Based on the size of 
compartment 1, has a mass similar to extracellular water space, and M, and IVIs are most 
probably Intracellular pools of 3MH (Table 2). Muscle biopsy data from lambs (21) indicate that 
compartments 2 and 3 are probably muscle specific for 3MI-I. 
This study confirmed that model estimates of 3MH production correspond to urinary SIVIIH 
production. Means were not different when expressed on body weight basis or on urinary 
creatinine basis, but they were 16% higher than urinary estimates. Comparable parameters 
were measured in cattle (20) where model and urinary 3MH production results were similar, but 
tended to return lower urine values. 
Use of urinary 3MH has been criticized because skin and gastrointestinal tract may 
contribute significantly to daily production of 3MH (15,16). However, recent data in humans 
with varying degrees of infection indicate the release of 3MH from the leg was highly correlated 
with the urinary output of 3MH (25) and the splanchnic region contributes less than 10% to 
total urinary 3MH production. In addition, the distribution of composition of protein bound-
3MH indicates that skeletal muscle is the primary source of urinary SMiH (27). The model, as 
currently constructed, cannot distinguish between muscle, skin, and intestinal production of 
3MH. However, based on previous studies it is reasonable to assume that changes in 3MH 
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production are largely reflective of muscle metabolism. 
An advantage of a compartmental model of 3MH is that it provides additional Information 
about the metabolism of 3MH. Urinary 3MH cannot provide information about compartment 
sizes nor about transport between compartments. In Table 3 we demonstrate a relationship 
between FFM and M,, an intracellular pool of 3MH. In addition, FFM was correlated with 3MH 
production as estimated by the model. The relationship of FFM with urinary 3MH has been 
demonstrated in humans (12, 13, 14). Therefore, this initial information indicates that the 
model may have practical application as an estimator of muscle mass. 
In conclusion, measuring 3MH production is important in understanding the regulation in 
myofibrillar proteolysis. This model offers advantages over the traditional measurement of 
urinary 3MH as: 1) it does not necessitate quantitative urine collection; 2) it reduces error due 
to the frequency of plasma sampling vs. the infrequency of urine collection in other models; 3) it 
gives information about compartment size and transfer rates; and 4) it is related to body 
composition. This model does, however, need further validation as a method for estimating 
3MH production under physiological states where muscle proteolysis is altered. 
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GENERAL DISCUSSION 
Overview of Compartmentel Models of 3-Methylhistidine 
The works presented in this dissertation are a consequence of an interest in directly 
measuring muscle protein degradation in lambs. However, there was no direct method available 
to estimate muscle proteolysis in sheep or pigs. The majority of my research has dealt with 
describing the metabolism of the unique amino acid 3-methylhistidine. Urinary 3MH had been 
used in cattle and humans as an index of muscle protein breakdown but was invalid for use in 
pigs and lambs. 3-methylhistidine is produced in these species but is not quantitatively excreted 
in the urine. An objective was to eliminate urine collections therefore we have pursued kinetic 
methodology using a tracer. Initial studies employed stochastic analysis (constant infusion of a 
tracer to steady state), but after a 12 hour infusion no steady state was achieved. Next studies 
were designed utilizing the decay of a tracer of 3MH over a 5 day period. From these data a 
compartmental model in lambs was developed and a steady state production rate of 3MH was 
estimated. However, with most isotopic models it is difficult to validate them, because there are 
no non-isotopic methods to validate the isotope models. The approach taken to validate the 3-
methylhistidine model in sheep was comparative, using species which urinary 3MH is a valid 
index of muscle proteolysis. Studies in cattle, humans and dogs were used to compare the 
estimates of 3MH as estimated from the model to urinary 3MH production. Succeeding studies 
have used this methodology in experimental designs where other methods have shown the 
fractional breakdown to be affected. Although not presented in this document such effectors 
included: p-adrenergic agonists, trenbolone acetate and dietary protein. 
The major accomplishments of presented experiments are: 1) isotopic decay of a tracer of 
3MH can be described by a 3-compartment model in sheep and pigs where urinary 3MH is an 
invalid index of muscle proteolysis; 2) 3MH production as estimated by the model in humans, 
cattle and dogs was qualitatively similar to urinary 3MH production; 3) a minimal 1-compartment 
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Figure 1. Model illustrations of 3-methylhistidine metabolism in humans,cattle, dogs, sheep and 
swine. 
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There are three assumptions that must be accepted when using linear compartmental 
models. The volume or mass of the compartment is assumed to remain constant. Secondly, 
the compartments are well stirred, that is, when you sample a compartment a representative 
sample of the entire compartment is taken. Finally, the rate constants remain constant. The 
3MH model in general also has specific assumptions. 3-Methylhistidine is not reutilized to a 
significant extent; there is no tRNA for 3MH. Secondly, the precursor pool does not change; 
the myofibrillar protein-bound 3MH does not change with the experimental conditions. There is 
some indication that the pool increases shortly after birth. Thirdly, 3MH is quantitatively 
excreted in the urine or if metabolic products of free 3MH does occur it is accounted for in the 
model; this true for humans, cattle and dogs but not for sheep and pigs. In sheep and pigs a 
large proportion is retained in muscle as balenine but the model was adjusted to explain this 
process. Fourthly, renal absorption does not change or is similar between treatments. This 
may be one explanation why sheep and pigs do not quantitatively excrete 3I\4H in the urine. 
These species may selectively reabsorb 3MH. Fifthly, no 3MH in the diet or if present 3r 1H 
calculations must be corrected for dietary 3MH. Finally, the primary source of 3l\^iH is from 
skeletal muscle myofibrillar protein. This assumption has caused the most controversy 
between researchers. On a organ basis, skeletal muscle contains more than 90% of the 
protein-bound 3MH. However, researchers who dispute the validity of the 3MH model maintain 
that the myofibrillar proteins in the other tissues probably turnover faster than skeletal 
myofibrillar protein. In response to this, V.R. Young and C. I. Harris criticized the experimental 
designs of these researchers and have presented other data to show otherwise. 
Figures 1 and 2 and Tables 1 and 2 are a summary of the efforts to model 3MH 
metabolism using a 3 compartment model in humans and cattle, dogs which quantitatively 
excrete 3MH in urine, as compared to sheep and swine which do not quantitatively excrete 
3MH into urine. Figure 1 is a comparison of model structures between the species. The diversity 
of models between cattle, dogs and humans and sheep and pigs reflects differences in known 
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Figure 2. Species comparison of S-Imethyl-^Hjl-methylhistidine tracer decay curves plotted on a 
semilog plot; time (min) on a linear x-axis and traceritracee enrichment on semilog y-
axis. 
physiology. In each species the tracer is injected into compartment 1 which based on the size 
(volume and mass) is similar to plasma and extracellular water space. Compartment 1 was the 
sampling compartment and the compartment from which the steady state calculations were 
initiated. From the steady state calculations the de novo production of 3MH was obtained into 
compartment 3 for humans, cattle and dogs and into compartment 2 for sheep and pigs. The 
models also depict differences in the route by which 3MH exits the system. In cattle, humans 
and dogs 3MH is quantitatively excreted in the urine illustrated by the exit from compartment 1 
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where as sheep excrete only 15% of total daily 3MH produced in the urine and pigs 1.5 %/d. 
Therefore, accurate accounting of 3MH production in sheep and pigs required an exit out of the 
system from compartment 3. This exit accounts for appreciable loss of 3MH into a balenine 
'sink' which turns over slowly or not at all during the time frame of the study. 
Representative plasma decay curves following a single dosing of 3-[methyi-^H3]-
methylhistidine tracer is illustrated in Figure 2. In general, each species exhibited a similar 
exponential decay; characterized by rapid decay over the first 2-3 hours, followed by a slower 
decay through 12 hours, and exhibited a steady state decay over the remainder of the study. 
The decays of tracer are representative of the models used. Cattle, humans and dogs exhibit 
very similar decays while sheep and pigs are very different. 
Table 1. Comparison of 3-methylhistidine kinetic parameters. 
Species 
Parameter Cattle Humans Dogs Swine Sheep 
Animals, n 39 4 5 20 40 
Urinary 3MH loss, % 100 100 100 1 17 
Fractional transfer rate, min"'' 
.18 .08 .11 .23 .21 
^1,2 .06 .06 .06 .09 .08 
^3,2 .003 .009 .006 .014 .007 
L,3 .002 .002 .008 .006 .005 
^),3 0 0 0 .0009 .0004 
.006 .004 .02 0 .0003 
'Fractional transfer rate (L|j) from compartment j to i. 
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Table 1 lists the model parameters, fractional transfer rates and Table 2 compares the 
compartment masses and mass transfer rates between compartments for each species. Also 
listed is the de novo production rate calculated by the model in Table 2. An important feature 
of these models is the description of 3-methylhistidine metabolism within the body. The 
significance of mass transfer rates and compartment sizes is not fully understood. However, 
the model parameters and mass transfer rates may explain the failure of sheep and swine to 
quantitatively excrete 3-methylhistidine in the urine. Three mechanisms may explain this failure: 
Table 2. Steady state compartment masses and mass transfer rates of a 3-
compartment model of 3-methylhistidine (3MH) metabolism 
Parameter Human Cattle Pigs Sheep Dogs 
n 4 39 20 40 5 
Plasma 3MH, 2.9 8.6 10.4 36.9 21.8 
M,,nmoMcg''* 603 807 1110 5308 3227 
Mj, nmol-kg'' 912 2291 2857 12483 7973 
M], nmol-kg'' 7938 8079 6151 17017 9261 
Rji , nmol'kg''-min'"' 51 101 247 944 319 
R,2, nmol-kg''*min'' 53 105 247 946 329 
Rjj, nmol'kg"'>min'' 7.9 5.8 37 81 56 
R23,nmol-kg''-min'' 9.6 9.9 32 77 56 
Roi,nmol-kg''-min'' 2.2 4.1 NA 1.4 9 
RQ3,nmol'kg'''min'' NA NA 5.0 5.8 NA 
3MH Production, /imol-kg''-d''° 
3.1 6.0 7.2 10.3 12 
'M| = compartment mass i. 
''Ry = mass transfer rate between compartment j and i. 
°3MH production was obtained from the model. 
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(1) 3MH transport between the compartments limits the excretion of 3MH; (2) 3MH avidly 
reabsorbed by the kidney, and (3) enzymatic conversion of 3MH to balenine is enhanced. In 
comparison of data from Tables 1 and 2, the low rate of 3MH excretion in sheep and swine is 
not due to impaired transfer of 3MH out of and between compartments. Cattle appear to have 
slower exchange of 3MH between tissues despite of near quantitative urinary excretion. The 
reason is likely that sheep and swine kidneys are very efficient in conserving of 3MH, which in 
turn increases compartment size and plasma concentration, and through mass action could 
increase the synthesis of balenine. 
An unexpected finding from these studies was the relationship between the 
compartment mass of 3MH and body composition. From the three compartment model of 3MH 
metabolism the pool size of these compartments are calculated. The first pool is the 
compartment where the tracer is introduced and has the volume and mass comparable to 
plasma plus extracellular fluid. Compartments 2 and 3 are intracellular pools of 3MH. Greater 
than 90 percent of 3MH is found in muscle, therefore the mass of 3MH in these compartments 
should be proportional to muscle mass. In Table 3 we have correlated the compartment mass of 
a particular species with muscle. In the first example with pigs the mass of compartment 3 was 
positively correlated with carcass protein which would be primarily from muscle. In these pigs 
the muscle and adipose tissue were dissected from the bone and analyzed for crude protein. In 
the second example in steers the only indicator of muscle that could be obtained at slaughter 
was the loineye area (68). This is crude estimate of total muscle but was positively correlated 
to the mass of 3MH in compartment 2. Finally, in a preliminary human subject (4 subjects were 
studied) study the mass of compartment 2 was highly correlated to muscle mass as determined 
by under water weighing. This relationship is an area where future research would be of 
benefit. The model would possibly allow for the simultaneous measurement of muscle 
proteolysis and body composition. The meaningful explanation of protein kinetics measurement 
is dependent on an estimate of body composition, and skeletal muscle (lean) is important 
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component. 
Another objective of this research was to be able to use this model in a more practical 
situation. In essence, we wanted to move from a metabolism cage, characterized by high 
stress, depressed dietary intakes and questionable realistic metabolism, to a feedlot (normal 
environment) situation, which would eliminated many of the problem associated with solitary 
confinement. To accomplish this objective, fewer blood samples would have to be taken (4 or 5 
compared to 14 to 25) and the 3-compartment model would have to be minimized (3 
compartment to 1 compartments). The minimal model was evaluated in two studies so far. In 
the minimal model the three pools of the 3-compartment model are combined to form one 
Table 3. Relationship of model steady state compartment mass with body composition* 
Correlation Correlation coefficient P-value 
Ms vs. kg of carcass CP, pigs'' .47 .04 
M2VS. Loineye area, steers" .47 .05 
M2 vs. muscle, humans' .91 .09 
'Compartment mass was calculated using a 3-compartment model of 3-methylhistidine 
metabolism. 
''Mass of 3MH in compartment 3 (nmoles) correlated to the protein contained in the soft tissue of 
carcass. 
°Mass of 3MH in compartment 2 (nmoles) correlated to loineye area . 
''Mass of 3MH in compartment 2 (nmoles) correlated to fat free mass. 
homogeneous pool of 3MH, characterized by a de novo production into the body pool and one 
exit from the model. The kinetic data between 720 and 4320 min was used for the analysis; 
this time frame corresponds to apparent linear steady state portion of the decay curve. Similar 
results were obtained in dogs when comparing the complete model (three compartment) to the 
minimal model. However, in implanted cattle the minimal model estimates of 3MH production 
was 30% higher, but the estimates of were highly correlated (r=0.93, P < 0.0001). 
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The structural configurations of these models are not unique, and alternative 
arrangements may also be compatible with the data. The present models represent a 
framework and methodological approach describing steady state 3-methylhistidine kinetics in the 
whole animal and constitutes a working theory for testing by further experimentation with 
designs altering muscle protein breakdown. The rate of 3MH production is an important tool In 
understanding the regulation of muscle protein degradation. The advantages of these models 
are that 1) it does not necessitate quantitative urine collection (plasma model); 2) it reduces 
error due to the frequency of plasma sampling versus the infrequency of urine collection in the 
other models; 3) it measures the total production rate independent of the determination of free 
or conjugated forms; 4) it gives information about pool size and transfer rates; and 5) it does 
not require restraint of the animals for long periods. 
Possible Application of the Model 
Skeletal muscle protein is a major tissue in whole body protein turnover. However, 
little information is available for the maintenance of the protein reserve of skeletal muscle and 
the contribution of this tissue to overall protein turnover under different nutritional, hormonal 
and disease states. 3-MethYihistidine would be useful tool in evaluating muscle proteolysis 
directly in these situations. 
Nutritional status of an animal has a major impact on the rate of muscle protein 
turnover. Both protein synthesis and protein degradation can be involved in the regulation of 
tissue protein growth. Muscle protein turnover is sensitive to alterations in the adequacy of 
dietary protein and energy intakes (57) (35)(62). Starvation has also been shown to have a 
catabolic effect on muscle protein and has been well documented (5,6,21,66,91). 
Hormones, both natural and pharmacological, have been postulated to have an effect 
on muscle degradation. Since 1983 there has been a considerable interest in using p-adrenergic 
agonist to promote protein deposition and improve carcass quality by reducing fat deposition. It 
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has been demonstrated well that p-adrenergic agonists Increase muscle protein deposition, but 
the mechanism by which this is accomplished Is controversial. There are data that supports a 
mechanism of decrease in proteolysis (9,20,69,83,87) and data which favor a Increase in 
protein synthesis (7,8,14,18). 
Implants In the form of steroid hormones have been used for a number of years to 
Increase growth rates, improve feed efficiency and Increase lean tissue In the carcass of cattle. 
The mode of action by which these compounds increase protein gain is still not clear. It appears 
that estrogens and androgens act through different mechanisms to increase muscle protein 
accretion. Estrogens seem to increase muscle protein synthesis indirectly by increasing growth 
hormone secretion (72), where as, trenbolone acetate decreases muscle protein breakdown 
(75,81,82). However, it appears that testosterone may effect muscle protein accretion by 
increasing the fractional synthetic rate (51). 
Glucocorticoid, a steroid hormone, have been shown to Increase muscle protein 
degradation in vitro studies (24,53) and in vivo (64,65,80), and have been shown to decrease 
muscle protein synthesis (44,53,64). Myofibrillar protein brealcdown in skeletal muscle 
progresses through two stages in response to chronic administration of glucocorticoid in the rat 
(64). An early phase characterized by an Increase In proteolysis lasting 4 to 5 days, followed by 
a decrease in proteolysis. 
This list of hormonal modulators discussed is by far not complete. There are many 
other hormones and growth factors that may effect muscle proteolysis. Insulin is plays a major 
role in controlling protein turnover (4,21,86). Insulin plays a role in decreasing muscle 
proteolysis and increasing muscle protein synthesis. Prostaglandins are important in the control 
of muscle protein turnover (70). Thyroid hormone status also effects muscle protein breakdown 
(1,11,26,78), with hyperthyroidism causing a increase in muscle protein breakdown. 
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APPENDIX A 
Developing a Compartmental Model of 3-Methylhlstldine 
Using the compartmental model described in this thesis is not as easy as it might 
appear. It is not as simple as sitting down at a computer and generating results. It has taken 
this author two years to become familiar with modeling kinetic data. Another hurdle is the use 
of stable isotopes used for modeling a system; many of the programs and models used 
previously were developed using radio-labeled tracers. 
The program I utilized for kinetic analysis was the Simulation Analysis and Modeling 
program (SAAM). The first objective is to become familiar with the program and this may be 
accomplished by becoming familiar with the terminology in the SAAM manual, Consam User's 
guide and Consam User's Manual. I also suggest working through all of SAAM tutorials. If 
these materials are insufficient to answer your questions, it may be helpful to contact either the 
Resource Facility for Kinetic Analysis, Center for Bioengineering, FL-20, University of 
Washington, Seattle, WA 98195 (1-800-421-SAAM) or Loren Zech, NIH/NGI Lab of 
Mathematical Biology, building 10, room 6B13, Bethesda, MD 20892 (Voice 1-301-496-8915, 
FAX 1-301-480-2871). 
The kinetic data generated by gas chromatography/mass spectrometry must be 
formatted properly. Two items of information are needed, the average concentration of 3MH in 
plasma and the isotopic ratio of tracer:tracee in relation to time. The average concentration in 
plasma is the average of sample time points taken over the duration of study. The isotopic ratio 
is calculated by subtracting the baseline enrichment (ion abundance 241/238 m/z) (0 min) from 
experimental sample enrichment (ion abundance 241/238 m/z) (1, 2, 5 and etc. min). In the 
model you will have to know the dose of tracer given, therefore, it must be accurately 
weighed. Next, the data can be incorporated into the model, I have found it easiest to copy 
from Excel and paste into Word Perfect. Model parameters and files are available for each 
species on the D:\allpublk\samin\*.dat directory of Dr. Nissen's Laboratory Network. 
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The following is the input deck as it would be entered into saam and a brief explanation of 
what these parameters mean will follow the deck. 
123456789012345678901234567890123456789012345678901234567890 
1 A SAAM31 CRATE 10 PIG 282 
2 C BLOCK 3 GROUP 2 
3 C 3-METHYLHISTIDINE SWINE 
4 C 
5 C 11/91 
6 H DAT 
7 M(l) 
8 M(2) 
9 M(3) 
10 U(2) 
11 R(2,l) 
12 R(l,2) 
13 R{0,3) 
14 R(3,2) 
15 R(2,3) 
16 XG(1)=F(1)/P(90) 
17 lOlG(l) /66318.9 FSD=.l 
18 0 
19 1 0.510054 
20 2 0.331941 
21 4 0.237059 
22 6 0.212967 
23 8 0.189671 
24 10 0.175456 
25 15 0.151927 
26 30 0.119257 
27 45 0.107447 
28 60 0.099849 
29 90 0.090196 
30 120 0.083549 
31 180 0.076337 
32 240 0.071592 
33 300 0.061342 
34 360 0.063427 
35 480 0.058349 
36 600 0.057174 
37 720 0.044086 
38 1440 0.031401 
39 2160 0.021269 
40 2880 0.011802 
41 4320 0.006743 
42 5760 0.003104 
43 H PAR 
44 IC(1) 1 
45 K(l) 1.672225E-04 9.999998E-07 1. OOOOOOE+00 
46 L(2,l) 3.663404E-01 9.999998E-03 9. OOOOOOE-01 
47 L(l,2) 1.315510E-01 9.999998E-04 9. OOOOOOE-01 
48 L(0,3) 9.801533E-04 9.999998E-07 1. OOOOOOE-02 
49 L(3,2) 1.893098E-02 9.999998E-06 5. OOOOOOE-02 
50 L(2,3) 9.395287E-03 9.999998E-06 5. OOOOOOE-02 
51 P(90) 16.45 
52 H STE 
53 M(l)=16.45/K(l) 
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54 U(2) 4.899166E+02 1000 
55 Y 
Explanation of line in problem deck. 
Line# 
1 Title. 
2 C indicates a comment line. 
6 Signifies a data stream to follow. 
7-9 Request steady state data on M(i), Mass of compartment i. 
10 Request the rate of de novo 3MH production be reported. 
11-15 Request the, R(j,i), mass transfer rate from compartment i to j be reported. 
16 Tell SAAM to express calculated data as ratio of tracer:tracee. 
17 Defines the data entered in compartment 1; 101G(1) = specifies the 
following data to be entered into compartment 1, 66318.9 = Dose of tracer 
in nmoles,FSD = Fractional standard deviation (variation associated with 
data). 
18-19 Data input, time is in min, data is entered as traceritracee and converted to 
fraction of dose by dividing by the dose. 
43 H PAR, Signifies the start of a parameter stream. 
44 Initial conditions in compartment 1 
45 Inverse space of distribution 
46-50 Fractional transfer coefficients (L,,,) for value of last iteration with minimum 
and maximum constraints 
51 Actual concentration of 3MH in plasma, nmol/ml 
52 H STE, Signifies that a steady state solution is requested 
53 Equation describing the mass of compartment 1 
54 Estimate of the production rate into compartment 2 
55 Stop command 
You are now ready to model your data using the PC-version of SAAM. The 486 
computers in Dr. Nissen's lab have Consam ready to run. They can be started by clicking on 
the Icon. From the SAAM prompt type in 'File Deck', followed by the location of your file 
D;\ailpubik\samin\*.dat. Next, type 'Deck', if there are no errors, proceed by typing 'Solve'. 
You may now want to evaluate the fit of your data by typing 'Plot g1 Q(1)'. It is now time to 
converge on your data by typing 'Iter' until your the model has converged on your observed 
data. Next evaluate the goodness of fit of your data. This can be done subjectively by 
observation of the plot or quantitatively by the variation of your parameters (FSDti)) and residual 
sum of squares. To assure a unique fit of your data, make changes in the model parameters 
and converge on the observed data again. Similar solutions should be obtained repeatedly. 
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APPENDIX B 
The Use of Compartmental Models of 3-Methylhlstldlne Flux to Evaluate Skeletal Muscle Protein 
Turnover In Implanted Steers 
J. A. Rathmacher, A. Trenkle and S. Nissen 
Anabolic hormone implants have been used to increase daily weight gain, improve feed 
efficiency, increase nitrogen retention, increase carcass weight and the protein of the carcass. 
The anabolic response of muscle is a result of alterations in muscle protein turnover: either by 
an increase synthesis or by a decrease proteolysis. These implants mode of action has been 
postulated to act directly on the muscle or indirectly through modulation of hormone secretion. 
Typically, Estrogenic implants, estradiol or estrogen like compound and androgenic implants, the 
synthetic androgen trenbolone acetate have been used alone and in combination in cattle. The 
growth response appears to be additive when combining trenbolone acetate and estrogenic 
implant. 
Estimation of muscle protein degradation directly is difficult. Whole body methodology 
which involves infusing a labeled AA, yielding indirect measurements of whole body synthesis 
and degradation. Methods are available where by muscle protein synthesis is directly measured 
and muscle protein degradation is calculated from the difference of accretion and synthesis. A 
more direct approach for measuring muscle protein degradation involves measuring urinary 3-
methylhistidine. It is now also possible to measure 3MH production kinetically, using a 3-
compartment model we have been able to measure 3MH production in cattle, humans, dogs, 
pigs and sheep. We feel that this approach offers certain advantages: 1) it does not necessitate 
quantitative urine collection, 2) it measures the total production rate, not dependent on the 
determination of free or conjugated forms, 3) it gives information about pool size and transfer 
rates, and 4) it does not require restraint of the animals for long periods. It is our hope minimize 
the number of samples taken evolve to a minimal model where we lump the three compartments 
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DE8IGNINQ A MINIMAL MODBL 
COMPLETE 
TMEfMNXIOOei 
MINIMAL 
TMEomxiaoci 
Figure 1. Complete model: Disappearance of tracer, 3-[^H3-methyl]-methylhistidine, as a ratio of 
3-['H3-methyl]-methylhistidine:3-methylhistidine in plasma as described by a 3-
compartment model of 3-methylhistidine. Symbols (•) represent observed data, and the 
line (-) represents best fit generated by the model. Minimal model: Disappearance of 
tracer, 3-(^H3-methyll-methylhistidine, as a ratio of 3-[^H3-methyll-methylhistidine;3-
methylhistidine in plasma as described by a 1-compartment model of 3-methylhistidine. 
together and take 4 to 5 samples instead of 14 to 15 as is required in the complete model. We 
feel that the minimal model is more practical. 
The hypothesis was put forth: Muscle protein degradation is partly responsible for the 
anabolic effect of hormone implants on growth. To investigate the role of muscle protein 
degradation in the anabolic response to hormone implanted cattle, compartmental kinetic models 
based on kinetic plasma decay of a tracer of 3-methylhistidine were used. Twenty steer were 
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Figure 2. Weight gain in implanted cattle 
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•complete 
Figure 3. Effect of hormone implantation on 3-methylhistidine production 
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assigned to treatments (n = 5) in a factorial design and implanted as follows: control (C), 
estradiol-17p (EST), trenbolone acetate (TBA), and EST + TBA. The steers were catheterized 
and given a bolus dose of tracer, [methyl-^HjI-S-methyihistidine ((/3-3MH), which was followed 
by serial blood samples for three days. The plasma enrichment of was analyzed by gas 
chromatography-mass spectrometry and the isotopic decay was modeled by the SAAM 
modeling program. Two models were used to estimate the de novo production rate of 3MI-I; a 
three compartment model (complete) and a one compartment model, based on the terminal 
slope of the decay curve (minimal) (Figure 1). 
For each model the de novo production rate of 3MIH ( mmol-d '. Figure 3) and the 
fractional breakdown rate of muscle protein (FBR,%-d'^ ,Figure 4) were calculated. Weight gains 
for these cattle while on feed for 158 days were 134 kg for controls, 174 kg for androgen 
implanted cattle, 180 kg for estrogenic and the combination implanted cattle gained 202 kg 
(Figure 4). These results are typical with an additive benefit of using the combination implant. 
/ P-VALUE 
EST OM 
ANDR 0^ 
ESPANDR 0.13 
@ minimal 
•complete 
0 CONmOL EtTROaiN ANDROGEN EtT+ANDR 
TREATMENTS 
Figure 4. Effect of hormone implantation on the fractional breakdown rate of muscle protein 
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In summary, the minimal model resulted in higher PR values compared to the 
complete model but the results were qualitative and highly correlated (r = .92, P < 0.0001). 
There were no significant EST and TBA main effects for 3MH production and FBR. IHowever, 
there was a trend for a EST'TBA interaction. There was a 20% decrease 3MH production in the 
TBA treatment group as compared to controls, whereas the combination of EST and TBA 
prevented this decrease. In conclusion, the minimal model will be useful in evaluating relative 
changes in muscle protein degradation and anabolic response of TBA alone may be a result of a 
decrease in muscle protein breakdown. 
166 
APPENDiX C 
Muscle Protein Turnover in Large and Small Frame Cattle 
John A. Rathmacher, Steve Nissen and Allen Trenkle 
(Research funded by the Wise Burroughs Endowment) 
The objective of this study was to evaluate and quantitate muscle protein synthesis 
and degradation in growing cattle from different genetic backgrounds. Specifically, muscle 
protein breakdown was measured by a compartmental model of 3-methylhistidine metabolism 
and muscle protein synthesis was evaluated by the phenylalanine flooding dose method. 
Sixteen steers differing in frame size (Large and Small) were obtained from the Rhodes 
and Chariton research farms. They were fed individually in the Calan gate area of the ISU Beef 
Nutrition Research Farm. Approximately four months after the feeding program was initiated 
the isotopic study was performed. The steers were given a bolus dose of N'-t^Hs-methyl]-
methylhistidine which was followed by serial blood samples for 3 days. On day 4 of the 
isotopic study a flooding dose of phenylalanine (natural Phe + 1-^^C-Phe) was given. Blood 
samples were taken at 10, 20 and 30 min after the flooding dose and at 30 min muscle biopsies 
were taken from the longissimus dorsi and semitendinosus muscles. Three months later the 
steers were slaughtered at a commercial slaughtering plant and carcass data was obtained. 
The mean weights and average daily gains are presented in table 1. The large frame 
animals were heavier and were growing at faster rate of gain (P < 0.07) than the small framed 
steers during the time period before the isotope study. However, the large framed steers did 
out gain them after the isotope study. 
The feed Intake and feed efficiency data is in table 5. The large framed steers seemed 
to be more efficient in converting feed into gain during the pre-isotope portion of the study, P 
< 0.14. 
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The carcass data is presented in table 2. The large framed steers had heavier carcasses (P < 
0.0001) and had larger ribeye areas but not significantly (P < 0.20). 
There were no differences seen in the fractional transfer rates in the 3-
methylhistidine model (table 3). However, when comparing the steady state mass transfer rates 
(table 4) the large frame steers produced more 3-methylhistidine per min than the smaller 
framed steers (P < 0.01116), but when expressed on a per kg of body weight basis there was 
no difference using one-way ANOVA. However, when using ADG during the pre-isotope 
portion of the study as the covariant, the large framed steers were producing more 3-
methylhistidine, which would correspond to a higher fractional breakdown rate of myofibrillar 
protein. We are planning on determining the fractional synthetic rate of muscle protein in this 
experiment and Figures 1 and 2 show our initial analyses of this procedure. Plasma 
phenylalanine concentration increased 12 fold and decreased linearly through 30 min. 
The finding of our research to this point indicate that the large framed steers have a 
higher fractional breakdown rate than the small framed steers and combined with the fact that 
they are growing faster leads me to speculate that they must also have a much higher fractional 
synthetic rate as compared to the small framed steers. 
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Table 1. Mean weight and average daily gains for large and small framed cattle. 
Large frame Small frame 
Means SD* C.V.'' Means SD C.V. 
Before isotope study 
Initial weight" 3/30/92 425 27.4 
Weight 5/25/92 509 27.3 
After isotope study 
Weight 6/8/92 521 25.1 
Final weight 9/7/92 605 30.4 
Before isotope study 
1.49 0.34 
6% 
5% 
5% 
5% 
356 
424 
434 
502 
ADC 
After isotope study 
ADG 0.86 
'Standard deviation. 
''Coefficient of Variation. 
<^eight on specifted date recorded in kg. 
'' Average daily gain from specified date to date in kg/d. 
36.6 
44.3 
46.7 
48.7 
0.28 32% 0.77 0.27 
10% 
10% 
1 1 %  
10% 
23% 1.21 0.26 21% 
36% 
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Table 2. Carcass data from steers of two frame sizes 
Large frame Small firame 
Means SD' C.V." Means SD C.V. 
HCWT-, kg 376.3 14.95 4% 316.3 28.26 9% 
REA'^ cm^ 88.5 10.93 12% 81.5 8.82 11% 
Fat depth, mm 8.1 2.10 26% 7.9 2.27 29% 
Yield grade 2.2 0.53 24% 2.3 0.59 26% 
Quality grade 10.4 0.74 7% 10.4 0.74 7% 
KPH', * 2.6 0.42 16% 2.4 0.53 23% 
'Standard deviation. 
HToefficient of Variation. 
"Hot carcass weight, 
'Ribeye area. 
"Kidney, heart and pelvic fat. 
Table 3. Fractional transfer rates from a three compartment model of 3-methylhistidine 
metabolism 
Large frame Small frame 
Means SD' C.V."- Means SD C.V. 
Volume of distribution, mL 43570 14368 33% 34030 11208 33% 
Fractional transfer rate, fraction/min 
L(2<-1)° 0.157 0.1548 98% 0.235 0.3789 162% 
L(l<-2) 0.051 0.0305 60% 0.058 0.0389 67% 
L(0<-1) 0.0065 0.00364 56% 0.0062 0.00437 70% 
L(3<-2) 0.0020 0.00072 37% 0.0026 0.00114 44% 
L(2^3) 0.0011 0.00046 41% 0.0014 0.00048 35% 
'Standard deviation. 
''Coefficient of Variation. 
'Fractional transfer rate from compartment one to two. 
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Table 4. 3-methylhistidine model steady state compartment size and mass transfer rates 
adjusted for the weight of the steers 
Large frame Small frame 
Means SD* C.V.'' Means SD C.V. 
Compartment size Otmol>kg'') 
Compartment 1 0.71 0.184 26% 0.74 0.224 30% 
Compartment 2 2.12 0.903 43% 1.90 0.405 21% 
ConqNurtment 3 7.91 2.949 37% 7.68 3.327 43% 
Mass transfer rates ( Oimol-kg''-niin'') 
De novo production 0.0041 0.00090 22% 0.0037 0.00023 6% 
R(2*-l)« 0.0911 0.04314 47% 0.1007 0.05957 59% 
R(l4-2) 0.0952 0.04345 46% 0.1044 0.05957 57% 
R(0<-1) 0.0041 0.00090 22% 0.0037 0.00023 6% 
R(3«-2) 0.0038 0.00106 28% 0.0046 0.00170 37% 
R(2*-3) 0.0079 0.00189 24% 0.0083 0.00170 21% 
•Standard deviation. 
''Coefficient of variation. 
"Mass transfer rate. 
Table 5. Dry matter intake and feed efficiency in steers of large and small frame size 
Large fi^me Small frame 
Means SD^ c!v> Means SD Cv! 
DMI°, kg/d 
Before isotope study 8.42 0.829 10% 8.04 0.670 8% 
After isotope study 8.58 0.667 8% 7.53 1.079 14% 
Feed:gain ratio 
Before isotope study 5.85 1.172 20% 6.87 0.617 9% 
After isotope study 11.00 3.881 35% 10.82 4.267 39% 
'Standard deviation. 
"X^oefficient of variation. 
°Diy matter intake. 
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Igure 2. Atoms percent excess following flooding dose. 
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APPENDIX D 
Ractopamine Differentially Affects Muscle Protein Turnover in Finisliing Pigs Fed High and Low 
Protein 
J. A. Rathmacher, S. Nissen, R. Paxton and D. B. Anderson 
Department of Animal Science 
and 
Lilly Research Laboratories 
The mechanism by which p-adrenergic agonist affect muscle protein metabolism is 
unclear. Some reports suggest an increase in protein synthesis while others suggest a decrease 
in protein breakdown. Dietary crude protein (CP) affects the response of ractopamine (RAC). 
Previously, RAC increased nitrogen retention, ADG and loin eye area (LEA) with 18% CP, but 
with 10% CP, nitrogen retained and ADG were not improved, however, LEA and urinary 
creatinine (UCN) were increased. Until recently it has been impossible to utilize 3-
methylhistidine (3MH) as an index of muscle protein breakdown. The production rate of 3-
methylhistidine can now be estimated by a three pool kinetic compartmental model. 
Twenty crossbred barrows (67.3 ± 1 kg) acclimated to metabolism crate were used to 
evaluate the effects of RAC (0 and 20 ppm, 16 d) on nitrogen metabolism and muscle protein 
turnover at low and high dietary protein levels (10% and 18% CP). Ten pigs were allotted to 
dietary CP treatment based on urinary urea nitrogen (UUN) excretion during a 5-d period while 
on 16% CP diet. The pigs were then blocked with protein based on UUN excretion during CP 
treatment and allotted to RAC. On day 12 of RAC treatment, a bolus of [methyl-^Hgl-SMH was 
given to determine the 3MH production rate and the corresponding fractional breakdown rate 
(FBR) of muscle protein. Following the bolus injection, 25 serial blood samples were taken from 
0 to 5760 min and the plasma kinetic data were analyzed using the SAAM program. These data 
were fitted to a 3-compartment model of 3MH metabolism. 
Urinary creatinine (UCN), blood urea nitrogen (BUN) and plasma 3MH (PL3MH) were also 
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determined. In general, increased protein intake was associated with a decrease in muscle 
proteolysis and increase in NRET and UCN excretion. As In previous studies RAC added to 18% 
CP diets improved all indicators of nitrogen metabolism and RAC decreased 3MH production by 
10%. However, in pigs fed limited amounts of protein RAC did not positively affect nitrogen 
retention and in turn 3MH PRKG was decreased by 20%. In conclusion, changes in 3MH 
production may be explain the differences seen In RAC response with low and high protein, 
which could result from a differential alteration in protein turnover. 
Table 1. The effect of ractopamine and dietary protein on nitrogen metabolism 
.TLMimant t4ain.£fissis 
Crude protein (%) 10 10 18 18 CP RAC CP'RA 
Ractopamine (ppm) 0 20 0 20 P< P< P< 
N 5 5 5 5 
Nitrogen retained, g/d 12.7 11.1 22.5 28.8 .0001 .0004 .0001 
ADG, kg/d .58 .60 .73 .90 .0001 .0215 .0480 
Urinary urea nitrogen, g/d 10.4 10.7 23.2 17.8 .0001 .0001 .0001 
Urinary creatinine, g/d 2.49 2.74 2.69 3.15 .0026 .0068 .2496 
Blood urea nitrogen, mg/dL 10.9 10.8 17.5 12.4 .0028 .0315 .0373 
Plasma 3-methylhistidine, pM 15.08 11.81 9.14 5.68 .0407 .0012 .8850 
3-MH production, //mol/d/kg 7.04 8.69 6.82 6.17 .0747 .2870 .0322 
Fractional breakdown rate, %/d 2.80 3.52 2.23 2.04 .0206 .4138 .1511 
APPENDIX E 
Correlation Matrix of Model Parameters and Body Composition in Pigs 
Table 1. Pearson correlation coefficients / probability > iRl under IHo: Rho = 0 (N = 20) 
Parameter Predicted' 
lean, kg 
Carcass 
CP^,kg 
Carcass composition 
Carcass Fat free 
EE°, kg mass', kg 
Loineye 
area', kg 
Nitrogen 
Retained^, g/d 
Plasma 3MH*, iM -0.52 •0.42 0.23 -0.52 -0.55 -0.64 
0.02 0.06 0.32 0.02 0.01 0.002 
Compartment mass**, 
mnoles 
M(l) -0.37 -0.25 0.23 -0.24 -0.31 -0.34 
0.11 0.28 0.32 0.30 0.19 0.13 
M(2) -0.10 0.05 -0.33 -0.02 -0.07 -0.05 
0.67 0.81 0.15 0,94 0.75 0.84 
M(3) 0.46 0.47 -0.43 0.59 0.45 0.61 
0.04 0.04 0.06 0,006 0.05 0.004 
Mass transfer rate', 
nmoles/min 
R(2,l) -0.53 -0.55 0.45 -0,48 -0.42 -0.51 
0.02 0.01 0.05 0.03 0.07 0.02 
R(1.2) -0.53 -0.55 0.45 -0.47 -0.42 -0.51 
0.02 0.01 0.05 0.03 0.07 0.02 
R(3,2) -0.64 -0.74 0,51 -0.64 -0.51 -0.65 
0.003 0.0002 0.02 0.002 0.02 0.002 
R(2,3) -0.64 -0.74 0.51 -0.64 -0.51 -0.65 
0.002 0.0002 0.02 0.002 0.02 0.002 
3MH production, /tmol/d -0.31 -0.44 0.21 -0.30 -0.20 -0.29 
0.19 0.05 0.34 0.19 0.38 0.22 
Fractional transfer rate*. 
/min 
L(2,l) -0.38 -0.44 0.29 -0.43 -0.32 -0.36 
0.10 0.05 0.25 0.06 0.17 0.11 
m.2) -0.46 -0.52 0.47 -0.44 -0.34 -0.46 
0.04 0.02 0.04 0.05 0.13 0.04 
L(3,2) -0.52 -0.66 0.51 -0.55 -0.42 -0.56 
0.02 0.001 0.02 0.01 0.07 0.009 
L(2,3) -0.63 -0.75 0.48 -0.68 -0.56 -0.67 
0.003 0.0001 0.03 0.001 0.01 0.001 
L(0,3) -0.46 -0.54 0.39 -0.57 -0.44 -0.56 
0.04 0.01 0.09 0.008 0.05 0.01 
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Table 1 (cont.) 
Urinary creatinines g/d 0.73 0.49 -0.33 0.69 0.62 0.66 
0.0002 0.03 0.16 0.0008 0.03 0.002 
3MH;creatinine, -0.66 -0.63 0.35 -0.63 -0.53 -0.57 
/imol/tng 0.001 0.003 0.13 0.003 0.02 0.008 
FBR', %/d •0.S8 -0.84 0.40 -0.63 -0.53 -0.54 
0.008 0.0001 0.08 0.003 0.02 0.01 
'Lean tissue (kg) was predicted using a previously reported equation (Mowrey et al., 1991). 
'<^tude protein (kg) of the soft tissue in the carcass (muscle and fat). 
'Ether extract (kg) of the soft tissue in the carcxass (muscle + fat). 
''Crude protein and water minus ether extract (kg) of the soft tissue in the carcass (muscle and fat). 
'Cross-sectional area (cm^ of the longisimus dorsi muscle between the 10th and 11th rib. 
'Nitrogen balance (g/d) determined during the time period of the kinetic study. 
*Plasma concentation of 3-methylhistidne was an average calculated from blood samples taken from 0 
to 5760 min after the bolus of tracer was given. 
''M(i) = the mass of compartment i in nmoles. 
'R(j,i) = the mass transfer rate of 3-methylhistidne from compartment i to j. 
'L(j,i) =the fractional transfer rate of 3-methylhistidne tracer from compartment i to j. 
'Urinary creatinine (mg/d) determined during the time period of the kinetic study. 
'FBR= the fractional breakdown rate of muscle protein. 
